RxNorm Semantic Concepts Index - 136
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "136".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 136 | Abrin | Designated preferred name (PT) | NO | |
| RxCUI: 136 | Abrin | Full form of descriptor (FN) | NO | |
| RxCUI: 1360000 | atropine sulfate 2.86 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360001 | meperidine hydrochloride 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360002 | hydromorphone hydrochloride 1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360002 | hydromorphone hydrochloride 1 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360004 | atropine sulfate 0.833 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360005 | alprostadil 0.04 MG/ML Prefilled Syringe [Caverject] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360006 | vitamin B12 1 MG/ML Prefilled Syringe [Rubramin PC] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360007 | tinzaparin sodium 10000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360008 | peginterferon alfa-2a 0.27 MG/ML Prefilled Syringe [Pegasys] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360009 | midazolam 1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360011 | phenylephrine hydrochloride 0.1 MG/mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360011 | phenylephrine hydrochloride 0.1 MG/mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360013 | paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360014 | EPO 20000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360014 | EPO 20000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360014 | EPO 20000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360015 | beclomethasone dipropionate 0.042 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360016 | albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [Ventolin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360016 | albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [Ventolin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360019 | ENX sodium 100 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360019 | ENX sodium 100 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360021 | selegiline 0.375 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360022 | cloNIDine 0.00417 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360022 | cloNIDine 0.00417 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360023 | estradiol 0.00208 MG/HR / norethindrone acetate 0.00583 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360024 | beclomethasone dipropionate 0.084 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360025 | ipratropium bromide 0.018 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360029 | tinzaparin sodium 20000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360030 | sodium hyaluronate 1 % prefilled syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360030 | sodium hyaluronate 1 % prefilled syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360032 | midazolam 0.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360033 | interferon alfa-2a 12000000 UNT/ML Prefilled Syringe [Roferon-A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360035 | hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe [Recombivax] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360036 | insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector [Humalog Mix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360036 | insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector [Humalog Mix] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360037 | interferon alfa-2b 3000000 UNT/ACTUAT Prefilled Syringe [Intron A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360038 | diphenhydramine hydrochloride 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360038 | diphenhydramine hydrochloride 50 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360039 | atropine sulfate 0.714 MG/ML Auto-Injector [Atropen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360039 | atropine sulfate 0.714 MG/ML Auto-Injector [Atropen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360041 | testosterone 0.208 MG/HR Transdermal System [Androderm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360041 | testosterone 0.208 MG/HR Transdermal System [Androderm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360043 | testosterone 0.25 MG/HR Transdermal System [Testoderm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360043 | testosterone 0.25 MG/HR Transdermal System [Testoderm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360044 | cloNIDine 0.0125 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360044 | cloNIDine 0.0125 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360046 | fluticasone propionate 0.25 MG/ACTUAT Dry Powder Inhaler [Flovent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360047 | fluticasone propionate 250 MCG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360047 | fluticasone propionate 250 MCG/ACTUAT Dry Powder Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360047 | fluticasone propionate 250 MCG/ACTUAT Dry Powder Inhaler | Designated preferred name (PT) | NO | |
| RxCUI: 1360047 | fluticasone propionate 250 MCG/ACTUAT Dry Powder Inhaler | Full form of descriptor (FN) | NO | |
| RxCUI: 1360048 | MS 2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360048 | MS 2 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360050 | leuprolide acetate 60 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360051 | fulvestrant 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360052 | sodium hyaluronate 20 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360053 | peginterferon alfa-2b 0.24 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360054 | etomidate 2 MG/ML Prefilled Syringe [Amidate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360055 | lanreotide 240 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360056 | penicillin G procaine 600000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360057 | hepatitis B surface antigen vaccine 0.005 MG/ML Prefilled Syringe [Recombivax] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360058 | insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360059 | lidocaine hydrochloride 20 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360061 | hylan G-F 20 4.8 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360062 | nitroglycerin 0.3 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360062 | nitroglycerin 0.3 MG/HR Transdermal System [Nitro-Dur] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360062 | nitroglycerin 0.3 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360062 | nitroglycerin 0.3 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360063 | formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360064 | fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler [Advair] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360064 | fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler [Advair] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360064 | fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler [Advair] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360067 | fulvestrant 50 MG/ML Prefilled Syringe [Faslodex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360068 | hypromellose 18 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360069 | estradiol 0.00312 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360071 | fentanyl 0.025 MG/HR Transdermal System [Duragesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360071 | fentanyl 0.025 MG/HR Transdermal System [Duragesic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360071 | fentanyl 0.025 MG/HR Transdermal System [Duragesic] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360072 | nicotine 0.625 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360073 | fluticasone propionate 220 MCG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360073 | fluticasone propionate 220 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360074 | beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360074 | beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360075 | EPINEPHrine 0.22 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360075 | EPINEPHrine 0.22 MG/ACTUAT Metered Dose Inhaler | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360078 | somatropin 2.4 MG/ML Prefilled Syringe [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360078 | somatropin 2.4 MG/ML Prefilled Syringe [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360079 | tetanus immune globulin, human 250 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360081 | certolizumab pegol 200 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360082 | calcium chloride 0.68 MEQ/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360084 | somatropin 12 MG/ML Cartridge [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360084 | somatropin 12 MG/ML Cartridge [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360085 | peginesatide 2 MG/ML Prefilled Syringe [Omontys] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360088 | hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360093 | codeine phosphate 60 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360094 | hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe [Vaqta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360094 | hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe [Vaqta] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360095 | interferon alfa-2a 6000000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360096 | pramlintide acetate 1 MG/ML Pen Injector [Symlin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360096 | pramlintide acetate 1 MG/ML Pen Injector [Symlin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360097 | adalimumab 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360098 | hepatitis B surface antigen vaccine 0.0025 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360100 | estradiol 0.00313 MG/HR Transdermal System [Vivelle] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360100 | estradiol 0.00313 MG/HR Transdermal System [Vivelle] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360101 | Granisetron 129.167 microgram/hour prolonged-release transdermal patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360101 | Granisetron 129.167 microgram/hour prolonged-release transdermal patch | Designated preferred name (PT) | NO | |
| RxCUI: 1360101 | Granisetron 129.167 microgram/hour prolonged-release transdermal patch | Full form of descriptor (FN) | NO | |
| RxCUI: 1360104 | LORazepam 2 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360104 | LORazepam 2 MG/ML Cartridge | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360105 | liraglutide 6 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360106 | MS 15 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360106 | MS 15 MG/ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360107 | rivastigmine 0.192 MG/HR Transdermal System [Exelon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360107 | rivastigmine 0.192 MG/HR Transdermal System [Exelon] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360108 | nitroglycerin 0.2 MG/HR Transdermal System [Nitrodisc] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360108 | nitroglycerin 0.2 MG/HR Transdermal System [Nitrodisc] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360108 | nitroglycerin 0.2 MG/HR Transdermal System [Nitrodisc] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360108 | nitroglycerin 0.2 MG/HR Transdermal System [Nitrodisc] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360111 | rotigotine 0.333 MG/HR Transdermal System [Neupro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360111 | rotigotine 0.333 MG/HR Transdermal System [Neupro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360113 | methylphenidate 1.11 MG/HR Transdermal System [Daytrana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360113 | methylphenidate 1.11 MG/HR Transdermal System [Daytrana] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360114 | methylphenidate 3.33 MG/HR Transdermal System [Daytrana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360114 | methylphenidate 3.33 MG/HR Transdermal System [Daytrana] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360115 | nitroglycerin 0.6 MG/HR Transdermal System [Minitran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360115 | nitroglycerin 0.6 MG/HR Transdermal System [Minitran] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360115 | nitroglycerin 0.6 MG/HR Transdermal System [Minitran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360115 | nitroglycerin 0.6 MG/HR Transdermal System [Minitran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360119 | buprenorphine 0.0525 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360120 | cloNIDine 0.00833 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360120 | cloNIDine 0.00833 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360122 | rivastigmine 0.554 MG/HR Transdermal System [Exelon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360122 | rivastigmine 0.554 MG/HR Transdermal System [Exelon] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360126 | ePHEDrine hydrochloride 3 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360126 | ePHEDrine hydrochloride 3 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360127 | epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360127 | epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360133 | baclofen 0.05 MG/ML Prefilled Syringe [Gablofen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360134 | atropine sulfate 2.86 MG/ML Auto-Injector [Atropen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360134 | atropine sulfate 2.86 MG/ML Auto-Injector [Atropen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360135 | naloxone hydrochloride 0.4 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360136 | fibrinogen, human 106 MG/ML / thrombin, human 6.5 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360140 | thiopental 25 MG/ML Prefilled Syringe [Pentothal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360141 | somatropin 3.2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360142 | hepatitis B immune globulin 217 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360143 | ibandronic acid 1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360144 | triamcinolone acetonide 40 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360145 | hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360146 | hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360147 | iopamidol 610 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360149 | diazepam 5 MG/ML Rectal Gel | Designated preferred name (PT) | NO | |
| RxCUI: 1360149 | diazepam 5 MG/ML Rectal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360149 | diazepam 5 MG/ML Rectal Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360149 | diazepam 5 MG/ML Rectal Gel | Full form of descriptor (FN) | NO | |
| RxCUI: 1360151 | peginesatide 10 MG/ML Prefilled Syringe [Omontys] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360152 | peginesatide 2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360154 | estradiol 0.00417 MG/HR Transdermal System [Alora] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360154 | estradiol 0.00417 MG/HR Transdermal System [Alora] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360155 | nitroglycerin 0.8 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360155 | nitroglycerin 0.8 MG/HR Transdermal System [Nitro-Dur] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360155 | nitroglycerin 0.8 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360155 | nitroglycerin 0.8 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360156 | nicotine 0.875 MG/HR Transdermal System [Habitrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360156 | nicotine 0.875 MG/HR Transdermal System [Habitrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360157 | insulin human, rDNA origin 3 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360159 | cromolyn sodium 0.8 MG/ACTUAT Metered Dose Inhaler [Intal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360162 | EPO 10000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360162 | EPO 10000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360162 | EPO 10000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360163 | pegfilgrastim 10 MG/ML Prefilled Syringe [Neulasta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360164 | thiopental 25 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360167 | leuprolide acetate 11.25 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360168 | leuprolide acetate 11.25 MG/ML Prefilled Syringe [Lupron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360169 | sodium hyaluronate 30 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360170 | penicillin G benzathine 450000 UNT/ML / penicillin G procaine 150000 UNT/ML Prefilled Syringe [Bicillin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360171 | acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360172 | insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360174 | estradiol 0.1 MG/Day Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360174 | estradiol 0.1 MG/Day Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360174 | estradiol 0.1 MG/Day Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360174 | estradiol 0.1 MG/Day Transdermal System | Designated preferred name (PT) | NO | |
| RxCUI: 1360174 | estradiol 0.1 MG/Day Transdermal System | Full form of descriptor (FN) | NO | |
| RxCUI: 1360175 | nitroglycerin 0.2 MG/HR Transdermal System [Deponit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360175 | nitroglycerin 0.2 MG/HR Transdermal System [Deponit] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360175 | nitroglycerin 0.2 MG/HR Transdermal System [Deponit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360175 | nitroglycerin 0.2 MG/HR Transdermal System [Deponit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360178 | budesonide 0.09 MG/ACTUAT Dry Powder Inhaler [Pulmicort] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360178 | budesonide 0.09 MG/ACTUAT Dry Powder Inhaler [Pulmicort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360179 | leuprolide acetate 3.75 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360180 | MS 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360180 | MS 10 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360181 | methohexital sodium 10 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360181 | methohexital sodium 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360182 | fondaparinux sodium 5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360183 | ketorolac tromethamine 30 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360184 | pramlintide acetate 1 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360185 | leuprolide acetate 15 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360186 | alprostadil 0.04 MG/ML Cartridge [Edex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360186 | alprostadil 0.04 MG/ML Cartridge [Edex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360187 | bupivacaine hydrochloride 2.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360187 | bupivacaine hydrochloride 2.5 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360188 | meperidine hydrochloride 100 MG/ML Cartridge [Demerol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360188 | meperidine hydrochloride 100 MG/ML Cartridge [Demerol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360189 | somatropin 7.2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360190 | somatropin 2.5 MG/ML Pen Injector [Nutropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360190 | somatropin 2.5 MG/ML Pen Injector [Nutropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360192 | estradiol 0.00208 MG/HR Transdermal System [Esclim] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360192 | estradiol 0.00208 MG/HR Transdermal System [Esclim] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360193 | estradiol 0.00188 MG/HR / levonorgestrel 0.000625 MG/HR Transdermal System [Climara Pro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360194 | fentaNYL 0.075 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360194 | fentaNYL 0.075 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360194 | fentaNYL 0.075 MG/HR Transdermal System | Designated preferred name (PT) | NO | |
| RxCUI: 1360194 | fentaNYL 0.075 MG/HR Transdermal System | Full form of descriptor (FN) | NO | |
| RxCUI: 1360195 | estradiol 0.0025 MG/HR Transdermal System [Climara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360195 | estradiol 0.0025 MG/HR Transdermal System [Climara] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360196 | estradiol 0.00208 MG/HR Transdermal System [Alora] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360196 | estradiol 0.00208 MG/HR Transdermal System [Alora] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360197 | rotigotine 0.25 MG/HR Transdermal System [Neupro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360197 | rotigotine 0.25 MG/HR Transdermal System [Neupro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360199 | nicotine 0.917 MG/HR Transdermal System [ProStep] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360199 | nicotine 0.917 MG/HR Transdermal System [ProStep] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360200 | fluticasone propionate 50 MCG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360200 | fluticasone propionate 50 MCG/ACTUAT Dry Powder Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360200 | fluticasone propionate 50 MCG/ACTUAT Dry Powder Inhaler | Designated preferred name (PT) | NO | |
| RxCUI: 1360200 | fluticasone propionate 50 MCG/ACTUAT Dry Powder Inhaler | Full form of descriptor (FN) | NO | |
| RxCUI: 1360201 | albuterol 90 MCG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360201 | albuterol 90 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360202 | pirbuterol acetate 200 MCG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360202 | pirbuterol acetate 200 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360206 | leuprolide acetate 120 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360207 | epinephrine 1 MG/ML Auto-Injector [Adrenaclick] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360207 | epinephrine 1 MG/ML Auto-Injector [Adrenaclick] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360207 | epinephrine 1 MG/ML Auto-Injector [Adrenaclick] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360208 | cephapirin 30 MG/ML Prefilled Syringe [Tomorrow] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360209 | somatropin 5.6 MG/ML Prefilled Syringe [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360209 | somatropin 5.6 MG/ML Prefilled Syringe [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360212 | sodium bicarbonate 4.2 % Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360212 | sodium bicarbonate 4.2 % Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360212 | sodium bicarbonate 4.2 % Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360213 | isoproterenol hydrochloride 0.02 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360215 | rotigotine 0.0417 MG/HR Transdermal System [Neupro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360215 | rotigotine 0.0417 MG/HR Transdermal System [Neupro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360216 | fluticasone propionate 0.1 MG/ACTUAT Dry Powder Inhaler [Flovent] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360216 | fluticasone propionate 0.1 MG/ACTUAT Dry Powder Inhaler [Flovent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360217 | budesonide 0.09 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360219 | chondroitin sulfates 40 MG/ML / sodium hyaluronate 17 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360220 | enoxaparin sodium 150 MG/ML Prefilled Syringe [Lovenox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360220 | enoxaparin sodium 150 MG/ML Prefilled Syringe [Lovenox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360221 | somatropin 10 MG/ML Pen Injector [Norditropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360221 | somatropin 10 MG/ML Pen Injector [Norditropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360223 | sodium hyaluronate 14 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360224 | peginterferon alfa-2b 0.1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360226 | insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Prefilled Syringe [Novolin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360226 | insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Prefilled Syringe [Novolin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360229 | somatropin 12 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360231 | ondansetron 2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360232 | rotigotine 0.25 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360233 | testosterone 0.0833 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360234 | nicotine 0.292 MG/HR Transdermal System [Habitrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360234 | nicotine 0.292 MG/HR Transdermal System [Habitrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360235 | formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.1 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360244 | leuprolide acetate 7.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360245 | meperidine hydrochloride 25 MG/ML Cartridge [Demerol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360245 | meperidine hydrochloride 25 MG/ML Cartridge [Demerol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360247 | Estradiol 3.333 microgram/hour prolonged-release transdermal patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360247 | Estradiol 3.333 microgram/hour prolonged-release transdermal patch | Designated preferred name (PT) | NO | |
| RxCUI: 1360247 | Estradiol 3.333 microgram/hour prolonged-release transdermal patch | Full form of descriptor (FN) | NO | |
| RxCUI: 1360249 | nicotine 0.583 MG/HR Transdermal System [Nicoderm C-Q] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360249 | nicotine 0.583 MG/HR Transdermal System [Nicoderm C-Q] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360251 | estradiol 0.000313 MG/HR Vaginal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360252 | triamcinolone acetonide 0.075 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360253 | ciclesonide 0.16 MG/ACTUAT Metered Dose Inhaler [Alvesco] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360257 | thiopental 20 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360259 | lidocaine hydrochloride 100 MG/ML Prefilled Syringe [LidoPen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360261 | nitroglycerin 0.1 MG/HR Transdermal System [Minitran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360261 | nitroglycerin 0.1 MG/HR Transdermal System [Minitran] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360261 | nitroglycerin 0.1 MG/HR Transdermal System [Minitran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360261 | nitroglycerin 0.1 MG/HR Transdermal System [Minitran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360262 | nicotine 0.292 MG/HR Transdermal System [Nicoderm C-Q] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360262 | nicotine 0.292 MG/HR Transdermal System [Nicoderm C-Q] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360264 | estradiol 0.00104 MG/HR Transdermal System [Esclim] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360264 | estradiol 0.00104 MG/HR Transdermal System [Esclim] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360266 | estradiol 0.00208 MG/HR / norethindrone acetate 0.0104 MG/HR Transdermal System [Combipatch] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360267 | rivastigmine 0.554 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360269 | ciclesonide 0.08 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360270 | Rho(D) immune globulin 1250 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360272 | somatropin 4.8 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360273 | bretylium 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360274 | interferon alfa-2a 0.0666 MG/ML Prefilled Syringe [Roferon-A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360275 | interferon beta-1a 0.088 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360276 | choriogonadotropin alfa 0.5 MG/ML Prefilled Syringe [Ovidrel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360276 | choriogonadotropin alfa 0.5 MG/ML Prefilled Syringe [Ovidrel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360277 | LORazepam 4 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360277 | LORazepam 4 MG/ML Cartridge | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360278 | somatropin 3.33 MG/ML Pen Injector [Norditropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360278 | somatropin 3.33 MG/ML Pen Injector [Norditropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360281 | insulin detemir 100 UNT/ML Pen Injector [Levemir] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360281 | insulin detemir 100 UNT/ML Pen Injector [Levemir] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360283 | hydromorphone hydrochloride 0.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360283 | hydromorphone hydrochloride 0.5 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360285 | iopamidol 760 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360286 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360289 | methoxy polyethylene glycol-epoetin beta 0.25 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360290 | hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360291 | pegfilgrastim 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360292 | albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [Proventil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360293 | fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360293 | fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360294 | beclomethasone dipropionate 0.04 MG/ACTUAT Metered Dose Inhaler [Qvar] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360294 | beclomethasone dipropionate 0.04 MG/ACTUAT Metered Dose Inhaler [Qvar] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360296 | sodium hyaluronate 23 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360297 | interferon alfa-2b 10000000 UNT/ACTUAT Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360298 | peginesatide 4 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360299 | methylphenidate 1.67 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360300 | methylphenidate 3.33 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360304 | budesonide 80 MCG/ACTUAT / formoterol fumarate 4.5 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360304 | budesonide 80 MCG/ACTUAT / formoterol fumarate 4.5 MG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360307 | vitamin K1 2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360308 | tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360309 | penicillin G benzathine 900000 UNT/ML / penicillin G procaine 300000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360311 | somatropin 6.4 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360312 | acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360313 | Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe [Ixiaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360314 | phenylephrine hydrochloride 0.4 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360316 | nicotine 0.875 MG/HR Transdermal System [Nicoderm C-Q] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360316 | nicotine 0.875 MG/HR Transdermal System [Nicoderm C-Q] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360317 | rotigotine 0.0833 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360320 | selegiline 0.375 MG/HR Transdermal System [Emsam] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360320 | selegiline 0.375 MG/HR Transdermal System [Emsam] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360321 | granisetron 0.129 MG/HR Transdermal System [Sancuso] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360321 | granisetron 0.129 MG/HR Transdermal System [Sancuso] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360322 | estradiol 0.000313 MG/HR Vaginal System [Estring] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360322 | estradiol 0.000313 MG/HR Vaginal System [Estring] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360323 | interferon alfa-2b 25000000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360325 | triamcinolone acetonide 80 MG/ML Prefilled Syringe [Trivaris] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360326 | sodium hyaluronate 12 MG/ML Prefilled Syringe [Amvisc] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360327 | lanreotide 300 MG/ML Prefilled Syringe [Somatuline] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360328 | somatropin 3.2 MG/ML Prefilled Syringe [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360328 | somatropin 3.2 MG/ML Prefilled Syringe [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360329 | NaHCO3 0.893 MEQ/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360329 | NaHCO3 0.893 MEQ/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360330 | phenylephrine hydrochloride 0.04 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360332 | fentanyl 0.012 MG/HR Transdermal System [Duragesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360332 | fentanyl 0.012 MG/HR Transdermal System [Duragesic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360332 | fentanyl 0.012 MG/HR Transdermal System [Duragesic] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360333 | fluticasone propionate 110 MCG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360333 | fluticasone propionate 110 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360334 | metaproterenol sulfate 0.65 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360336 | interferon alfa-2a 9000000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360337 | EPINEPHrine 0.5 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360337 | EPINEPHrine 0.5 MG/ML Auto-Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360339 | nitroglycerin 0.4 MG/HR Transdermal System [Deponit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360339 | nitroglycerin 0.4 MG/HR Transdermal System [Deponit] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360339 | nitroglycerin 0.4 MG/HR Transdermal System [Deponit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360339 | nitroglycerin 0.4 MG/HR Transdermal System [Deponit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 136034 | ferrous lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1360340 | testosterone 0.0833 MG/HR Transdermal System [Androderm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360340 | testosterone 0.0833 MG/HR Transdermal System [Androderm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360341 | fentaNYL 0.05 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360341 | fentaNYL 0.05 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360341 | fentaNYL 0.05 MG/HR Transdermal System | Designated preferred name (PT) | NO | |
| RxCUI: 1360341 | fentaNYL 0.05 MG/HR Transdermal System | Full form of descriptor (FN) | NO | |
| RxCUI: 1360342 | estradiol 0.00104 MG/HR Transdermal System [Climara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360342 | estradiol 0.00104 MG/HR Transdermal System [Climara] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360343 | nicotine 0.625 MG/HR Transdermal System [Nicotrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360343 | nicotine 0.625 MG/HR Transdermal System [Nicotrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360344 | estradiol 0.00208 MG/HR Vaginal System [Femring] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360344 | estradiol 0.00208 MG/HR Vaginal System [Femring] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360345 | epinephrine 0.22 MG/ACTUAT Metered Dose Inhaler [Primatene Mist Inhaler] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360345 | epinephrine 0.22 MG/ACTUAT Metered Dose Inhaler [Primatene Mist Inhaler] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360345 | epinephrine 0.22 MG/ACTUAT Metered Dose Inhaler [Primatene Mist Inhaler] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360345 | epinephrine 0.22 MG/ACTUAT Metered Dose Inhaler [Primatene Mist Inhaler] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360345 | epinephrine 0.22 MG/ACTUAT Metered Dose Inhaler [Primatene Mist Inhaler] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360348 | somatropin 8 MG/ML Prefilled Syringe [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360348 | somatropin 8 MG/ML Prefilled Syringe [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360350 | interferon alfa-2a 0.0666 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360351 | chondroitin sulfates 40 MG/ML / sodium hyaluronate 17 MG/ML Prefilled Syringe [DisCoVisc] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360352 | apomorphine 5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360353 | magnesium sulfate 4 MEQ/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360354 | L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled Syringe [Gardasil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360356 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Adacel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360357 | nitroglycerin 0.4 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360357 | nitroglycerin 0.4 MG/HR Transdermal System [Nitro-Dur] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360357 | nitroglycerin 0.4 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360357 | nitroglycerin 0.4 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360359 | zanamivir 5 MG/ACTUAT Dry Powder Inhaler [Relenza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360362 | darbepoetin alfa 0.06 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360363 | darbepoetin alfa 0.06 MG/ML Prefilled Syringe [Aranesp] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360364 | meperidine hydrochloride 75 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360366 | hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360367 | verapamil hydrochloride 2.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360368 | glatiramer acetate 20 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360369 | interferon beta-1a 0.06 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360370 | interferon alfa-2b 3000000 UNT/ACTUAT Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360371 | denosumab 60 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360372 | atropine sulfate 0.833 MG/ML Auto-Injector [Atropen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360372 | atropine sulfate 0.833 MG/ML Auto-Injector [Atropen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360373 | sodium hyaluronate 15 MG/ML Prefilled Syringe [Orthovisc] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360375 | estradiol 0.00156 MG/HR Transdermal System [Esclim] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360375 | estradiol 0.00156 MG/HR Transdermal System [Esclim] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360376 | rotigotine 0.167 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360377 | somatropin 2.4 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360378 | somatropin 0.8 MG/ML Prefilled Syringe [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360378 | somatropin 0.8 MG/ML Prefilled Syringe [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360379 | interferon alfa-2a 0.0222 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360380 | somatropin 5.6 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360381 | SUMAtriptan 12 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360381 | SUMAtriptan 12 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360382 | interferon alfa-2a 18000000 UNT/ML Prefilled Syringe [Roferon-A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360383 | insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360383 | insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360384 | denosumab 60 MG/ML Prefilled Syringe [Prolia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360385 | human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360386 | nitroglycerin 0.6 MG/HR Transdermal System [Nitrek] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360386 | nitroglycerin 0.6 MG/HR Transdermal System [Nitrek] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360386 | nitroglycerin 0.6 MG/HR Transdermal System [Nitrek] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360386 | nitroglycerin 0.6 MG/HR Transdermal System [Nitrek] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360388 | TNG 0.4 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360388 | TNG 0.4 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360388 | TNG 0.4 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360389 | TNG 0.1 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360389 | TNG 0.1 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360389 | TNG 0.1 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360390 | estradiol 0.00104 MG/HR Transdermal System [Alora] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360390 | estradiol 0.00104 MG/HR Transdermal System [Alora] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360391 | TNG 0.2 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360391 | TNG 0.2 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360391 | TNG 0.2 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360392 | flunisolide 0.25 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360393 | albuterol 0.1 MG/ACTUAT / ipratropium bromide 0.02 MG/ACTUAT Inhalation Spray [Combivent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360394 | isoproterenol hydrochloride 0.131 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360398 | sodium hyaluronate 12 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360399 | interferon alfa-2a 6000000 UNT/ML Prefilled Syringe [Roferon-A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360400 | meperidine hydrochloride 100 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360401 | L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360402 | budesonide 180 MCG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360402 | budesonide 180 MCG/ACTUAT Dry Powder Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360403 | beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler [Qvar] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360404 | levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360410 | methoxy polyethylene glycol-epoetin beta 0.667 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360413 | alprostadil 0.005 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360414 | peginterferon alfa-2b 0.3 MG/ML Prefilled Syringe [Pegintron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360416 | codeine phosphate 30 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360420 | NaHCO3 1 MEQ/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360420 | NaHCO3 1 MEQ/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360421 | ardeparin sodium 20000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360422 | testosterone 0.25 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360423 | rivastigmine 0.396 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360427 | epinephrine 0.5 MG/ML Auto-Injector [Epipen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360427 | epinephrine 0.5 MG/ML Auto-Injector [Epipen] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360427 | epinephrine 0.5 MG/ML Auto-Injector [Epipen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360428 | EPO 2000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360428 | EPO 2000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360428 | EPO 2000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360429 | darbepoetin alfa 0.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360430 | etanercept 50 MG/ML Prefilled Syringe [Enbrel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360431 | poliovirus vaccine inactivated Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360431 | poliovirus vaccine inactivated Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360433 | diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Decavac] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360434 | interferon beta-1a 0.06 MG/ML Prefilled Syringe [Avonex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360435 | insulin, regular, human 100 UNT/ML Prefilled Syringe [Novolin R] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360435 | insulin, regular, human 100 UNT/ML Prefilled Syringe [Novolin R] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360436 | golimumab 100 MG/ML Prefilled Syringe [Simponi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360437 | interferon alfa-2b 5000000 UNT/ACTUAT Prefilled Syringe [Intron A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360438 | chondroitin sulfates 4 % / sodium hyaluronate 3 % Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360438 | chondroitin sulfates 4 % / sodium hyaluronate 3 % Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360439 | peginesatide 6 MG/ML Prefilled Syringe [Omontys] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360440 | buprenorphine 0.01 MG/HR Transdermal System [BuTrans] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360440 | buprenorphine 0.01 MG/HR Transdermal System [BuTrans] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360441 | selegiline 0.25 MG/HR Transdermal System [Emsam] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360441 | selegiline 0.25 MG/HR Transdermal System [Emsam] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360442 | selegiline 0.5 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360443 | salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler | Full form of descriptor (FN) | NO | |
| RxCUI: 1360443 | salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler | Designated preferred name (PT) | NO | |
| RxCUI: 1360443 | salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360443 | salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360444 | follitropin alfa 600 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360445 | tetanus immune globulin, human 250 UNT/ML Prefilled Syringe [Hypertet] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360445 | tetanus immune globulin, human 250 UNT/ML Prefilled Syringe [Hypertet] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360447 | NaHCO3 75 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360447 | NaHCO3 75 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360448 | chondroitin sulfates 40 MG/ML / hyaluronate 30 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360449 | Rho(D) immune globulin, human 750 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360451 | alprostadil 0.02 MG/ML Cartridge [Edex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360451 | alprostadil 0.02 MG/ML Cartridge [Edex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360452 | atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector [Duodote] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360454 | exenatide 0.01 MG/ACTUAT Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360455 | sodium hyaluronate 12 MG/ML Prefilled Syringe [Shellgel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360457 | estradiol 0.00417 MG/HR Transdermal System [Minivelle] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360457 | estradiol 0.00417 MG/HR Transdermal System [Minivelle] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360458 | buprenorphine 0.02 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360459 | epinephrine 0.16 MG/ACTUAT Metered Dose Inhaler [Medihaler-Epi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360459 | epinephrine 0.16 MG/ACTUAT Metered Dose Inhaler [Medihaler-Epi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360462 | ganirelix acetate 0.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360463 | etomidate 2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360464 | interferon beta-1a 0.044 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360465 | dalteparin sodium 12500 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360467 | somatropin 5 MG/ML Cartridge [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360467 | somatropin 5 MG/ML Cartridge [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360468 | somatropin 1.6 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360469 | methoxy polyethylene glycol-epoetin beta 0.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360470 | peginterferon alfa-2b 0.24 MG/ML Prefilled Syringe [Pegintron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360471 | cephapirin 20 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360472 | somatropin 6.4 MG/ML Prefilled Syringe [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360472 | somatropin 6.4 MG/ML Prefilled Syringe [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360474 | ampicillin 6.25 MG/ML Prefilled Syringe [Hetacin-K] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360476 | nitroglycerin 0.3 MG/HR Transdermal System [Nitrodisc] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360476 | nitroglycerin 0.3 MG/HR Transdermal System [Nitrodisc] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360476 | nitroglycerin 0.3 MG/HR Transdermal System [Nitrodisc] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360476 | nitroglycerin 0.3 MG/HR Transdermal System [Nitrodisc] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360477 | estradiol 0.00188 MG/HR / levonorgestrel 0.000625 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360478 | fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler [Flovent] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360478 | fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler [Flovent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360479 | aclidinium bromide 0.4 MG/ACTUAT Dry Powder Inhaler [Tudorza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360479 | aclidinium bromide 0.4 MG/ACTUAT Dry Powder Inhaler [Tudorza] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360480 | ipratropium bromide 0.018 MG/ACTUAT Metered Dose Inhaler [Atrovent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360481 | ciclesonide 0.08 MG/ACTUAT Metered Dose Inhaler [Alvesco] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360482 | insulin, regular, human 100 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360484 | diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360485 | meperidine hydrochloride 25 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360486 | isoproterenol hydrochloride 0.2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360488 | estradiol 0.025 MG/Day Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360488 | estradiol 0.025 MG/Day Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360488 | estradiol 0.025 MG/Day Transdermal System | Designated preferred name (PT) | NO | |
| RxCUI: 1360488 | estradiol 0.025 MG/Day Transdermal System | Full form of descriptor (FN) | NO | |
| RxCUI: 1360489 | fentanyl 0.05 MG/HR Transdermal System [Duragesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360489 | fentanyl 0.05 MG/HR Transdermal System [Duragesic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360489 | fentanyl 0.05 MG/HR Transdermal System [Duragesic] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360490 | nicotine 0.875 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360491 | EPINEPHrine 0.16 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360491 | EPINEPHrine 0.16 MG/ACTUAT Metered Dose Inhaler | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360493 | sumatriptan 4 MG Cartridge [Imitrex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360493 | sumatriptan 4 MG Cartridge [Imitrex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360493 | sumatriptan 4 MG Cartridge [Imitrex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360494 | cephapirin 20 MG/ML Prefilled Syringe [Today] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360495 | liraglutide 6 MG/ML Pen Injector [Victoza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360495 | liraglutide 6 MG/ML Pen Injector [Victoza] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360496 | VCR Sulfate 1 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360496 | VCR Sulfate 1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360496 | VCR Sulfate 1 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360497 | leuprolide acetate 30 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360498 | leuprolide acetate 15 MG/ML Prefilled Syringe [Lupron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360499 | amiodarone hydrochloride 50 MG/ML Prefilled Syringe [Nexterone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360500 | fluphenazine decanoate 25 MG/ML Prefilled Syringe [Prolixin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360500 | fluphenazine decanoate 25 MG/ML Prefilled Syringe [Prolixin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360501 | medroxyprogesterone acetate 160 MG/ML Prefilled Syringe [depo-subQ provera] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360501 | medroxyprogesterone acetate 160 MG/ML Prefilled Syringe [depo-subQ provera] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360502 | hepatitis B immune globulin 217 UNT/ML Prefilled Syringe [Hyperhep B] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360503 | peginesatide 6 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360504 | buprenorphine 0.005 MG/HR Transdermal System [BuTrans] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360504 | buprenorphine 0.005 MG/HR Transdermal System [BuTrans] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360505 | estradiol 0.00208 MG/HR Transdermal System [Climara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360505 | estradiol 0.00208 MG/HR Transdermal System [Climara] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360506 | testosterone 0.208 MG/HR Transdermal System [Testoderm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360506 | testosterone 0.208 MG/HR Transdermal System [Testoderm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360507 | testosterone 0.167 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360508 | nicotine 0.938 MG/HR Transdermal System [Nicotrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360508 | nicotine 0.938 MG/HR Transdermal System [Nicotrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360509 | budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360509 | budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360509 | budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360510 | glucose 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360511 | apomorphine hydrochloride 10 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360512 | peginterferon alfa-2b 0.16 MG/ML Prefilled Syringe [Pegintron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360514 | abatacept 125 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360515 | estradiol 0.00417 MG/HR Transdermal System [Esclim] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360515 | estradiol 0.00417 MG/HR Transdermal System [Esclim] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360516 | buprenorphine 0.02 MG/HR Transdermal System [BuTrans] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360516 | buprenorphine 0.02 MG/HR Transdermal System [BuTrans] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360517 | rotigotine 0.167 MG/HR Transdermal System [Neupro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360517 | rotigotine 0.167 MG/HR Transdermal System [Neupro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360518 | rotigotine 0.0417 MG/HR Transdermal System | Full form of descriptor (FN) | NO | |
| RxCUI: 1360518 | rotigotine 0.0417 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360518 | rotigotine 0.0417 MG/HR Transdermal System | Designated preferred name (PT) | NO | |
| RxCUI: 1360519 | nitroglycerin 0.6 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360519 | nitroglycerin 0.6 MG/HR Transdermal System [Nitro-Dur] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360519 | nitroglycerin 0.6 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360519 | nitroglycerin 0.6 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360521 | estradiol 0.00208 MG/HR Vaginal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360522 | albuterol 0.1 MG/ACTUAT / ipratropium bromide 0.02 MG/ACTUAT Inhalation Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360525 | alprostadil 0.01 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360528 | pegaptanib 3.33 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360529 | peginesatide 4 MG/ML Prefilled Syringe [Omontys] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360530 | phenylephrine hydrochloride 0.05 MG/ML Prefilled Syringe | Designated preferred name (PT) | NO | |
| RxCUI: 1360530 | phenylephrine hydrochloride 0.05 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360530 | phenylephrine hydrochloride 0.05 MG/ML Prefilled Syringe | Full form of descriptor (FN) | NO | |
| RxCUI: 1360621 | Mycoplasma pneumoniae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1360622 | Eclipta prostrata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1360623 | Oriental arborvitae pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360623 | Oriental arborvitae pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1360624 | Sanguisorba officinalis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1360625 | Tripterygium wilfordii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1360626 | (all-Z)-4,7,10,13,16-docosapentaenoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1360627 | pine needle oil (pinus mugo) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1360628 | Rumex crispus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1360629 | Zanthoxylum bungeanum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1360630 | Artemisia vulgaris top oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1360631 | Oil of mustard | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1360631 | Oil of mustard | Designated preferred name (PT) | NO | |
| RxCUI: 1360631 | Oil of mustard | Full form of descriptor (FN) | NO | |
| RxCUI: 1360631 | Oil of mustard | Designated preferred name (PT) | NO | |
| RxCUI: 1360631 | Oil of mustard | Full form of descriptor (FN) | NO | |
| RxCUI: 1360632 | rotigotine 2 MG/Day 24HR Transdermal System (7) / rotigotine 4 MG/Day 24HR Transdermal System (7) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1360632 | rotigotine 2 MG/Day 24HR Transdermal System (7) / rotigotine 4 MG/Day 24HR Transdermal System (7) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1360633 | Neupro Titration Kit for Parkinson's disease Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1360633 | Neupro Titration Kit for Parkinson's disease Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1360633 | Neupro Titration Kit for Parkinson's disease Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1360634 | amoxicillin 100 MG [Amoxi-tabs] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1360635 | Amoxi-tabs 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360635 | Amoxi-tabs 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360635 | Amoxi-tabs 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360636 | amoxicillin 50 MG [Amoxi-tabs] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1360637 | Amoxi-tabs 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360637 | Amoxi-tabs 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360637 | Amoxi-tabs 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360638 | 1 nighttime (dextromethorphan hydrobromide 30 MG / doxylamine succinate 12.5 MG per 30 mL Oral Solution) / 1 daytime (dextromethorphan hydrobromide 15 MG per 15 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1360638 | 1 nighttime (dextromethorphan hydrobromide 30 MG / doxylamine succinate 12.5 MG per 30 mL Oral Solution) / 1 daytime (dextromethorphan hydrobromide 15 MG per 15 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1360638 | 1 nighttime (dextromethorphan hydrobromide 30 MG / doxylamine succinate 12.5 MG per 30 mL Oral Solution) / 1 daytime (dextromethorphan hydrobromide 15 MG per 15 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1360648 | corn starch 0.8 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1360649 | cornstarch 80 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360649 | cornstarch 80 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360649 | cornstarch 80 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360650 | corn starch 0.8 MG/MG [Soothe & Cool Powder] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1360651 | SOOTHE & COOL 80 % Topical Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360651 | SOOTHE & COOL 80 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360651 | SOOTHE & COOL 80 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360651 | SOOTHE & COOL 80 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360652 | witch hazel Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1360653 | witch hazel 0.1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360653 | witch hazel 0.1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360653 | witch hazel 0.1 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360654 | Pepcid AC 20 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360654 | Pepcid AC 20 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360654 | Pepcid AC 20 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360654 | Pepcid AC 20 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360713 | Tucoprim | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1360714 | sulfadiazine 0.333 MG/MG / trimethoprim 0.067 MG/MG [Tucoprim] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1360714 | sulfadiazine 0.333 MG/MG / trimethoprim 0.067 MG/MG [Tucoprim] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360715 | sulfadiazine / trimethoprim Oral Powder [Tucoprim] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1360715 | sulfadiazine / trimethoprim Oral Powder [Tucoprim] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360716 | Tucoprim Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1360717 | Tucoprim Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360720 | thonzylamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1360721 | Thonzylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1360721 | Thonzylamine | Designated preferred name (PT) | YES | |
| RxCUI: 1360721 | Thonzylamine | Full form of descriptor (FN) | YES | |
| RxCUI: 1360722 | thonzylamine hydrochloride 3.33 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1360723 | phenylephrine / thonzylamine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1360724 | phenylephrine / thonzylamine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1360725 | phenylephrine / thonzylamine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1360726 | phenylephrine / thonzylamine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1360727 | phenylephrine HCl 10 MG / thonzylamine HCl 50 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1360727 | phenylephrine HCl 10 MG / thonzylamine HCl 50 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1360727 | phenylephrine HCl 10 MG / thonzylamine HCl 50 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1360728 | Nasopen PE | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1360729 | phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML [Nasopen PE] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1360730 | phenylephrine / thonzylamine Oral Solution [Nasopen PE] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1360731 | Nasopen PE Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1360732 | Nasopen PE Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1360733 | NASOPEN PE 10 MG / 50 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1360733 | NASOPEN PE 10 MG / 50 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1360733 | NASOPEN PE 10 MG / 50 MG in 15 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1360734 | chlophedianol / phenylephrine / thonzylamine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1360735 | chlophedianol / phenylephrine / thonzylamine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1360736 | chlophedianol / phenylephrine / thonzylamine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1360737 | chlophedianol / phenylephrine / thonzylamine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1360738 | chlophedianol hydrochloride 1.67 MG/mL / phenylephrine hydrochloride 0.667 MG/mL / thonzylamine hydrochloride 3.33 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360738 | chlophedianol hydrochloride 1.67 MG/mL / phenylephrine hydrochloride 0.667 MG/mL / thonzylamine hydrochloride 3.33 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360738 | chlophedianol hydrochloride 1.67 MG/mL / phenylephrine hydrochloride 0.667 MG/mL / thonzylamine hydrochloride 3.33 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360739 | Vanacof APE | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1360740 | chlophedianol hydrochloride 1.67 MG/ML / phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML [Vanacof APE] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1360741 | chlophedianol / phenylephrine / thonzylamine Oral Solution [Vanacof APE] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1360742 | Vanacof APE Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1360743 | Vanacof APE Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1360744 | chlophedianol hydrochloride 1.67 MG/ML / phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution [Vanacof APE] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1360744 | chlophedianol hydrochloride 1.67 MG/ML / phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution [Vanacof APE] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360745 | salicyclic acid 3 % / zinc pyrithione 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360745 | salicyclic acid 3 % / zinc pyrithione 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360745 | salicyclic acid 3 % / zinc pyrithione 1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360746 | camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1360746 | camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1360746 | camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1360948 | hydrocortisone acetate 10 MG/ML [U-Cort] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1360949 | U-Cort 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1360949 | U-Cort 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1360949 | U-Cort 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1360949 | U-Cort 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1360950 | hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML [Analpram HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1360954 | Analpram HC Cream 1 % / 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1360954 | Analpram HC Cream 1 % / 1 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1360954 | Analpram HC Cream 1 % / 1 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1360955 | hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML [Analpram HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1360956 | Analpram HC 2.5 % / 1 % Rectal Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1360956 | Analpram HC 2.5 % / 1 % Rectal Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1360956 | Analpram HC 2.5 % / 1 % Rectal Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1361 | Benactyzine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1361 | Benactyzine | Designated preferred name (PT) | NO | |
| RxCUI: 1361 | Benactyzine | Full form of descriptor (FN) | NO | |
| RxCUI: 1361015 | papaverine hydrochloride 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361018 | phentolamine mesylate 0.235 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361019 | phentolamine mesylate 0.4 MG in 1.7 ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1361019 | phentolamine mesylate 0.4 MG in 1.7 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361019 | phentolamine mesylate 0.4 MG in 1.7 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361020 | phentolamine mesylate 0.235 MG/ML [OraVerse] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1361021 | OraVerse 0.4 MG in 1.7 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1361021 | OraVerse 0.4 MG in 1.7 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361021 | OraVerse 0.4 MG in 1.7 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361021 | OraVerse 0.4 MG in 1.7 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361023 | phentolamine mesylate 5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361023 | phentolamine mesylate 5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1361026 | heparin sodium, porcine 10 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361029 | heparin sodium, porcine 10 UNT/ML Injectable Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1361029 | heparin sodium, porcine 10 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1361029 | heparin sodium, porcine 10 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361029 | heparin sodium, porcine 10 UNT/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1361033 | heparin sodium, porcine 10 UNT/ML [Hep-Pak] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1361035 | heparin sodium, porcine 10 UNT/ML Injectable Solution [Hep-Pak] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1361035 | heparin sodium, porcine 10 UNT/ML Injectable Solution [Hep-Pak] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361045 | cat skin extract 20000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361046 | Felis catus skin extract 20,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361046 | Felis catus skin extract 20,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361046 | Felis catus skin extract 20,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361047 | heparin sodium, porcine 100 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361048 | heparin sodium, porcine 100 UNT/ML Injectable Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1361048 | heparin sodium, porcine 100 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1361048 | heparin sodium, porcine 100 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361048 | heparin sodium, porcine 100 UNT/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1361197 | heparin sodium, porcine 100 UNT/ML [Hep-Pak] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1361198 | heparin sodium, porcine 100 UNT/ML Injectable Solution [Hep-Pak] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1361198 | heparin sodium, porcine 100 UNT/ML Injectable Solution [Hep-Pak] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361199 | corn starch 0.79 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361200 | kaolin 0.04 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361201 | cornstarch 79 % / kaolin 4 % / zinc oxide 15 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1361201 | cornstarch 79 % / kaolin 4 % / zinc oxide 15 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361201 | cornstarch 79 % / kaolin 4 % / zinc oxide 15 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361201 | cornstarch 79 % / kaolin 4 % / zinc oxide 15 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361204 | lidocaine hydrochloride 0.007 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361205 | lidocaine HCl 0.7 % / menthol 0.2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1361205 | lidocaine HCl 0.7 % / menthol 0.2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361205 | lidocaine HCl 0.7 % / menthol 0.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361208 | iodine 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361209 | chloroxylenol / iodine / menthol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1361210 | chloroxylenol / iodine / menthol Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1361211 | chloroxylenol / iodine / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1361212 | menthol 1.27 % / chloroxylenol 0.5 % / iodine 0.02 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361212 | menthol 1.27 % / chloroxylenol 0.5 % / iodine 0.02 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361212 | menthol 1.27 % / chloroxylenol 0.5 % / iodine 0.02 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1361213 | Absorbine Veterinary Liniment | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1361214 | chloroxylenol 5 MG/ML / iodine 0.2 MG/ML / menthol 12.7 MG/ML [Absorbine Veterinary Liniment] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1361215 | chloroxylenol / iodine / menthol Topical Solution [Absorbine Veterinary Liniment] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1361216 | Absorbine Veterinary Liniment Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1361217 | ABSORBINE VETERINARY LINIMENT 1.27 % / 0.5 % / 0.02 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361217 | ABSORBINE VETERINARY LINIMENT 1.27 % / 0.5 % / 0.02 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1361217 | ABSORBINE VETERINARY LINIMENT 1.27 % / 0.5 % / 0.02 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1361225 | heparin sodium, porcine 1000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361226 | heparin sodium, porcine 1000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361226 | heparin sodium, porcine 1000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1361397 | Backaid IPF | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1361398 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG [Backaid IPF] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1361399 | acetaminophen / aspirin / caffeine Oral Tablet [Backaid IPF] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1361400 | Backaid IPF Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1361401 | Backaid IPF Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1361402 | BACKAID IPF Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1361402 | BACKAID IPF Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361402 | BACKAID IPF Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361402 | BACKAID IPF Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361406 | capsaicin 0.000325 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361407 | lidocaine 0.045 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361408 | methyl salicylate 0.275 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361409 | capsaicin / lidocaine / menthol / methyl salicylate Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1361410 | capsaicin 0.0325 % / lidocaine 4.5 % / menthol 10 % / methyl salicylate 27.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1361410 | capsaicin 0.0325 % / lidocaine 4.5 % / menthol 10 % / methyl salicylate 27.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361410 | capsaicin 0.0325 % / lidocaine 4.5 % / menthol 10 % / methyl salicylate 27.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361461 | Atropa belladona whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1361462 | Sus scrofa large intestine preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1361463 | Tylophora indica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1361491 | Bidens tripartita flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1361492 | glimepiride 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361493 | glimepiride 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361493 | glimepiride 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1361494 | glimepiride 8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361495 | glimepiride 8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361495 | glimepiride 8 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1361510 | Nexafed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1361511 | pseudoephedrine hydrochloride 30 MG [Nexafed] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1361512 | pseudoephedrine Oral Tablet [Nexafed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1361513 | Nexafed Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1361514 | Nexafed Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1361515 | Nexafed 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361515 | Nexafed 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361515 | Nexafed 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1361535 | propylhexedrine Nasal Inhalant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1361536 | propylhexedrine 250 MG Nasal Inhalant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361536 | propylhexedrine 250 MG Nasal Inhalant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1361537 | propylhexedrine Nasal Inhalant [Benzedrex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1361538 | Benzedrex 250 MG Nasal Inhalant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361538 | Benzedrex 250 MG Nasal Inhalant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361538 | Benzedrex 250 MG Nasal Inhalant | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1361561 | heparin sodium, porcine 2.5 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361562 | heparin sodium, porcine 2.5 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361563 | Follistim AQ 300 UNT in 0.36 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361563 | Follistim AQ 300 UNT in 0.36 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1361563 | Follistim AQ 300 UNT in 0.36 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361563 | Follistim AQ 300 UNT in 0.36 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361567 | heparin sodium, porcine 2000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361568 | heparin sodium, porcine 10,000 UNT in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361568 | heparin sodium, porcine 10,000 UNT in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1361568 | heparin sodium, porcine 10,000 UNT in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361569 | Follistim AQ 600 UNT in 0.72 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361569 | Follistim AQ 600 UNT in 0.72 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1361569 | Follistim AQ 600 UNT in 0.72 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361569 | Follistim AQ 600 UNT in 0.72 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361572 | Follistim AQ 900 UNT in 1.08 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361572 | Follistim AQ 900 UNT in 1.08 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1361572 | Follistim AQ 900 UNT in 1.08 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361572 | Follistim AQ 900 UNT in 1.08 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361573 | heparin sodium, porcine 20000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361574 | heparin sodium, porcine 20,000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361574 | heparin sodium, porcine 20,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361574 | heparin sodium, porcine 20,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1361576 | heparin sodium, porcine 2500 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361577 | heparin sodium, porcine 25,000 UNT in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361577 | heparin sodium, porcine 25,000 UNT in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1361577 | heparin sodium, porcine 25,000 UNT in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361593 | heparin sodium, porcine 25000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361594 | heparin sodium, porcine 25,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361594 | heparin sodium, porcine 25,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361606 | heparin sodium, porcine 40 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361607 | heparin sodium, porcine 20,000 UNT in 500 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1361607 | heparin sodium, porcine 20,000 UNT in 500 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361607 | heparin sodium, porcine 20,000 UNT in 500 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361608 | heparin sodium, porcine 40000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361609 | heparin sodium, porcine 40,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361609 | heparin sodium, porcine 40,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361612 | heparin sodium, porcine 50 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361614 | heparin sodium, porcine 5000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361615 | heparin sodium, porcine 5000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361615 | heparin sodium, porcine 5000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1361654 | ethylenediamine tetraethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1361655 | guaraprolose (3500 MPA.S at 1 % ) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361655 | guaraprolose (3500 MPA.S at 1 % ) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1361656 | propylene glycol alginate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1361657 | 123-I | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361657 | 123-I | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1361657 | 123-I | Designated preferred name (PT) | YES | |
| RxCUI: 1361657 | 123-I | Full form of descriptor (FN) | YES | |
| RxCUI: 1361657 | 123-I | Designated preferred name (PT) | YES | |
| RxCUI: 1361657 | 123-I | Full form of descriptor (FN) | YES | |
| RxCUI: 1361658 | phenoxyethyl caprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1361659 | dimethicone/vinyl dimethicone crosspolymer (soft particle) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361659 | dimethicone/vinyl dimethicone crosspolymer (soft particle) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1361660 | Picrasma quassioides wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1361664 | typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.025 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361665 | hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1361666 | hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1361667 | hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1361668 | 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.025 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361669 | hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.025 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361678 | iodine 0.025 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361679 | iodine 25 MG per 1 L Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361679 | iodine 25 MG per 1 L Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1361679 | iodine 25 MG per 1 L Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361688 | Neutraphorus Rex Skin Protectant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1361689 | dimethicone 10 MG/ML [Neutraphorus Rex Skin Protectant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1361690 | dimethicone Topical Cream [Neutraphorus Rex Skin Protectant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1361691 | Neutraphorus Rex Skin Protectant Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1361692 | Neutraphorus Rex Skin Protectant 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1361692 | Neutraphorus Rex Skin Protectant 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1361692 | Neutraphorus Rex Skin Protectant 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361692 | Neutraphorus Rex Skin Protectant 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361693 | Biclora-D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1361694 | chlophedianol hydrochloride 25 MG / chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG [Biclora-D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1361695 | chlophedianol / chlorcyclizine / pseudoephedrine Oral Tablet [Biclora-D] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1361696 | Biclora-D Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1361697 | Biclora-D Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1361698 | chlophedianol hydrochloride 25 MG / chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet [Biclora-D] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361698 | chlophedianol hydrochloride 25 MG / chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet [Biclora-D] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1361701 | chlophedianol hydrochloride 25 MG / chlorcyclizine hydrochloride 25 MG [Biclora] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1361702 | chlophedianol / chlorcyclizine Oral Tablet [Biclora] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1361703 | Biclora Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1361704 | biclora 25 MG / 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1361704 | biclora 25 MG / 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361704 | biclora 25 MG / 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1361705 | calcium carbonate 497 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361706 | calcium carbonate / sodium bicarbonate Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1361707 | calcium carbonate / sodium bicarbonate Oral Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1361708 | calcium carbonate 497 MG / sodium bicarbonate 600 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361708 | calcium carbonate 497 MG / sodium bicarbonate 600 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1361708 | calcium carbonate 497 MG / sodium bicarbonate 600 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361757 | heparin sodium, bovine 5000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361760 | heparin sodium, bovine 5,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361760 | heparin sodium, bovine 5,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361768 | aluminum acetate 53 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1361769 | aluminum acetate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1361770 | aluminum acetate 5.3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1361770 | aluminum acetate 5.3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1361770 | aluminum acetate 5.3 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1361852 | heparin sodium, porcine 10000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1361853 | heparin sodium, porcine 5000 UNT in 0.5 ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1361853 | heparin sodium, porcine 5000 UNT in 0.5 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1361853 | heparin sodium, porcine 5000 UNT in 0.5 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 136198 | darifenacin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 136198 | darifenacin | Designated preferred name (PT) | YES | |
| RxCUI: 136198 | darifenacin | Full form of descriptor (FN) | YES | |
| RxCUI: 136198 | darifenacin | Designated preferred name (PT) | YES | |
| RxCUI: 136198 | darifenacin | Full form of descriptor (FN) | YES | |
| RxCUI: 1362 | Diphenhydramine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1362 | Diphenhydramine hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 1362 | Diphenhydramine hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1362 | Diphenhydramine hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 1362023 | heparin sodium, porcine 1 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362025 | heparin sodium, porcine 1 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362026 | heparin sodium, porcine 10 UNT per 10 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362026 | heparin sodium, porcine 10 UNT per 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362032 | undecylenate Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1362034 | FungiCure Maximum Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1362036 | undecylenate Topical Gel [FungiCure Maximum Strength] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1362037 | FungiCure Maximum Strength Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1362039 | undecylenic acid 25 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362039 | undecylenic acid 25 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362039 | undecylenic acid 25 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362040 | undecylenic acid 0.25 MG/MG [FungiCure Maximum Strength] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1362041 | FungiCURE Maximum Strength 25 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362041 | FungiCURE Maximum Strength 25 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362041 | FungiCURE Maximum Strength 25 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362041 | FungiCURE Maximum Strength 25 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362042 | minocycline 100 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362042 | minocycline 100 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362042 | minocycline 100 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362043 | Soft Dine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1362044 | iodine 5 MG/ML [Soft Dine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1362045 | iodine Topical Solution [Soft Dine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1362046 | Soft Dine Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1362047 | SOFT DINE 0.5 % Iodine Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362047 | SOFT DINE 0.5 % Iodine Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362047 | SOFT DINE 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362047 | SOFT DINE 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362049 | heparin sodium, porcine 10 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362050 | menthol 0.1 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362050 | menthol 0.1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362050 | menthol 0.1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362054 | heparin sodium, porcine 30 UNT in 3 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362054 | heparin sodium, porcine 30 UNT in 3 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362054 | heparin sodium, porcine 30 UNT in 3 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362058 | heparin sodium, porcine 100 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362059 | heparin sodium, porcine 1000 UNT in 10 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362059 | heparin sodium, porcine 1000 UNT in 10 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362059 | heparin sodium, porcine 1000 UNT in 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362060 | heparin sodium, porcine 200 UNT in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1362060 | heparin sodium, porcine 200 UNT in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362060 | heparin sodium, porcine 200 UNT in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362061 | heparin sodium, porcine 250 UNT in 2.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362061 | heparin sodium, porcine 250 UNT in 2.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362061 | heparin sodium, porcine 250 UNT in 2.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362062 | heparin sodium, porcine 300 UNT in 3 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1362062 | heparin sodium, porcine 300 UNT in 3 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362062 | heparin sodium, porcine 300 UNT in 3 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362063 | heparin sodium, porcine 500 UNT per 5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362063 | heparin sodium, porcine 500 UNT per 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362063 | heparin sodium, porcine 500 UNT per 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362064 | heparin sodium, porcine 2 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1362067 | heparin sodium, porcine 6000 UNT in 3 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362067 | heparin sodium, porcine 6000 UNT in 3 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362067 | heparin sodium, porcine 6000 UNT in 3 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362068 | heparin sodium, porcine 2000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362069 | heparin sodium, porcine 1000 UNT per 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362069 | heparin sodium, porcine 1000 UNT per 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362070 | heparin sodium, porcine 1000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362071 | hyaluronate Prefilled Syringe [Supartz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1362072 | Supartz 1 % in 2 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362072 | Supartz 1 % in 2 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362072 | Supartz 1 % in 2 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362073 | sodium hyaluronate 10 MG/ML Prefilled Syringe [Supartz] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362073 | sodium hyaluronate 10 MG/ML Prefilled Syringe [Supartz] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362078 | undecylenic acid 250 MG/ML [FungiCure Maximum Strength] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1362079 | undecylenate Topical Solution [FungiCure Maximum Strength] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1362080 | FungiCURE 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362080 | FungiCURE 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362080 | FungiCURE 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362080 | FungiCURE 25 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1362082 | Aggrenox 25 MG / 200 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362082 | Aggrenox 25 MG / 200 MG 12HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362082 | Aggrenox 25 MG / 200 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362082 | Aggrenox 25 MG / 200 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362082 | Aggrenox 25 MG / 200 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 136209 | Venofer | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1362131 | nepafenac 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1362132 | nepafenac 0.3 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362132 | nepafenac 0.3 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362132 | nepafenac 0.3 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1362134 | arabica coffee oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362135 | Oil of basil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362135 | Oil of basil | Designated preferred name (PT) | YES | |
| RxCUI: 1362135 | Oil of basil | Full form of descriptor (FN) | YES | |
| RxCUI: 1362136 | tetrahydrocurcumin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362136 | tetrahydrocurcumin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362137 | Oil of hyssop | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362137 | Oil of hyssop | Designated preferred name (PT) | YES | |
| RxCUI: 1362137 | Oil of hyssop | Full form of descriptor (FN) | YES | |
| RxCUI: 1362138 | jojoba butter | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362139 | ziprasidone hydrochloride anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1362139 | ziprasidone hydrochloride anhydrous | Designated preferred name (PT) | NO | |
| RxCUI: 1362139 | ziprasidone hydrochloride anhydrous | Full form of descriptor (FN) | NO | |
| RxCUI: 1362140 | ascorbyl tocopheryl maleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362141 | Picea mariana leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362142 | prolinamidoethyl imidazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362143 | sodium carbonate decahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1362144 | C12-15 pareth-9 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362145 | PEG-120 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362146 | linalool, ()- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362147 | hydroxyethyl cellulose (100 MPA.S at 2%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362150 | zinc oxide 145 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362151 | zinc oxide 14.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362151 | zinc oxide 14.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362151 | zinc oxide 14.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362151 | zinc oxide 14.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362206 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362206 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362206 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362206 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362206 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362206 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362211 | Analpram 2.5 % / 1 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362211 | Analpram 2.5 % / 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362211 | Analpram 2.5 % / 1 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1362212 | hydrocortisone acetate 2.5 % / pramoxine 1 % Rectal Cream (30 x 4 GM) / pramoxine HCl 1 % Medicated Pad (18) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1362212 | hydrocortisone acetate 2.5 % / pramoxine 1 % Rectal Cream (30 x 4 GM) / pramoxine HCl 1 % Medicated Pad (18) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362213 | Analpram E 2.5 % / 1 % Rectal Cream (30 X 4 GM) / Prax 1 % Medicated Pad (18) Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1362213 | Analpram E 2.5 % / 1 % Rectal Cream (30 X 4 GM) / Prax 1 % Medicated Pad (18) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362213 | Analpram E 2.5 % / 1 % Rectal Cream (30 X 4 GM) / Prax 1 % Medicated Pad (18) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362214 | albuterol 2.5 MG / ipratropium bromide 0.5 MG per 2.5 ML Inhalation Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1362214 | albuterol 2.5 MG / ipratropium bromide 0.5 MG per 2.5 ML Inhalation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362214 | albuterol 2.5 MG / ipratropium bromide 0.5 MG per 2.5 ML Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362214 | albuterol 2.5 MG / ipratropium bromide 0.5 MG per 2.5 ML Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362214 | albuterol 2.5 MG / ipratropium bromide 0.5 MG per 2.5 ML Inhalation Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1362220 | hydrocortisone 2.5 % / pramoxine HCl 1 % Rectal Cream (4 GM) / pramoxine HCl 1 % Medicated Wipe (1) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1362220 | hydrocortisone 2.5 % / pramoxine HCl 1 % Rectal Cream (4 GM) / pramoxine HCl 1 % Medicated Wipe (1) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362221 | Analpram E 2.5 % / 1 % Rectal Cream (4 GM) / Prax 1 % Wipe (1) Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1362221 | Analpram E 2.5 % / 1 % Rectal Cream (4 GM) / Prax 1 % Wipe (1) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362221 | Analpram E 2.5 % / 1 % Rectal Cream (4 GM) / Prax 1 % Wipe (1) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362222 | hydrocortisone acetate 2.5 % / pramoxine 1 % Rectal Cream (28.4 GM) / pramoxine 1 % Medicated Pad (6) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1362222 | hydrocortisone acetate 2.5 % / pramoxine 1 % Rectal Cream (28.4 GM) / pramoxine 1 % Medicated Pad (6) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362223 | Analpram E 2.5 % / 1 % Rectal Cream (28.4 GM) / Prax 1 % Medicated Pad (6) Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1362223 | Analpram E 2.5 % / 1 % Rectal Cream (28.4 GM) / Prax 1 % Medicated Pad (6) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362223 | Analpram E 2.5 % / 1 % Rectal Cream (28.4 GM) / Prax 1 % Medicated Pad (6) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362234 | dextromethorphan hydrobromide 40 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 10 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362234 | dextromethorphan hydrobromide 40 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 10 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362234 | dextromethorphan hydrobromide 40 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 10 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362234 | dextromethorphan hydrobromide 40 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 10 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362234 | dextromethorphan hydrobromide 40 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 10 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362234 | dextromethorphan hydrobromide 40 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 10 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362577 | 1,2,6-hexanetriol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362584 | 1,2-hexanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362615 | 2-octanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362616 | 7-dehydrocholesterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362617 | chloroxylenol 3.75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362618 | chloroxylenol 0.375 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362618 | chloroxylenol 0.375 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362618 | chloroxylenol 0.375 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362685 | betadex | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362686 | diamond | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362688 | Shiitake mushroom extract | Designated preferred name (PT) | YES | |
| RxCUI: 1362688 | Shiitake mushroom extract | Full form of descriptor (FN) | YES | |
| RxCUI: 1362688 | Shiitake mushroom extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362689 | protocatechualdehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362690 | rose bengal sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1362691 | 1-butene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362692 | Hydroxyethylmethylmethacrylate resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362692 | Hydroxyethylmethylmethacrylate resin | Designated preferred name (PT) | YES | |
| RxCUI: 1362692 | Hydroxyethylmethylmethacrylate resin | Full form of descriptor (FN) | YES | |
| RxCUI: 1362692 | Hydroxyethylmethylmethacrylate resin | Designated preferred name (PT) | YES | |
| RxCUI: 1362692 | Hydroxyethylmethylmethacrylate resin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362692 | Hydroxyethylmethylmethacrylate resin | Full form of descriptor (FN) | YES | |
| RxCUI: 1362693 | menthol 10 % / methyl salicylate 12 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362693 | menthol 10 % / methyl salicylate 12 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362693 | menthol 10 % / methyl salicylate 12 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362693 | menthol 10 % / methyl salicylate 12 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362694 | cadmium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362695 | Ammonium sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362695 | Ammonium sulfate | Designated preferred name (PT) | YES | |
| RxCUI: 1362695 | Ammonium sulfate | Full form of descriptor (FN) | YES | |
| RxCUI: 1362695 | Ammonium sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362696 | butyric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1362697 | Carnosine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362697 | Carnosine | Designated preferred name (PT) | YES | |
| RxCUI: 1362697 | Carnosine | Full form of descriptor (FN) | YES | |
| RxCUI: 1362698 | Chloroform | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362698 | Chloroform | Designated preferred name (PT) | YES | |
| RxCUI: 1362698 | Chloroform | Full form of descriptor (FN) | YES | |
| RxCUI: 1362698 | Chloroform | Designated preferred name (PT) | YES | |
| RxCUI: 1362698 | Chloroform | Full form of descriptor (FN) | YES | |
| RxCUI: 1362699 | Indium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362699 | Indium | Designated preferred name (PT) | NO | |
| RxCUI: 1362699 | Indium | Full form of descriptor (FN) | NO | |
| RxCUI: 1362699 | Indium | Designated preferred name (PT) | NO | |
| RxCUI: 1362699 | Indium | Full form of descriptor (FN) | NO | |
| RxCUI: 1362701 | benzocaine / cetylpyridinium / menthol Mucosal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1362702 | benzocaine / cetylpyridinium / menthol Mucous Membrane Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1362703 | benzocaine / cetylpyridinium / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1362704 | benzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362704 | benzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362704 | benzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1362705 | mexiletine hydrochloride 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1362706 | mexiletine HCl 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362706 | mexiletine HCl 150 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1362706 | mexiletine HCl 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1362706 | mexiletine HCl 150 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1362707 | mexiletine hydrochloride 150 MG [Mexitil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1362708 | mexiletine hydrochloride 150 MG Oral Capsule [Mexitil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362708 | mexiletine hydrochloride 150 MG Oral Capsule [Mexitil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362711 | mexiletine hydrochloride 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1362712 | mexiletine HCl 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362712 | mexiletine HCl 200 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1362712 | mexiletine HCl 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1362712 | mexiletine HCl 200 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1362713 | mexiletine hydrochloride 200 MG [Mexitil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1362714 | mexiletine hydrochloride 200 MG Oral Capsule [Mexitil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362714 | mexiletine hydrochloride 200 MG Oral Capsule [Mexitil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362719 | mexiletine hydrochloride 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1362720 | mexiletine HCl 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362720 | mexiletine HCl 250 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1362720 | mexiletine HCl 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1362720 | mexiletine HCl 250 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1362721 | mexiletine hydrochloride 250 MG [Mexitil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1362722 | mexiletine hydrochloride 250 MG Oral Capsule [Mexitil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362722 | mexiletine hydrochloride 250 MG Oral Capsule [Mexitil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362723 | mexiletine hydrochloride 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362724 | Mexiletine hydrochloride 25 mg/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362724 | Mexiletine hydrochloride 25 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 1362724 | Mexiletine hydrochloride 25 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 1362725 | mexiletine hydrochloride 360 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362726 | mexiletine HCl 360 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362726 | mexiletine HCl 360 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362726 | mexiletine HCl 360 MG Extended Release Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 1362726 | mexiletine HCl 360 MG Extended Release Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 1362727 | mexiletine hydrochloride 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362728 | mexiletine HCl 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362728 | mexiletine HCl 50 MG Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 1362728 | mexiletine HCl 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362728 | mexiletine HCl 50 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 1362729 | mexiletine hydrochloride 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362730 | mexiletine HCl 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362730 | mexiletine HCl 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362731 | mexiletine hydrochloride 200 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362732 | mexiletine hydrochloride 250 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362735 | phlorhizin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362737 | fludeoxyglucose (18F) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362737 | fludeoxyglucose (18F) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362738 | Octhilinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362738 | Octhilinone | Designated preferred name (PT) | YES | |
| RxCUI: 1362738 | Octhilinone | Full form of descriptor (FN) | YES | |
| RxCUI: 1362738 | Octhilinone | Designated preferred name (PT) | YES | |
| RxCUI: 1362738 | Octhilinone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362738 | Octhilinone | Full form of descriptor (FN) | YES | |
| RxCUI: 1362739 | 2-tert-butylbenzene-1,4-diol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362739 | 2-tert-butylbenzene-1,4-diol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362739 | 2-tert-butylbenzene-1,4-diol | Full form of descriptor (FN) | YES | |
| RxCUI: 1362739 | 2-tert-butylbenzene-1,4-diol | Designated preferred name (PT) | YES | |
| RxCUI: 1362739 | 2-tert-butylbenzene-1,4-diol | Full form of descriptor (FN) | YES | |
| RxCUI: 1362739 | 2-tert-butylbenzene-1,4-diol | Designated preferred name (PT) | YES | |
| RxCUI: 1362740 | 1,4-phenylenediamine base | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362740 | 1,4-phenylenediamine base | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362740 | 1,4-phenylenediamine base | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362740 | 1,4-phenylenediamine base | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362740 | 1,4-phenylenediamine base | Designated preferred name (PT) | NO | |
| RxCUI: 1362740 | 1,4-phenylenediamine base | Full form of descriptor (FN) | NO | |
| RxCUI: 1362740 | 1,4-phenylenediamine base | Designated preferred name (PT) | NO | |
| RxCUI: 1362740 | 1,4-phenylenediamine base | Full form of descriptor (FN) | NO | |
| RxCUI: 1362741 | ceramide NP | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362741 | ceramide NP | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362742 | cobalt sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362743 | dipyrithione | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362744 | dodicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362746 | teprenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362746 | teprenone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362747 | calcium formate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1362748 | formate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362751 | melatonin Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1362752 | melatonin Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1362753 | melatonin 2.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362753 | melatonin 2.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1362767 | brompheniramine maleate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362768 | Brompheniramine maleate 10 mg/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362768 | Brompheniramine maleate 10 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 1362768 | Brompheniramine maleate 10 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 1362769 | brompheniramine maleate 10 MG/ML [Codimal A] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1362770 | brompheniramine maleate 10 MG/ML Injectable Solution [Codimal A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362770 | brompheniramine maleate 10 MG/ML Injectable Solution [Codimal A] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362781 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362781 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362782 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML [Codimal DH] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1362782 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML [Codimal DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362783 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution [Codimal DH] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362783 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution [Codimal DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362783 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution [Codimal DH] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362783 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution [Codimal DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362789 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362789 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362790 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML [Codimal DH Reformulated Oct 2007] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1362790 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML [Codimal DH Reformulated Oct 2007] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362791 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Codimal DH Reformulated Oct 2007] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362791 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Codimal DH Reformulated Oct 2007] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362791 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Codimal DH Reformulated Oct 2007] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362791 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Codimal DH Reformulated Oct 2007] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1362794 | Vernakalant | Designated preferred name (PT) | NO | |
| RxCUI: 1362794 | Vernakalant | Full form of descriptor (FN) | NO | |
| RxCUI: 1362797 | brompheniramine maleate 10 MG/ML [Nasahist B] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1362798 | brompheniramine maleate 10 MG/ML Injectable Solution [Nasahist B] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362798 | brompheniramine maleate 10 MG/ML Injectable Solution [Nasahist B] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362800 | brompheniramine maleate 10 MG/ML [Histine-B] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1362801 | brompheniramine maleate 10 MG/ML Injectable Solution [Histine-B] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362801 | brompheniramine maleate 10 MG/ML Injectable Solution [Histine-B] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362802 | vitamin K 0.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1362803 | calcium carbonate / cholecalciferol / vitamin K Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1362804 | calcium carbonate / cholecalciferol / vitamin K Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1362805 | calcium 500 MG / vitamin D3 1000 UNT / phytonadione 40 MCG Chewable Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362805 | calcium 500 MG / vitamin D3 1000 UNT / phytonadione 40 MCG Chewable Tablet, as calcium carbonate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1362805 | calcium 500 MG / vitamin D3 1000 UNT / phytonadione 40 MCG Chewable Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362806 | betaine hydrochloride 162 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1362807 | papain 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1362808 | betaine / bromelains / pancreatin / papain / pepsin A Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1362809 | betaine / bromelains / pancreatin / papain / pepsin A Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1362810 | betaine / bromelains / pancreatin / papain / pepsin A Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1362811 | betaine / bromelains / pancreatin / papain / pepsin A | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1362812 | betaine HCl 162 MG / bromelains 125 MG / pancreatin 250 MG / papain 125 MG / pepsin A 65 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362812 | betaine HCl 162 MG / bromelains 125 MG / pancreatin 250 MG / papain 125 MG / pepsin A 65 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1362813 | Acacia decurrens extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362814 | magnesium nitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362815 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362815 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362815 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362815 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362815 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362816 | chlorpheniramine maleate 12 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362821 | heparin sodium, porcine 7500 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362822 | heparin sodium, porcine 7500 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362823 | heparin sodium, porcine 8 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362824 | heparin sodium, porcine 8 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362829 | heparin sodium, bovine 1000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362830 | heparin sodium, bovine 1000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362831 | heparin sodium, porcine 10,000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1362831 | heparin sodium, porcine 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362831 | heparin sodium, porcine 10,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1362832 | heparin sodium, bovine 10000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362833 | heparin sodium, bovine 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362833 | heparin sodium, bovine 10,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362836 | heparin sodium, porcine 12500 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362837 | heparin sodium, porcine 12,500 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362837 | heparin sodium, porcine 12,500 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362871 | N-acetylglucosamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362871 | N-acetylglucosamine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362872 | propanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362872 | propanol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362873 | Di-n-butylphthalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362873 | Di-n-butylphthalate | Designated preferred name (PT) | NO | |
| RxCUI: 1362873 | Di-n-butylphthalate | Full form of descriptor (FN) | NO | |
| RxCUI: 1362873 | Di-n-butylphthalate | Designated preferred name (PT) | NO | |
| RxCUI: 1362873 | Di-n-butylphthalate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362873 | Di-n-butylphthalate | Full form of descriptor (FN) | NO | |
| RxCUI: 1362874 | diatomaceous earth | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362875 | dodecanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362876 | maleic anhydride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362877 | propane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362878 | styrene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362879 | sulfur dioxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362880 | pentylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362880 | pentylene glycol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362881 | acetyltributyl citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362882 | alfadex | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362882 | alfadex | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362883 | Ammonium acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362883 | Ammonium acetate | Designated preferred name (PT) | YES | |
| RxCUI: 1362883 | Ammonium acetate | Full form of descriptor (FN) | YES | |
| RxCUI: 1362883 | Ammonium acetate | Designated preferred name (PT) | YES | |
| RxCUI: 1362883 | Ammonium acetate | Full form of descriptor (FN) | YES | |
| RxCUI: 1362884 | ammonium hydroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362885 | benzimidazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362885 | benzimidazole | Designated preferred name (PT) | NO | |
| RxCUI: 1362885 | benzimidazole | Full form of descriptor (FN) | NO | |
| RxCUI: 1362885 | benzimidazole | Designated preferred name (PT) | NO | |
| RxCUI: 1362885 | benzimidazole | Full form of descriptor (FN) | NO | |
| RxCUI: 1362886 | chlorozotocin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362887 | cholesteryl nonanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362888 | chrysin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362889 | Cinnamyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362889 | Cinnamyl alcohol | Designated preferred name (PT) | NO | |
| RxCUI: 1362889 | Cinnamyl alcohol | Full form of descriptor (FN) | NO | |
| RxCUI: 1362889 | Cinnamyl alcohol | Designated preferred name (PT) | NO | |
| RxCUI: 1362889 | Cinnamyl alcohol | Full form of descriptor (FN) | NO | |
| RxCUI: 1362890 | citral | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362890 | citral | Designated preferred name (PT) | YES | |
| RxCUI: 1362890 | citral | Full form of descriptor (FN) | YES | |
| RxCUI: 1362891 | ethohexadiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362892 | ethylparaben | Designated preferred name (PT) | YES | |
| RxCUI: 1362892 | ethylparaben | Full form of descriptor (FN) | YES | |
| RxCUI: 1362892 | ethylparaben | Designated preferred name (PT) | YES | |
| RxCUI: 1362892 | ethylparaben | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362892 | ethylparaben | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362892 | ethylparaben | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362892 | ethylparaben | Full form of descriptor (FN) | YES | |
| RxCUI: 1362893 | Hydroxycitronellal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362893 | Hydroxycitronellal | Designated preferred name (PT) | YES | |
| RxCUI: 1362893 | Hydroxycitronellal | Full form of descriptor (FN) | YES | |
| RxCUI: 1362893 | Hydroxycitronellal | Designated preferred name (PT) | YES | |
| RxCUI: 1362893 | Hydroxycitronellal | Full form of descriptor (FN) | YES | |
| RxCUI: 1362894 | maltol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362895 | mangiferin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362896 | mica | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362897 | myristyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362898 | polyoxyethylene-24-cholesteryl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362899 | potassium metabisulfite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362900 | BHA - Butylated hydroxyanisole | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362900 | BHA - Butylated hydroxyanisole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362900 | BHA - Butylated hydroxyanisole | Designated preferred name (PT) | YES | |
| RxCUI: 1362900 | BHA - Butylated hydroxyanisole | Full form of descriptor (FN) | YES | |
| RxCUI: 1362900 | BHA - Butylated hydroxyanisole | Designated preferred name (PT) | YES | |
| RxCUI: 1362900 | BHA - Butylated hydroxyanisole | Full form of descriptor (FN) | YES | |
| RxCUI: 1362901 | calcium pyrophosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362902 | dimyristoylphosphatidylcholine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Designated preferred name (PT) | YES | |
| RxCUI: 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Full form of descriptor (FN) | YES | |
| RxCUI: 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362904 | glycylglycine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362905 | Raffinose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362905 | Raffinose | Designated preferred name (PT) | NO | |
| RxCUI: 1362905 | Raffinose | Full form of descriptor (FN) | NO | |
| RxCUI: 1362906 | Sarcosine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362906 | Sarcosine | Designated preferred name (PT) | YES | |
| RxCUI: 1362906 | Sarcosine | Full form of descriptor (FN) | YES | |
| RxCUI: 1362907 | Benzyl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362907 | Benzyl salicylate | Designated preferred name (PT) | YES | |
| RxCUI: 1362907 | Benzyl salicylate | Full form of descriptor (FN) | YES | |
| RxCUI: 1362907 | Benzyl salicylate | Designated preferred name (PT) | YES | |
| RxCUI: 1362907 | Benzyl salicylate | Full form of descriptor (FN) | YES | |
| RxCUI: 1362908 | butyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362909 | Carbomer-940 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362909 | Carbomer-940 | Designated preferred name (PT) | NO | |
| RxCUI: 1362909 | Carbomer-940 | Full form of descriptor (FN) | NO | |
| RxCUI: 1362909 | Carbomer-940 | Designated preferred name (PT) | NO | |
| RxCUI: 1362909 | Carbomer-940 | Full form of descriptor (FN) | NO | |
| RxCUI: 1362910 | creosol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362911 | diethanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362912 | saccharin calcium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1362913 | isododecane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362914 | saccharin sodium anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1362917 | aluminum silicate | British preferred term (PTGB) | YES | |
| RxCUI: 1362917 | aluminum silicate | Full form of descriptor (FN) | YES | |
| RxCUI: 1362917 | aluminum silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362917 | aluminum silicate | Designated preferred name (PT) | YES | |
| RxCUI: 1362920 | pentigide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362921 | Diethylphthalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362921 | Diethylphthalate | Designated preferred name (PT) | YES | |
| RxCUI: 1362921 | Diethylphthalate | Full form of descriptor (FN) | YES | |
| RxCUI: 1362921 | Diethylphthalate | Designated preferred name (PT) | YES | |
| RxCUI: 1362921 | Diethylphthalate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362921 | Diethylphthalate | Full form of descriptor (FN) | YES | |
| RxCUI: 1362922 | diisopropanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362925 | diisopropylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362926 | N,N-dimethylamphetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362926 | N,N-dimethylamphetamine | Full form of descriptor (FN) | NO | |
| RxCUI: 1362926 | N,N-dimethylamphetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362926 | N,N-dimethylamphetamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362926 | N,N-dimethylamphetamine | Designated preferred name (PT) | NO | |
| RxCUI: 1362926 | N,N-dimethylamphetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362927 | lauryl sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362927 | lauryl sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362928 | isostearyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362929 | methyl isobutyl ketone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362930 | rhodamine B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1362931 | Rosin | Designated preferred name (PT) | YES | |
| RxCUI: 1362931 | Rosin | Full form of descriptor (FN) | YES | |
| RxCUI: 1362931 | Rosin | Designated preferred name (PT) | YES | |
| RxCUI: 1362931 | Rosin | Full form of descriptor (FN) | YES | |
| RxCUI: 1362931 | Rosin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362931 | Rosin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362932 | methyl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362932 | methyl laurate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362933 | isohexadecane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1362933 | isohexadecane | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1362935 | heparin sodium, porcine 2 UNT/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362935 | heparin sodium, porcine 2 UNT/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362936 | tolnaftate Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1362937 | tolnaftate 1 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362937 | tolnaftate 1 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362937 | tolnaftate 1 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362938 | Molecular AF | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1362939 | tolnaftate 10 MG/ML [Molecular AF] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1362940 | tolnaftate Topical Oil [Molecular AF] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1362941 | Molecular AF Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1362942 | Molecular AF 1 % Antifungal Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1362942 | Molecular AF 1 % Antifungal Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362942 | Molecular AF 1 % Antifungal Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362942 | Molecular AF 1 % Antifungal Topical Oil | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1362943 | heparin sodium, porcine 15000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362944 | heparin sodium, porcine 15,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362944 | heparin sodium, porcine 15,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362945 | heparin sodium, porcine 250 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362946 | heparin sodium, porcine 250 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362947 | heparin sodium, porcine 3000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362948 | heparin sodium, porcine 3,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362948 | heparin sodium, porcine 3,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362949 | heparin sodium, porcine 4000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362950 | heparin sodium, porcine 4,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362950 | heparin sodium, porcine 4,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362951 | heparin sodium, porcine 6000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362952 | heparin sodium, porcine 6,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362952 | heparin sodium, porcine 6,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362953 | heparin sodium, porcine 66 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362954 | heparin sodium, porcine 66 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362957 | heparin sodium, porcine 8.3 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362958 | heparin sodium, porcine 8.3 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362961 | heparin sodium, porcine 0.25 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1362962 | heparin sodium, porcine 12.5 UNT per 50 ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1362962 | heparin sodium, porcine 12.5 UNT per 50 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1362962 | heparin sodium, porcine 12.5 UNT per 50 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 136300 | capromab pendetide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 136300 | capromab pendetide | Designated preferred name (PT) | NO | |
| RxCUI: 136300 | capromab pendetide | Full form of descriptor (FN) | NO | |
| RxCUI: 1363010 | brompheniramine maleate 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363011 | pseudoephedrine HCl 120 MG / brompheniramine maleate 10 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363011 | pseudoephedrine HCl 120 MG / brompheniramine maleate 10 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363014 | brompheniramine maleate 10 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363025 | brompheniramine maleate 10 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363025 | brompheniramine maleate 10 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363025 | brompheniramine maleate 10 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363027 | brompheniramine maleate 10 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363030 | propanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363030 | propanediol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363034 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363034 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363037 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / pseudoephedrine HCl 120 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363037 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / pseudoephedrine HCl 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363040 | isobutane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363043 | ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363043 | ether | Full form of descriptor (FN) | YES | |
| RxCUI: 1363043 | ether | Designated preferred name (PT) | YES | |
| RxCUI: 1363043 | ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363043 | ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363043 | ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363043 | ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363043 | ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363043 | ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363044 | diphenylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363045 | chromium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363046 | ferric nitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363047 | ferrous oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363048 | isobutyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363049 | Maltitol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363049 | Maltitol | Designated preferred name (PT) | YES | |
| RxCUI: 1363049 | Maltitol | Full form of descriptor (FN) | YES | |
| RxCUI: 1363050 | maltodextrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363051 | monophosphoryl lipid A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363052 | 1-decanol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363052 | 1-decanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363053 | Polydextrose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363053 | Polydextrose | Designated preferred name (PT) | YES | |
| RxCUI: 1363053 | Polydextrose | Full form of descriptor (FN) | YES | |
| RxCUI: 1363054 | salicyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363055 | sorbitan monolaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363056 | Sorbitan oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363056 | Sorbitan oleate | Designated preferred name (PT) | YES | |
| RxCUI: 1363056 | Sorbitan oleate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363056 | Sorbitan oleate | Full form of descriptor (FN) | YES | |
| RxCUI: 1363056 | Sorbitan oleate | Full form of descriptor (FN) | YES | |
| RxCUI: 1363056 | Sorbitan oleate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363057 | sorbitan monostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363058 | Sorbitan sesquioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363058 | Sorbitan sesquioleate | Designated preferred name (PT) | YES | |
| RxCUI: 1363058 | Sorbitan sesquioleate | Full form of descriptor (FN) | YES | |
| RxCUI: 1363058 | Sorbitan sesquioleate | Full form of descriptor (FN) | YES | |
| RxCUI: 1363059 | stannic oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363060 | sucrose stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363060 | sucrose stearate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363061 | tert-butyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363062 | 3-mercapto-1,2-propanediol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363062 | 3-mercapto-1,2-propanediol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363062 | 3-mercapto-1,2-propanediol | Full form of descriptor (FN) | YES | |
| RxCUI: 1363062 | 3-mercapto-1,2-propanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363062 | 3-mercapto-1,2-propanediol | Designated preferred name (PT) | YES | |
| RxCUI: 1363212 | 12 HR chlorpheniramine maleate 8 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363215 | chlorpheniramine maleate 8 MG / pseudoephedrine HCl 120 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363215 | chlorpheniramine maleate 8 MG / pseudoephedrine HCl 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363220 | 12 HR guaifenesin 400 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363220 | 12 HR guaifenesin 400 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1363223 | guaifenesin 400 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363223 | guaifenesin 400 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1363228 | Gentaved 100 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1363239 | brompheniramine maleate 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363240 | brompheniramine maleate 5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363241 | chlorpheniramine maleate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363242 | Chlorphenamine maleate 10 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363242 | Chlorphenamine maleate 10 mg/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363242 | Chlorphenamine maleate 10 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 1363242 | Chlorphenamine maleate 10 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 1363243 | chlorpheniramine maleate 10 MG/ML [Chlor-Trimeton] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363244 | chlorpheniramine maleate 10 MG/ML Injectable Solution [Chlor-Trimeton] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363244 | chlorpheniramine maleate 10 MG/ML Injectable Solution [Chlor-Trimeton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363245 | chlorpheniramine maleate 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363246 | chlorpheniramine maleate 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363256 | guaifenesin 600 MG / pseudoephedrine HCl 45 MG 12 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363256 | guaifenesin 600 MG / pseudoephedrine HCl 45 MG 12 HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1363256 | guaifenesin 600 MG / pseudoephedrine HCl 45 MG 12 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363256 | guaifenesin 600 MG / pseudoephedrine HCl 45 MG 12 HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1363263 | guaifenesin 600 MG / pseudoephedrine hydrochloride 45 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363263 | guaifenesin 600 MG / pseudoephedrine hydrochloride 45 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1363265 | brompheniramine maleate 12 MG / pseudoephedrine HCl 120 MG Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 1363265 | brompheniramine maleate 12 MG / pseudoephedrine HCl 120 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363265 | brompheniramine maleate 12 MG / pseudoephedrine HCl 120 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363265 | brompheniramine maleate 12 MG / pseudoephedrine HCl 120 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 1363267 | cabozantinib s-malate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1363267 | cabozantinib s-malate | Designated preferred name (PT) | YES | |
| RxCUI: 1363267 | cabozantinib s-malate | Full form of descriptor (FN) | YES | |
| RxCUI: 1363268 | cabozantinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363268 | cabozantinib | Designated preferred name (PT) | YES | |
| RxCUI: 1363268 | cabozantinib | Full form of descriptor (FN) | YES | |
| RxCUI: 1363268 | cabozantinib | Designated preferred name (PT) | YES | |
| RxCUI: 1363268 | cabozantinib | Full form of descriptor (FN) | YES | |
| RxCUI: 1363269 | cabozantinib 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1363270 | cabozantinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1363270 | cabozantinib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1363270 | cabozantinib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1363271 | cabozantinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1363272 | cabozantinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1363273 | cabozantinib 20 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1363273 | cabozantinib 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363273 | cabozantinib 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363273 | cabozantinib 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1363273 | cabozantinib 20 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1363274 | Cometriq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1363275 | cabozantinib 20 MG [Cometriq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1363276 | cabozantinib Oral Capsule [Cometriq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1363277 | Cometriq Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1363278 | Cometriq Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1363279 | Cometriq 20 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1363279 | Cometriq 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363279 | Cometriq 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363280 | cabozantinib 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1363281 | cabozantinib 80 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1363281 | cabozantinib 80 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363281 | cabozantinib 80 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363281 | cabozantinib 80 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1363281 | cabozantinib 80 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1363283 | cabozantinib 80 MG [Cometriq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1363284 | Cometriq 80 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1363284 | Cometriq 80 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363284 | Cometriq 80 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363288 | chlorpheniramine maleate 12 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1363288 | chlorpheniramine maleate 12 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363288 | chlorpheniramine maleate 12 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363289 | chlorpheniramine maleate 12 MG [Chlor-Trimeton] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1363290 | Chlor-Trimeton Allergy 12 MG 12HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1363290 | Chlor-Trimeton Allergy 12 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363290 | Chlor-Trimeton Allergy 12 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363290 | Chlor-Trimeton Allergy 12 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363291 | chlorpheniramine maleate 12 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363292 | chlorpheniramine maleate 12 MG Extended Release Oral Tablet [Chlor-Trimeton] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363292 | chlorpheniramine maleate 12 MG Extended Release Oral Tablet [Chlor-Trimeton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363293 | chlorpheniramine maleate 8 MG 8HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363293 | chlorpheniramine maleate 8 MG 8HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363293 | chlorpheniramine maleate 8 MG 8HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363294 | chlorpheniramine maleate 8 MG [Chlor-Trimeton] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363295 | 8 HR chlorpheniramine maleate 8 MG Extended Release Oral Tablet [Chlor-Trimeton] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363295 | 8 HR chlorpheniramine maleate 8 MG Extended Release Oral Tablet [Chlor-Trimeton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363295 | 8 HR chlorpheniramine maleate 8 MG Extended Release Oral Tablet [Chlor-Trimeton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363296 | chlorpheniramine maleate 8 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363297 | chlorpheniramine maleate 8 MG Extended Release Oral Tablet [Chlor-Trimeton] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363297 | chlorpheniramine maleate 8 MG Extended Release Oral Tablet [Chlor-Trimeton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363298 | pseudoephedrine sulfate 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363299 | pseudoephedrine sulfate 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363299 | pseudoephedrine sulfate 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363300 | Chlor-Trimeton Nasal Decongestant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1363301 | pseudoephedrine sulfate 60 MG [Chlor-Trimeton Nasal Decongestant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363302 | pseudoephedrine Oral Tablet [Chlor-Trimeton Nasal Decongestant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1363303 | Chlor-Trimeton Nasal Decongestant Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363304 | Chlor-Trimeton Nasal Decongestant Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363305 | pseudoephedrine sulfate 60 MG Oral Tablet [Chlor-Trimeton Nasal Decongestant] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363305 | pseudoephedrine sulfate 60 MG Oral Tablet [Chlor-Trimeton Nasal Decongestant] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363306 | chlorpheniramine maleate 2 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363306 | chlorpheniramine maleate 2 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1363306 | chlorpheniramine maleate 2 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363306 | chlorpheniramine maleate 2 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363306 | chlorpheniramine maleate 2 MG in 5 mL Oral Solution | Designated preferred name (PT) | YES | |
| RxCUI: 1363306 | chlorpheniramine maleate 2 MG in 5 mL Oral Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 1363307 | chlorpheniramine maleate 0.4 MG/ML [Chlor-Trimeton] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363308 | chlorpheniramine maleate 0.4 MG/ML Oral Solution [Chlor-Trimeton] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363308 | chlorpheniramine maleate 0.4 MG/ML Oral Solution [Chlor-Trimeton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363309 | chlorpheniramine maleate 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363309 | chlorpheniramine maleate 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363309 | chlorpheniramine maleate 4 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1363309 | chlorpheniramine maleate 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1363309 | chlorpheniramine maleate 4 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1363310 | chlorpheniramine maleate 4 MG [Chlor-Trimeton] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1363311 | Chlor-Trimeton 4Hour Allergy 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1363311 | Chlor-Trimeton 4Hour Allergy 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363311 | Chlor-Trimeton 4Hour Allergy 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363312 | cabozantinib 140 MG Daily Dose, 20 MG (84), 80 MG (28) Oral Capsule Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1363312 | cabozantinib 140 MG Daily Dose, 20 MG (84), 80 MG (28) Oral Capsule Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363312 | cabozantinib 140 MG Daily Dose, 20 MG (84), 80 MG (28) Oral Capsule Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363312 | cabozantinib 140 MG Daily Dose, 20 MG (84), 80 MG (28) Oral Capsule Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363314 | chlorpheniramine maleate 4 MG [Aller-Chlor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1363315 | Aller-Chlor 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363315 | Aller-Chlor 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363315 | Aller-Chlor 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1363316 | chlorpheniramine maleate 0.4 MG/ML [Aller-Chlor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363317 | chlorpheniramine maleate 0.4 MG/ML Oral Solution [Aller-Chlor] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363317 | chlorpheniramine maleate 0.4 MG/ML Oral Solution [Aller-Chlor] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363317 | chlorpheniramine maleate 0.4 MG/ML Oral Solution [Aller-Chlor] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363318 | chlorpheniramine maleate 4 MG [Diabetic Tussin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363319 | Diabetic Tussin Allergy Relief 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363319 | Diabetic Tussin Allergy Relief 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363319 | Diabetic Tussin Allergy Relief 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363320 | chlorpheniramine maleate 4 MG [Teldrin HBP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363321 | Teldrin HBP 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363321 | Teldrin HBP 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363321 | Teldrin HBP 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363322 | chlorpheniramine maleate 4 MG [Wal-finate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1363323 | Wal-Finate 4 Hour Allergy 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1363323 | Wal-Finate 4 Hour Allergy 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363323 | Wal-Finate 4 Hour Allergy 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363352 | hydroxyethyl starch 130-0.4 | Designated preferred name (PT) | YES | |
| RxCUI: 1363352 | hydroxyethyl starch 130-0.4 | Full form of descriptor (FN) | YES | |
| RxCUI: 1363352 | hydroxyethyl starch 130-0.4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363360 | ivermectin Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1363361 | ivermectin Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1363362 | ivermectin Oral Paste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1363363 | ivermectin 1.87 % Oral Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363363 | ivermectin 1.87 % Oral Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363363 | ivermectin 1.87 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363364 | guaiFENesin 525 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363364 | guaiFENesin 525 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1363364 | guaiFENesin 525 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363371 | guaifenesin 525 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363371 | guaifenesin 525 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1363375 | aluminum magnesium silicate 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363376 | sodium bicarbonate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363377 | aluminum magnesium silicate / calcium carbonate / sodium bicarbonate Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1363378 | aluminum magnesium silicate / calcium carbonate / sodium bicarbonate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1363379 | aluminum magnesium silicate / calcium carbonate / sodium bicarbonate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1363380 | aluminum magnesium silicate / calcium carbonate / sodium bicarbonate Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1363381 | aluminum magnesium silicate / calcium carbonate / sodium bicarbonate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1363382 | almasilate 125 MG / calcium carbonate 200 MG / sodium bicarbonate 200 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363382 | almasilate 125 MG / calcium carbonate 200 MG / sodium bicarbonate 200 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363382 | almasilate 125 MG / calcium carbonate 200 MG / sodium bicarbonate 200 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363382 | almasilate 125 MG / calcium carbonate 200 MG / sodium bicarbonate 200 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363383 | aluminum magnesium silicate 83.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363384 | calcium carbonate 133.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363385 | sodium bicarbonate 133.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363386 | aluminum magnesium silicate / calcium carbonate / sodium bicarbonate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1363387 | almasiliate 83.3 MG / calcium carbonate 133.3 MG / sodium bicarbonate 133.3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363387 | almasiliate 83.3 MG / calcium carbonate 133.3 MG / sodium bicarbonate 133.3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363387 | almasiliate 83.3 MG / calcium carbonate 133.3 MG / sodium bicarbonate 133.3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363387 | almasiliate 83.3 MG / calcium carbonate 133.3 MG / sodium bicarbonate 133.3 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363388 | hydroxyethyl starch 130-0.4 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1363389 | hydroxyethyl starch 130-0.4 Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1363390 | hydroxyethyl starch 130-0.4 Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1363391 | hydroxyethyl starch 130-0.4 6 % Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363391 | hydroxyethyl starch 130-0.4 6 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363391 | hydroxyethyl starch 130-0.4 6 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363392 | hydroxyethyl starch 130-0.4 60 MG/ML [Voluven] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1363394 | Voluven 6 % in 500 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1363394 | Voluven 6 % in 500 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363394 | Voluven 6 % in 500 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363408 | Cometriq 140 MG Daily Dose Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1363408 | Cometriq 140 MG Daily Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363408 | Cometriq 140 MG Daily Dose Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363408 | Cometriq 140 MG Daily Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363408 | Cometriq 140 MG Daily Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363409 | cabozantinib 100 MG Daily Dose, 20 MG (28), 80 MG (28) Oral Capsule Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1363409 | cabozantinib 100 MG Daily Dose, 20 MG (28), 80 MG (28) Oral Capsule Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363409 | cabozantinib 100 MG Daily Dose, 20 MG (28), 80 MG (28) Oral Capsule Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363409 | cabozantinib 100 MG Daily Dose, 20 MG (28), 80 MG (28) Oral Capsule Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363410 | Cometriq 100 MG Daily Dose Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1363410 | Cometriq 100 MG Daily Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363410 | Cometriq 100 MG Daily Dose Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363410 | Cometriq 100 MG Daily Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363410 | Cometriq 100 MG Daily Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363414 | Chlorate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1363415 | chlorpheniramine maleate 4 MG [Chlorate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363416 | chlorpheniramine Oral Tablet [Chlorate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1363417 | Chlorate Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363418 | Chlorate Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363419 | chlorpheniramine maleate 4 MG Oral Tablet [Chlorate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363419 | chlorpheniramine maleate 4 MG Oral Tablet [Chlorate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363422 | Gentaved 100 Irrigation Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363423 | GentaVed 100 100 MG/ML Irrigation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363423 | GentaVed 100 100 MG/ML Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363423 | GentaVed 100 100 MG/ML Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363423 | GentaVed 100 100 MG/ML Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363426 | boron nitride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363427 | sodium lauroyl lactylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1363429 | alpha-arbutin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363430 | Atropa belladonna whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363431 | caprylyl trisiloxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363432 | decarboxy carnosine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1363434 | isopropyl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363435 | lauric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1363437 | lime peel extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363438 | sodium starch glycolate type a corn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1363440 | Passiflora edulis seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363441 | polyethylene glycol 450 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363442 | methyl stearic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363443 | muskmelon extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363444 | phytosphingosine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363445 | polyglyceryl-2 dipolyhydroxystearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363446 | soy sterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363468 | Rhodomyrtus tomentosa fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363469 | Vachellia farnesiana flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363470 | Wal-Sleep Z | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1363471 | diphenhydramine hydrochloride 25 MG [Wal-Sleep Z] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1363471 | diphenhydramine hydrochloride 25 MG [Wal-Sleep Z] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1363472 | diphenhydrAMINE Oral Capsule [Wal-Sleep Z] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1363472 | diphenhydrAMINE Oral Capsule [Wal-Sleep Z] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1363473 | Wal-Sleep Z Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1363474 | Wal-Sleep Z Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1363475 | Wal-Sleep Z 25 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1363475 | Wal-Sleep Z 25 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1363475 | Wal-Sleep Z 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363475 | Wal-Sleep Z 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363486 | Ivercare | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1363487 | ivermectin 0.0187 MG/MG [Ivercare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363490 | IverCare 1.87 % Oral Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363490 | IverCare 1.87 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363490 | IverCare 1.87 % Oral Paste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363492 | xylometazoline hydrochloride 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1363493 | xylometazoline HCl 0.1 % Nasal Spray | Full form of descriptor (FN) | YES | |
| RxCUI: 1363493 | xylometazoline HCl 0.1 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363493 | xylometazoline HCl 0.1 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363493 | xylometazoline HCl 0.1 % Nasal Spray | Designated preferred name (PT) | YES | |
| RxCUI: 1363493 | xylometazoline HCl 0.1 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1363494 | Aqua Maris Decongestant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1363495 | xylometazoline hydrochloride 1 MG/ML [Aqua Maris Decongestant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363496 | xylometazoline Nasal Spray [Aqua Maris Decongestant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1363497 | Aqua Maris Decongestant Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363498 | Aqua Maris Decongestant Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363499 | AQUA MARIS Decongestant 0.1 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363499 | AQUA MARIS Decongestant 0.1 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363499 | AQUA MARIS Decongestant 0.1 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363500 | phenylpropanolamine hydrochloride 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363501 | brompheniramine maleate 12 MG / phenylephrine hydrochloride 15 MG / phenylpropanolamine hydrochloride 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363502 | brompheniramine maleate 6 MG / pseudoephedrine HCl 60 MG Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 1363502 | brompheniramine maleate 6 MG / pseudoephedrine HCl 60 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363502 | brompheniramine maleate 6 MG / pseudoephedrine HCl 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363502 | brompheniramine maleate 6 MG / pseudoephedrine HCl 60 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 1363503 | brompheniramine maleate 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363503 | brompheniramine maleate 6 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 1363503 | brompheniramine maleate 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363503 | brompheniramine maleate 6 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 1363504 | dexbrompheniramine maleate 6 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363504 | dexbrompheniramine maleate 6 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363505 | acetaminophen 500 MG / dexbrompheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363505 | acetaminophen 500 MG / dexbrompheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363505 | acetaminophen 500 MG / dexbrompheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363506 | APAP 500 MG / dexbrompheniramine maleate 2 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363506 | APAP 500 MG / dexbrompheniramine maleate 2 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363507 | acetaminophen 650 MG / dexbrompheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363507 | acetaminophen 650 MG / dexbrompheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363507 | acetaminophen 650 MG / dexbrompheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363508 | brompheniramine maleate 2 MG / dextromethorphan HBr 15 MG / guaiFENesin 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363508 | brompheniramine maleate 2 MG / dextromethorphan HBr 15 MG / guaiFENesin 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363508 | brompheniramine maleate 2 MG / dextromethorphan HBr 15 MG / guaiFENesin 200 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1363509 | brompheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363510 | brompheniramine tannate 2 MG/mL / dextromethorphan tannate 6 MG/mL / phenylephrine tannate 5 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363510 | brompheniramine tannate 2 MG/mL / dextromethorphan tannate 6 MG/mL / phenylephrine tannate 5 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363510 | brompheniramine tannate 2 MG/mL / dextromethorphan tannate 6 MG/mL / phenylephrine tannate 5 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363511 | brompheniramine maleate 2 MG/ML / phenylephrine hydrochloride 5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363512 | brompheniramine tannate 10 MG per 2 ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363512 | brompheniramine tannate 10 MG per 2 ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363513 | dexbrompheniramine maleate 2 MG / pseudoephedrine HCl 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363513 | dexbrompheniramine maleate 2 MG / pseudoephedrine HCl 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1363553 | PCxx Neutral Foam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1363554 | sodium fluoride 20 MG/ML [PCxx Neutral Foam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1363555 | sodium fluoride Oral Foam [PCxx Neutral Foam] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1363556 | PCxx Neutral Foam Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1363557 | PCxx Neutral Foam Oral Foam Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1363558 | PCxx Neutral Foam 2 % Oral Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363558 | PCxx Neutral Foam 2 % Oral Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363558 | PCxx Neutral Foam 2 % Oral Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363558 | PCxx Neutral Foam 2 % Oral Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1363559 | dimethicone 1.2 % Topical Lotion (227 GM) / dimethicone 1.3 % Topical Lotion (71 GM) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1363559 | dimethicone 1.2 % Topical Lotion (227 GM) / dimethicone 1.3 % Topical Lotion (71 GM) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363561 | slim amaranth pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363561 | slim amaranth pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363561 | slim amaranth pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363562 | Rumex acetosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363563 | white clover pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363563 | white clover pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363564 | alum, potassium anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1363565 | decyl palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363566 | laureth-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363567 | hypromellose 2910 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363568 | carbomer-974P | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363568 | carbomer-974P | Designated preferred name (PT) | YES | |
| RxCUI: 1363568 | carbomer-974P | Full form of descriptor (FN) | YES | |
| RxCUI: 1363569 | Dimethicone 350 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363569 | Dimethicone 350 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363569 | Dimethicone 350 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363570 | PEG-30 dipolyhydroxystearate (5000 MW) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363570 | PEG-30 dipolyhydroxystearate (5000 MW) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363570 | PEG-30 dipolyhydroxystearate (5000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363571 | 1,2-octanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363572 | methyl gluceth-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363573 | laureth-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363574 | methyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363575 | hexyldecanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363576 | cocamidopropylamine oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363577 | laureth-12 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363578 | cyclomethicone 4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363579 | dimethiconol (41 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363580 | dipalmitoyl hydroxyproline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363581 | sodium C14-16 olefin sulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1363583 | hypromellose 2910-5cP | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363584 | low-substituted hydroxypropyl cellulose, unspecified | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363584 | low-substituted hydroxypropyl cellulose, unspecified | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363585 | hydroxypropyl methylcellulose 2208 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363586 | hydroxypropyl methylcellulose 2910 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363587 | hydroxypropyl methylcellulose phthalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363588 | hypromellose 2208 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363589 | hypromellose 2910 3cP | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363590 | hypromellose 2910 50cP | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363593 | cocamidopropyl hydroxysultaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363594 | diethanolamine bis(C8-C18 perfluoroalkylethyl)phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363595 | diethanolamine cetyl phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363596 | diethylhexyl 2,6-naphthalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363597 | diglycol stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363598 | dihydroxyethyl cocamine oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363599 | diisobutyl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 13636 | o-nitro-p-phenylenediamine | Designated preferred name (PT) | NO | |
| RxCUI: 13636 | o-nitro-p-phenylenediamine | Full form of descriptor (FN) | NO | |
| RxCUI: 13636 | o-nitro-p-phenylenediamine | Designated preferred name (PT) | NO | |
| RxCUI: 13636 | o-nitro-p-phenylenediamine | Full form of descriptor (FN) | NO | |
| RxCUI: 1363600 | diisopropyl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363601 | diisopropyl sebacate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363602 | diisostearyl malate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363603 | Dilsea carnosa extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363604 | hydroxyethyl cellulose (3000 CPS at 1%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363605 | hydroxyethyl urea | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363606 | hydroxymethyl cellulose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363607 | hydroxypropyl corn starch (5% substitution by weight) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363608 | hydroxypropyl betadex | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363608 | hydroxypropyl betadex | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363608 | hydroxypropyl betadex | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363609 | Hypnea musciformis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363610 | melon extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363611 | PEG-15 glyceryl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363612 | PEG-20 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363613 | PEG-4 dilaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363614 | PEG-4 laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363615 | PEG-40 sorbitan diisostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363616 | PEG-5 oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363617 | PEG-6 lauramide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363618 | PEG-60 almond glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363619 | peg-75 lanolin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363620 | PEG-75 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363621 | PEG-8 dioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363622 | peg-8 distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363623 | PEG-8 laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363624 | pomelo extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363624 | pomelo extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363625 | quaternium-18 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363626 | quaternium-52 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363627 | Asparagopsis armata extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363628 | butyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363629 | brompheniramine tannate 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363630 | phenylephrine tannate 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363631 | phenylephrine tannate 15 MG / brompheniramine tannate 6 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363631 | phenylephrine tannate 15 MG / brompheniramine tannate 6 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363643 | sorbitan trioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363644 | squalane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363645 | steviol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363646 | sucrose acetate isobutyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363647 | sucrose monolaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363648 | brompheniramine maleate 6 MG / phenylephrine HCl 15 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363648 | brompheniramine maleate 6 MG / phenylephrine HCl 15 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363651 | chlorpheniramine maleate 2 MG / methscopolamine nitrate 1.25 MG / phenylephrine hydrochloride 15 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363696 | propylene carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363697 | sodium silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363697 | sodium silicate | Designated preferred name (PT) | YES | |
| RxCUI: 1363697 | sodium silicate | Full form of descriptor (FN) | YES | |
| RxCUI: 1363698 | aluminum tristearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363699 | stearamidoethyl diethylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363700 | dibutyl sebacate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363701 | sorbitan monopalmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363702 | Chlorothymol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363702 | Chlorothymol | Designated preferred name (PT) | YES | |
| RxCUI: 1363702 | Chlorothymol | Full form of descriptor (FN) | YES | |
| RxCUI: 1363703 | Wool fat | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1363703 | Wool fat | Designated preferred name (PT) | NO | |
| RxCUI: 1363703 | Wool fat | Full form of descriptor (FN) | NO | |
| RxCUI: 1363703 | Wool fat | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363704 | magnesium carbonate hydroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363705 | lauric acid diethanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363706 | Isoeugenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363706 | Isoeugenol | Designated preferred name (PT) | YES | |
| RxCUI: 1363706 | Isoeugenol | Full form of descriptor (FN) | YES | |
| RxCUI: 1363706 | Isoeugenol | Designated preferred name (PT) | YES | |
| RxCUI: 1363706 | Isoeugenol | Full form of descriptor (FN) | YES | |
| RxCUI: 1363708 | methylethyl ketone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363709 | N,N'-diphenyl-P-phenylenediamine | Designated preferred name (PT) | NO | |
| RxCUI: 1363709 | N,N'-diphenyl-P-phenylenediamine | Full form of descriptor (FN) | NO | |
| RxCUI: 1363709 | N,N'-diphenyl-P-phenylenediamine | Designated preferred name (PT) | NO | |
| RxCUI: 1363709 | N,N'-diphenyl-P-phenylenediamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363709 | N,N'-diphenyl-P-phenylenediamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363709 | N,N'-diphenyl-P-phenylenediamine | Full form of descriptor (FN) | NO | |
| RxCUI: 1363710 | N-isopropyl-N-phenyl-4-phenylenediamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363711 | Morpholinylmercaptobenzothiazole | Designated preferred name (PT) | NO | |
| RxCUI: 1363711 | Morpholinylmercaptobenzothiazole | Full form of descriptor (FN) | NO | |
| RxCUI: 1363711 | Morpholinylmercaptobenzothiazole | Designated preferred name (PT) | NO | |
| RxCUI: 1363711 | Morpholinylmercaptobenzothiazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363711 | Morpholinylmercaptobenzothiazole | Full form of descriptor (FN) | NO | |
| RxCUI: 1363712 | padimate A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363713 | TMTM - Tetramethylthiuram monosulfide | Full form of descriptor (FN) | NO | |
| RxCUI: 1363713 | TMTM - Tetramethylthiuram monosulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363713 | TMTM - Tetramethylthiuram monosulfide | Designated preferred name (PT) | NO | |
| RxCUI: 1363713 | TMTM - Tetramethylthiuram monosulfide | Full form of descriptor (FN) | NO | |
| RxCUI: 1363713 | TMTM - Tetramethylthiuram monosulfide | Designated preferred name (PT) | NO | |
| RxCUI: 1363713 | TMTM - Tetramethylthiuram monosulfide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363714 | neurotrophin 3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363716 | saffron stain | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363717 | isomalt | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363718 | Bacitracin methylenedisalycylic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363718 | Bacitracin methylenedisalycylic acid | Designated preferred name (PT) | NO | |
| RxCUI: 1363718 | Bacitracin methylenedisalycylic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 1363718 | Bacitracin methylenedisalycylic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363719 | Tylosin phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363719 | Tylosin phosphate | Designated preferred name (PT) | NO | |
| RxCUI: 1363719 | Tylosin phosphate | Full form of descriptor (FN) | NO | |
| RxCUI: 1363720 | myristyl lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363721 | niacinamide ascorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363722 | lithium benzoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1363724 | dextromethorphan tannate 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363725 | pyrilamine tannate 16 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363726 | dextromethorphan tannate 15 MG / phenylephrine tannate 10 MG / pyrilamine tannate 16 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363726 | dextromethorphan tannate 15 MG / phenylephrine tannate 10 MG / pyrilamine tannate 16 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363729 | Eucalyptus globulus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363730 | Sambucus nigra whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363731 | dextromethorphan tannate 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1363732 | pyrilamine tannate 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1363733 | dextromethorphan tannate 25 MG / phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363733 | dextromethorphan tannate 25 MG / phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1363736 | dextromethorphan tannate 5 MG/mL / phenylephrine tannate 2.5 MG/mL / pyrilamine tannate 6 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363736 | dextromethorphan tannate 5 MG/mL / phenylephrine tannate 2.5 MG/mL / pyrilamine tannate 6 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363749 | phenylephrine tannate 10 MG / pyrilamine tannate 16 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363749 | phenylephrine tannate 10 MG / pyrilamine tannate 16 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363750 | phenylephrine tannate 10 MG / pyrilamine tannate 16 MG [Deconsal CT] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363751 | Deconsal CT 10 MG / 16 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363751 | Deconsal CT 10 MG / 16 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363751 | Deconsal CT 10 MG / 16 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363752 | chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1363752 | chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363752 | chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363753 | sodium fluoride 0.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363754 | eucalyptol / menthol / sodium fluoride / thymol Dental Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1363755 | eucalyptol / menthol / sodium fluoride / thymol Mouthwash Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1363756 | eucalyptol / menthol / sodium fluoride / thymol Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1363757 | eucalyptol / menthol / sodium fluoride / thymol Mouthwash | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1363758 | eucalyptol / menthol / sodium fluoride / thymol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1363759 | eucalyptol 0.092 % / menthol 0.042 % / sodium fluoride 0.025 % / thymol 0.064 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363759 | eucalyptol 0.092 % / menthol 0.042 % / sodium fluoride 0.025 % / thymol 0.064 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363759 | eucalyptol 0.092 % / menthol 0.042 % / sodium fluoride 0.025 % / thymol 0.064 % Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363760 | ceftiofur hydrochloride 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1363761 | ceftiofur Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1363762 | ceftiofur HCl 500 MG in 10 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363762 | ceftiofur HCl 500 MG in 10 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363762 | ceftiofur HCl 500 MG in 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363763 | Spectramast | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1363764 | ceftiofur hydrochloride 50 MG/ML [Spectramast] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363765 | ceftiofur Prefilled Syringe [Spectramast] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1363766 | Spectramast Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363767 | Spectramast DC 500 MG in 10 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363767 | Spectramast DC 500 MG in 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363767 | Spectramast DC 500 MG in 10 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363767 | Spectramast DC 500 MG in 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363768 | ceftiofur hydrochloride 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363769 | ceftiofur hydrochloride 50 MG/ML Prefilled Syringe [Spectramast] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363769 | ceftiofur hydrochloride 50 MG/ML Prefilled Syringe [Spectramast] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363770 | phenylephrine tannate 2 MG/ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363771 | Ah-Chew D Suspension | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1363772 | phenylephrine tannate 2 MG/ML [Ah-Chew D Suspension] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363773 | phenylephrine Extended Release Suspension [Ah-Chew D Suspension] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1363774 | Ah-Chew D Suspension Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363775 | Ah-Chew D Suspension Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363776 | phenylephrine tannate 2 MG/ML Extended Release Suspension [Ah-Chew D Suspension] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363776 | phenylephrine tannate 2 MG/ML Extended Release Suspension [Ah-Chew D Suspension] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363776 | phenylephrine tannate 2 MG/ML Extended Release Suspension [Ah-Chew D Suspension] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363777 | phenylephrine HCl 10 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363777 | phenylephrine HCl 10 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363778 | phenylephrine hydrochloride 10 MG [Ah-Chew D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363779 | phenylephrine hydrochloride 10 MG Chewable Tablet [Ah-Chew D] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363779 | phenylephrine hydrochloride 10 MG Chewable Tablet [Ah-Chew D] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363780 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1363780 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1363780 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1363781 | chlorpheniramine maleate 12 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363784 | phenylephrine hydrochloride 10 MG [Nasop] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363785 | Nasop12 10 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363785 | Nasop12 10 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363785 | Nasop12 10 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363785 | Nasop12 10 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363786 | phenylephrine HCl 10 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363786 | phenylephrine HCl 10 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363787 | Nasop 10 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363787 | Nasop 10 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363787 | Nasop 10 MG Disintegrating Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363788 | phenylephrine tannate 2.5 MG/ML / pyrilamine tannate 6 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363789 | V-Tann Suspension | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1363790 | phenylephrine tannate 2.5 MG/ML / pyrilamine tannate 6 MG/ML [V-Tann Suspension] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363791 | phenylephrine / pyrilamine Oral Suspension [V-Tann Suspension] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1363792 | V-Tann Suspension Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363793 | V-Tann Suspension Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363794 | phenylephrine tannate 2.5 MG/ML / pyrilamine tannate 6 MG/ML Oral Suspension [V-Tann Suspension] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363794 | phenylephrine tannate 2.5 MG/ML / pyrilamine tannate 6 MG/ML Oral Suspension [V-Tann Suspension] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363795 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363795 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363796 | V-Tann Chewable | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1363797 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG [V-Tann Chewable] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363798 | phenylephrine / pyrilamine Chewable Tablet [V-Tann Chewable] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1363799 | V-Tann Chewable Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363800 | V-Tann Chewable Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363801 | V-Tann Chewable Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363802 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet [V-Tann Chewable] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363802 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet [V-Tann Chewable] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363816 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG [Viravan-T] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363817 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet [Viravan-T] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363817 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet [Viravan-T] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363818 | phenylephrine tannate 1.5 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363821 | Nasop Suspension | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1363822 | phenylephrine tannate 1.5 MG/ML [Nasop Suspension] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363823 | phenylephrine Oral Suspension [Nasop Suspension] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1363824 | Nasop Suspension Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363825 | Nasop Suspension Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363826 | phenylephrine tannate 1.5 MG/ML Oral Suspension [Nasop Suspension] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363826 | phenylephrine tannate 1.5 MG/ML Oral Suspension [Nasop Suspension] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363826 | phenylephrine tannate 1.5 MG/ML Oral Suspension [Nasop Suspension] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363827 | distearoylethyl hydroxyethylmonium methosulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363828 | acetaminophen 80 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363828 | acetaminophen 80 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1363828 | acetaminophen 80 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363831 | Pistacia lentiscus seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363896 | Berri-Freez | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1363897 | menthol 0.045 MG/MG [Berri-Freez] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1363898 | menthol Topical Gel [Berri-Freez] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1363899 | Berri-Freez Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1363900 | Berri-Freez 4.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363900 | Berri-Freez 4.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1363900 | Berri-Freez 4.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363900 | Berri-Freez 4.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1363900 | Berri-Freez 4.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1363915 | bis-ethoxydiglycol succinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363916 | carmoisine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363917 | Streptococcus pneumoniae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363918 | Streptococcus agalactiae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363919 | Streptococcus viridans group | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363920 | Streptococcus mutans | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363985 | Actinidia chinensis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363986 | triethanolamine lauryl sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363987 | sodium myristoyl sarcosinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1363989 | sodium cocoyl sarcosinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1363991 | limonene, ()- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1363992 | disodium ricinoleic monoethanolamide sulfosuccinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1363994 | monosodium ethylenediaminetetraacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1363996 | isostearyl isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1363997 | triethanolamine benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364048 | Lysol Touch of Foam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1364049 | benzalkonium chloride 1 MG/ML [Lysol Touch of Foam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1364050 | benzalkonium Medicated Liquid Soap [Lysol Touch of Foam] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1364051 | Lysol Touch of Foam Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1364052 | Lysol Touch of Foam 0.1 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1364052 | Lysol Touch of Foam 0.1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364052 | Lysol Touch of Foam 0.1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364052 | Lysol Touch of Foam 0.1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364052 | Lysol Touch of Foam 0.1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364053 | dimethicone 23 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1364054 | dimethicone 2.3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364054 | dimethicone 2.3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364054 | dimethicone 2.3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364055 | dimethicone 43.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1364056 | dimethicone 4.36 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364056 | dimethicone 4.36 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364056 | dimethicone 4.36 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364057 | Loxicom | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1364058 | meloxicam 5 MG/ML [Loxicom] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1364059 | meloxicam Injectable Solution [Loxicom] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1364060 | Loxicom Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1364061 | Loxicom 5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364061 | Loxicom 5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364061 | Loxicom 5 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1364062 | mineral oil 99.9 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364062 | mineral oil 99.9 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364062 | mineral oil 99.9 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364096 | methyl salicylate 0.025 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1364097 | camphor 1.2 % / menthol 2.7 % / methyl salicylate 2.5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364097 | camphor 1.2 % / menthol 2.7 % / methyl salicylate 2.5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364097 | camphor 1.2 % / menthol 2.7 % / methyl salicylate 2.5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364098 | chloroxylenol / triclosan Soap Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1364099 | chloroxylenol / triclosan Medicated Liquid Soap | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1364100 | chloroxylenol 0.2 % / triclosan 0.2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364100 | chloroxylenol 0.2 % / triclosan 0.2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364100 | chloroxylenol 0.2 % / triclosan 0.2 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364104 | pasireotide diaspartate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364104 | pasireotide diaspartate | Designated preferred name (PT) | NO | |
| RxCUI: 1364104 | pasireotide diaspartate | Full form of descriptor (FN) | NO | |
| RxCUI: 1364105 | pasireotide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364105 | pasireotide | Designated preferred name (PT) | YES | |
| RxCUI: 1364105 | pasireotide | Full form of descriptor (FN) | YES | |
| RxCUI: 1364105 | pasireotide | Designated preferred name (PT) | YES | |
| RxCUI: 1364105 | pasireotide | Full form of descriptor (FN) | YES | |
| RxCUI: 1364106 | pasireotide 0.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364109 | pasireotide 0.3 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364109 | pasireotide 0.3 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364109 | pasireotide 0.3 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364109 | pasireotide 0.3 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 136411 | sildenafil | Full form of descriptor (FN) | YES | |
| RxCUI: 136411 | sildenafil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 136411 | sildenafil | Designated preferred name (PT) | YES | |
| RxCUI: 136411 | sildenafil | Full form of descriptor (FN) | YES | |
| RxCUI: 136411 | sildenafil | Designated preferred name (PT) | YES | |
| RxCUI: 1364110 | Signifor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1364111 | pasireotide 0.3 MG/ML [Signifor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364113 | Signifor Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364114 | Signifor 0.3 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364114 | Signifor 0.3 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364114 | Signifor 0.3 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364114 | Signifor 0.3 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364115 | pasireotide 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364116 | pasireotide 0.6 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364116 | pasireotide 0.6 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364116 | pasireotide 0.6 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364116 | pasireotide 0.6 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364117 | pasireotide 0.6 MG/ML [Signifor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364118 | Signifor 0.6 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364118 | Signifor 0.6 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364118 | Signifor 0.6 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364118 | Signifor 0.6 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364119 | pasireotide 0.9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364120 | pasireotide 0.9 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364120 | pasireotide 0.9 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364120 | pasireotide 0.9 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364120 | pasireotide 0.9 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364121 | pasireotide 0.9 MG/ML [Signifor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364122 | Signifor 0.9 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364122 | Signifor 0.9 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364122 | Signifor 0.9 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364122 | Signifor 0.9 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364131 | Camellia sinensis seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364132 | tall oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364267 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 20 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364268 | Foam Safe | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1364269 | chlorhexidine gluconate 40 MG/ML [Foam Safe] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1364270 | chlorhexidine Medicated Liquid Soap [Foam Safe] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1364271 | Foam Safe Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1364272 | FOAM SAFE 4 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1364272 | FOAM SAFE 4 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364272 | FOAM SAFE 4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364272 | FOAM SAFE 4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364275 | isoprene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364276 | new coccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364277 | polydatin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364278 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364278 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364278 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364282 | Jointflex Ice | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1364283 | menthol 85 MG/ML [Jointflex Ice] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1364284 | menthol Topical Lotion [Jointflex Ice] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1364285 | Jointflex Ice Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1364286 | JointFlex-OUT PAIN ICE 8.5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364286 | JointFlex-OUT PAIN ICE 8.5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364286 | JointFlex-OUT PAIN ICE 8.5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364286 | JointFlex-OUT PAIN ICE 8.5 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1364287 | phenethylamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364288 | Echinacea pallida preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364289 | gadofosveset trisodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364290 | gadofosveset | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364290 | gadofosveset | Designated preferred name (PT) | NO | |
| RxCUI: 1364290 | gadofosveset | Full form of descriptor (FN) | NO | |
| RxCUI: 1364290 | gadofosveset | Designated preferred name (PT) | NO | |
| RxCUI: 1364290 | gadofosveset | Full form of descriptor (FN) | NO | |
| RxCUI: 1364291 | Lemon | Designated preferred name (PT) | YES | |
| RxCUI: 1364291 | Lemon | Full form of descriptor (FN) | YES | |
| RxCUI: 1364291 | Lemon | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364292 | Lobelia inflata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364292 | Lobelia inflata whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364293 | coco-caprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364294 | acetylated lanolin alcohols | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364295 | clove preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364296 | isobutylparaben | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364321 | Daunorubicin citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364321 | Daunorubicin citrate | Designated preferred name (PT) | NO | |
| RxCUI: 1364321 | Daunorubicin citrate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1364321 | Daunorubicin citrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1364347 | ponatinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364347 | ponatinib | Designated preferred name (PT) | YES | |
| RxCUI: 1364347 | ponatinib | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364347 | ponatinib | Full form of descriptor (FN) | YES | |
| RxCUI: 1364347 | ponatinib | Designated preferred name (PT) | YES | |
| RxCUI: 1364347 | ponatinib | Full form of descriptor (FN) | YES | |
| RxCUI: 1364348 | ponatinib 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364348 | ponatinib 15 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364349 | ponatinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1364349 | ponatinib Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364349 | ponatinib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1364349 | ponatinib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1364350 | ponatinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1364350 | ponatinib Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364351 | ponatinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1364351 | ponatinib Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364352 | PONATinib 15 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1364352 | PONATinib 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364352 | PONATinib 15 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364352 | PONATinib 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364352 | PONATinib 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364352 | PONATinib 15 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364352 | PONATinib 15 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1364353 | Iclusig | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1364354 | ponatinib 15 MG [Iclusig] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364354 | ponatinib 15 MG [Iclusig] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364355 | ponatinib Oral Tablet [Iclusig] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1364355 | ponatinib Oral Tablet [Iclusig] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364356 | Iclusig Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364357 | Iclusig Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364358 | Iclusig 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364358 | Iclusig 15 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364358 | Iclusig 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364358 | Iclusig 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364358 | Iclusig 15 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364358 | Iclusig 15 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364359 | ponatinib 45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364359 | ponatinib 45 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364360 | PONATinib 45 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1364360 | PONATinib 45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364360 | PONATinib 45 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364360 | PONATinib 45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364360 | PONATinib 45 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364360 | PONATinib 45 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364360 | PONATinib 45 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1364361 | ponatinib 45 MG [Iclusig] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364361 | ponatinib 45 MG [Iclusig] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364362 | Iclusig 45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364362 | Iclusig 45 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364362 | Iclusig 45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364362 | Iclusig 45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364362 | Iclusig 45 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364362 | Iclusig 45 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364374 | sulfamethazine sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364375 | levocarnitine tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364375 | levocarnitine tartrate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1364376 | stearamidopropyl dimethylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364376 | stearamidopropyl dimethylamine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364377 | hydrogenated coco-glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364378 | cetyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364379 | glyceryl stearate SE | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364380 | polyglyceryl-3 diisostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364381 | cetyl ricinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364382 | lauryl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364383 | polyethylene glycol 2000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364384 | poloxamer 338 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364385 | ceramide 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364386 | octyldodecyl neopentanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364387 | o-cymen-5-ol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364388 | lauramine oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364389 | salicylic acid 20 MG/ML [Stridex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364390 | salicylic acid Medicated Liquid Soap [Stridex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1364391 | Stridex Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364392 | STRIDEX Conditioning Acne Scrub 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364392 | STRIDEX Conditioning Acne Scrub 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364392 | STRIDEX Conditioning Acne Scrub 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364392 | STRIDEX Conditioning Acne Scrub 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364396 | Lasalocid A sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364396 | Lasalocid A sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364396 | Lasalocid A sodium | Designated preferred name (PT) | NO | |
| RxCUI: 1364396 | Lasalocid A sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 1364397 | lasalocid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364398 | sodium xylenesulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364403 | Irvingia gabonensis seed butter extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364404 | long pepper extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364406 | malpighia glabra fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364407 | Viola odorata leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364410 | ioxapine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364415 | Adasuve | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1364424 | Bivigam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1364425 | immunoglobulin G, human 100 MG/ML [Bivigam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364427 | Bivigam Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364429 | sodium cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364430 | apixaban | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364430 | apixaban | Designated preferred name (PT) | YES | |
| RxCUI: 1364430 | apixaban | Full form of descriptor (FN) | YES | |
| RxCUI: 1364430 | apixaban | Designated preferred name (PT) | YES | |
| RxCUI: 1364430 | apixaban | Full form of descriptor (FN) | YES | |
| RxCUI: 1364431 | apixaban 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364432 | apixaban Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1364432 | apixaban Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1364432 | apixaban Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1364433 | apixaban Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1364434 | apixaban Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1364435 | apixaban 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364435 | apixaban 2.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1364435 | apixaban 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364435 | apixaban 2.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1364436 | Eliquis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1364437 | apixaban 2.5 MG [Eliquis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364438 | apixaban Oral Tablet [Eliquis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1364439 | Eliquis Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364440 | Eliquis Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364441 | Eliquis 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364441 | Eliquis 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364441 | Eliquis 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364442 | disodium caproamphodipropionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364444 | apixaban 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364445 | apixaban 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364445 | apixaban 5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1364445 | apixaban 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364445 | apixaban 5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1364446 | apixaban 5 MG [Eliquis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364447 | Eliquis 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364447 | Eliquis 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364447 | Eliquis 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364449 | crofelemer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364449 | crofelemer | Designated preferred name (PT) | YES | |
| RxCUI: 1364449 | crofelemer | Full form of descriptor (FN) | YES | |
| RxCUI: 1364449 | crofelemer | Designated preferred name (PT) | YES | |
| RxCUI: 1364449 | crofelemer | Full form of descriptor (FN) | YES | |
| RxCUI: 1364450 | crofelemer 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364451 | crofelemer Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1364451 | crofelemer Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1364451 | crofelemer Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1364452 | crofelemer Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1364453 | crofelemer Delayed Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1364454 | crofelemer 125 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364454 | crofelemer 125 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364455 | Fulyzaq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1364456 | crofelemer 125 MG [Fulyzaq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1364457 | crofelemer Delayed Release Oral Tablet [Fulyzaq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1364458 | Fulyzaq Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1364459 | Fulyzaq Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1364460 | Fulyzaq 125 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1364460 | Fulyzaq 125 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364460 | Fulyzaq 125 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364461 | disodium cocoamphodiacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364462 | cocoamphodiacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364463 | disodium ethylene dicocamide PEG-15 disulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364465 | disodium sulfosalicylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364467 | Haemophilus influenzae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364468 | teduglutide | Full form of descriptor (FN) | YES | |
| RxCUI: 1364468 | teduglutide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364468 | teduglutide | Designated preferred name (PT) | YES | |
| RxCUI: 1364468 | teduglutide | Full form of descriptor (FN) | YES | |
| RxCUI: 1364468 | teduglutide | Designated preferred name (PT) | YES | |
| RxCUI: 1364470 | teduglutide Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1364470 | teduglutide Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1364470 | teduglutide Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 1364472 | teduglutide 5 MG Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 1364472 | teduglutide 5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364472 | teduglutide 5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364472 | teduglutide 5 MG Injection | Designated preferred name (PT) | YES | |
| RxCUI: 1364473 | Gattex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1364476 | Gattex Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364477 | Gattex 5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364477 | Gattex 5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364477 | Gattex 5 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364478 | Lomitapide mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364478 | Lomitapide mesilate | Full form of descriptor (FN) | YES | |
| RxCUI: 1364478 | Lomitapide mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364478 | Lomitapide mesilate | Designated preferred name (PT) | YES | |
| RxCUI: 1364479 | lomitapide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364479 | lomitapide | Designated preferred name (PT) | YES | |
| RxCUI: 1364479 | lomitapide | Full form of descriptor (FN) | YES | |
| RxCUI: 1364479 | lomitapide | Designated preferred name (PT) | YES | |
| RxCUI: 1364479 | lomitapide | Full form of descriptor (FN) | YES | |
| RxCUI: 1364480 | lomitapide 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364481 | lomitapide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1364481 | lomitapide Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1364481 | lomitapide Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1364482 | lomitapide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1364483 | lomitapide Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1364484 | lomitapide 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364484 | lomitapide 10 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1364484 | lomitapide 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364484 | lomitapide 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364484 | lomitapide 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364484 | lomitapide 10 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1364485 | Juxtapid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1364486 | lomitapide 10 MG [Juxtapid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364487 | lomitapide Oral Capsule [Juxtapid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1364488 | Juxtapid Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364489 | Juxtapid Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364490 | Juxtapid 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364490 | Juxtapid 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364490 | Juxtapid 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364490 | Juxtapid 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364491 | lomitapide 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364492 | lomitapide 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364492 | lomitapide 20 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1364492 | lomitapide 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364492 | lomitapide 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364492 | lomitapide 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364492 | lomitapide 20 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1364493 | lomitapide 20 MG [Juxtapid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364494 | Juxtapid 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364494 | Juxtapid 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364494 | Juxtapid 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364494 | Juxtapid 20 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364495 | lomitapide 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364496 | lomitapide 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364496 | lomitapide 5 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1364496 | lomitapide 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364496 | lomitapide 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364496 | lomitapide 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364496 | lomitapide 5 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1364497 | lomitapide 5 MG [Juxtapid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364498 | Juxtapid 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364498 | Juxtapid 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364498 | Juxtapid 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364498 | Juxtapid 5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364499 | sodium acrylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364500 | acrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364501 | sodium ascorbyl phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364503 | bedaquiline fumarate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364503 | bedaquiline fumarate | Designated preferred name (PT) | YES | |
| RxCUI: 1364503 | bedaquiline fumarate | Full form of descriptor (FN) | YES | |
| RxCUI: 1364504 | bedaquiline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364504 | bedaquiline | Designated preferred name (PT) | YES | |
| RxCUI: 1364504 | bedaquiline | Full form of descriptor (FN) | YES | |
| RxCUI: 1364504 | bedaquiline | Designated preferred name (PT) | YES | |
| RxCUI: 1364504 | bedaquiline | Full form of descriptor (FN) | YES | |
| RxCUI: 1364505 | bedaquiline 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364506 | bedaquiline Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1364506 | bedaquiline Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1364506 | bedaquiline Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1364507 | bedaquiline Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1364508 | bedaquiline Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1364509 | bedaquiline 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1364509 | bedaquiline 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364509 | bedaquiline 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364509 | bedaquiline 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364509 | bedaquiline 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1364510 | Sirturo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1364511 | bedaquiline 100 MG [Sirturo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364512 | bedaquiline Oral Tablet [Sirturo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1364513 | Sirturo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364514 | Sirturo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364515 | Sirturo 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364515 | Sirturo 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364515 | Sirturo 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364515 | Sirturo 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364516 | sodium C12-15 pareth-3 sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364518 | sodium diethyl oxalacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364520 | sodium lauroyl isethionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364522 | sodium methyl 2-sulfolaurate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364524 | sodium methyl cocoyl taurate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364526 | sodium sarcosinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364528 | sodium tripolyphosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364528 | sodium tripolyphosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364529 | triphosphoric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364530 | trisodium ethylenediamine disuccinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364532 | sodium pyrophosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364533 | pyrophosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364535 | Normlshield | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1364536 | dimethicone 45 MG/ML [Normlshield] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1364537 | dimethicone Topical Cream [Normlshield] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1364538 | Normlshield Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1364539 | Normlshield 4.5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1364539 | Normlshield 4.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364539 | Normlshield 4.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364539 | Normlshield 4.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364567 | trisodium HEDTA | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364568 | N-(hydroxyethyl)ethylenediaminetriacetic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364569 | sodium sulfide nonahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364570 | menthol 0.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1364571 | benzyl alcohol / menthol Mucosal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1364572 | benzyl alcohol / menthol Mucous Membrane Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1364573 | benzyl alcohol / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1364574 | benzyl alcohol 1 % / menthol 0.04 % Mucous Membrane Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364574 | benzyl alcohol 1 % / menthol 0.04 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364574 | benzyl alcohol 1 % / menthol 0.04 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364575 | Oragesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1364576 | benzyl alcohol 0.01 ML/ML / menthol 0.4 MG/ML [Oragesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1364577 | benzyl alcohol / menthol Mucous Membrane Topical Solution [Oragesic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1364578 | Oragesic Mucosal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1364579 | ORAGESIC 1 % / 0.04 % Mucous Membrane Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1364579 | ORAGESIC 1 % / 0.04 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364579 | ORAGESIC 1 % / 0.04 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364579 | ORAGESIC 1 % / 0.04 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364580 | cabozantinib 60 MG Daily Dose, 20 MG Oral Capsule 84 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1364580 | cabozantinib 60 MG Daily Dose, 20 MG Oral Capsule 84 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364580 | cabozantinib 60 MG Daily Dose, 20 MG Oral Capsule 84 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364580 | cabozantinib 60 MG Daily Dose, 20 MG Oral Capsule 84 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364581 | Cometriq 60 MG Daily Dose Carton | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1364581 | Cometriq 60 MG Daily Dose Carton | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364581 | Cometriq 60 MG Daily Dose Carton | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364581 | Cometriq 60 MG Daily Dose Carton | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364581 | Cometriq 60 MG Daily Dose Carton | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364582 | eltrombopag 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1364583 | eltrombopag 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364583 | eltrombopag 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364584 | eltrombopag 100 MG [Promacta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1364585 | Promacta 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1364585 | Promacta 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364585 | Promacta 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364585 | Promacta 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364586 | isoflupredone acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364586 | isoflupredone acetate | Designated preferred name (PT) | NO | |
| RxCUI: 1364586 | isoflupredone acetate | Full form of descriptor (FN) | NO | |
| RxCUI: 1364588 | isoflupredone acetate 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1364590 | isoflupredone Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1364591 | isoflupredone acetate 2 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364592 | Predef | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1364593 | isoflupredone acetate 2 MG/ML [Predef] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1364594 | isoflupredone Injectable Suspension [Predef] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1364595 | Predef Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1364596 | isoflupredone acetate 2 MG/ML Injectable Suspension [Predef] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1364596 | isoflupredone acetate 2 MG/ML Injectable Suspension [Predef] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364596 | isoflupredone acetate 2 MG/ML Injectable Suspension [Predef] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364791 | disodium myristoyl glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364793 | sodium arsenate, dibasic | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364794 | sodium arsenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364796 | sodium arsenate, dibasic, heptahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364806 | diphenhydramine hydrochloride 50 MG [Allermax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1364806 | diphenhydramine hydrochloride 50 MG [Allermax] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1364807 | Allermax 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364807 | Allermax 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364807 | Allermax 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1364807 | Allermax 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1364848 | Chateal 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1364848 | Chateal 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364848 | Chateal 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364849 | bovine intestinal mucosa preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364849 | bovine intestinal mucosa preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364850 | sodium lauroyl glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364852 | sodium taurodeoxycholate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364853 | taurine deoxycholate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364854 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vit-B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 1.1 MG / vit-B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 6.75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364855 | vit-C 60 MG / cholecalciferol 0.01 MG / folate 0.3 MG / vitamin B3 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / vitamin B1 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364856 | bis(1-methylamyl) sodium sulfosuccinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364858 | acetone sodium bisulfite | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364859 | ethylparaben sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364894 | etidronate tetrasodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364895 | sodium isethionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364896 | isethionic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364897 | sodium isostearoyl lactylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364899 | sodium laureth-2 sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364901 | sodium lauroyl sarcosinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364903 | brompheniramine maleate 4 MG / pseudoephedrine hydrochloride 60 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364903 | brompheniramine maleate 4 MG / pseudoephedrine hydrochloride 60 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364904 | sodium myristoyl isethionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364906 | sodium palm kernelate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364910 | sodium palmitate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364912 | sodium palmitoyl proline | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364914 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364914 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364914 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364914 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364914 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364915 | sodium percarbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364916 | brompheniramine maleate 1 MG/mL / dextromethorphan hydrobromide 4 MG/mL / pseudoephedrine hydrochloride 15 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364916 | brompheniramine maleate 1 MG/mL / dextromethorphan hydrobromide 4 MG/mL / pseudoephedrine hydrochloride 15 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364917 | Sodium pidolate | Full form of descriptor (FN) | YES | |
| RxCUI: 1364917 | Sodium pidolate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364917 | Sodium pidolate | Designated preferred name (PT) | YES | |
| RxCUI: 1364917 | Sodium pidolate | Full form of descriptor (FN) | YES | |
| RxCUI: 1364917 | Sodium pidolate | Designated preferred name (PT) | YES | |
| RxCUI: 1364918 | pseudoephedrine hydrochloride 8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1364919 | dextromethorphan hydrobromide 15 MG / guaifenesin 100 MG / pseudoephedrine hydrochloride 40 MG per 5 ML Syrup | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364919 | dextromethorphan hydrobromide 15 MG / guaifenesin 100 MG / pseudoephedrine hydrochloride 40 MG per 5 ML Syrup | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1364919 | dextromethorphan hydrobromide 15 MG / guaifenesin 100 MG / pseudoephedrine hydrochloride 40 MG per 5 ML Syrup | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364919 | dextromethorphan hydrobromide 15 MG / guaifenesin 100 MG / pseudoephedrine hydrochloride 40 MG per 5 ML Syrup | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1364920 | guaifenesin 200 MG / pseudoephedrine hydrochloride 40 MG per 5 ML Syrup | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364920 | guaifenesin 200 MG / pseudoephedrine hydrochloride 40 MG per 5 ML Syrup | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1364920 | guaifenesin 200 MG / pseudoephedrine hydrochloride 40 MG per 5 ML Syrup | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364920 | guaifenesin 200 MG / pseudoephedrine hydrochloride 40 MG per 5 ML Syrup | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1364921 | sodium polymetaphosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364922 | polymetaphosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364924 | sodium pyrrolidone carboxylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364926 | sodium starch glycolate type B potato | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364928 | diethylcarbamazine citrate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1364929 | diethylcarbamazine citrate 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364929 | diethylcarbamazine citrate 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364929 | diethylcarbamazine citrate 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364930 | diethylcarbamazine citrate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1364931 | diethylcarbamazine citrate 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364931 | diethylcarbamazine citrate 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364931 | diethylcarbamazine citrate 50 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 1364931 | diethylcarbamazine citrate 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364931 | diethylcarbamazine citrate 50 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 1364932 | sodium stearoyl glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364934 | diethylcarbamazine citrate 400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1364935 | diethylcarbamazine citrate 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1364935 | diethylcarbamazine citrate 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364935 | diethylcarbamazine citrate 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1364936 | sodium stearyl fumarate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364938 | sodium tallowate, beef | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364939 | sodium tallowate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364940 | sodium thioglycolate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1364943 | caldiamide sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364944 | caldiamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364945 | sodium cetostearyl sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364947 | 5-bromo-5-nitro-1,3-dioxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364948 | heptylundecyl hydroxystearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364949 | linoleamidopropyl dimethylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364950 | meadowfoamamidopropyl betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364953 | ponatinib hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1364953 | ponatinib hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 1364953 | ponatinib hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1364953 | ponatinib hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 1364986 | Aconitum kusnezoffi root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364987 | Carica papaya whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364988 | Ficus carica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364989 | Rosa centifolia flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1364990 | Rosmarinus officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364991 | Trifolium pratense leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1364992 | menthol 0.0252 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1364993 | camphor 3 % / menthol 2.52 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1364993 | camphor 3 % / menthol 2.52 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1364993 | camphor 3 % / menthol 2.52 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1364994 | Dr. Bob Arnot's Pain Patch | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1364995 | camphor 0.03 MG/MG / menthol 0.0252 MG/MG [Dr. Bob Arnot's Pain Patch] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1364997 | Dr. Bob Arnot's Pain Patch Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1364999 | DR. BOB ARNOT'S PAIN 3 % / 2.52 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1364999 | DR. BOB ARNOT'S PAIN 3 % / 2.52 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1364999 | DR. BOB ARNOT'S PAIN 3 % / 2.52 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365000 | camphor 1 % / menthol 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1365000 | camphor 1 % / menthol 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365000 | camphor 1 % / menthol 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1365575 | Equi-Bute | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1365576 | phenylbutazone 200 MG/ML [Equi-Bute] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1365577 | phenylbutazone Injectable Solution [Equi-Bute] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1365578 | Equi-Bute Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1365579 | phenylbutazone 200 MG/ML Injectable Solution [Equi-Bute] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365579 | phenylbutazone 200 MG/ML Injectable Solution [Equi-Bute] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 136560 | Nimbex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 136561 | Cisatracurium besilate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 136561 | Cisatracurium besilate | Full form of descriptor (FN) | YES | |
| RxCUI: 136561 | Cisatracurium besilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 136561 | Cisatracurium besilate | Designated preferred name (PT) | YES | |
| RxCUI: 1365652 | oxcarbazepine Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1365652 | oxcarbazepine Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365653 | OXcarbazepine 150 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1365653 | OXcarbazepine 150 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365653 | OXcarbazepine 150 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365653 | OXcarbazepine 150 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365653 | OXcarbazepine 150 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1365654 | oxcarbazepine 150 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1365654 | oxcarbazepine 150 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1365655 | Oxtellar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1365656 | oxcarbazepine 150 MG [Oxtellar] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1365656 | oxcarbazepine 150 MG [Oxtellar] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365657 | oxcarbazepine Extended Release Oral Tablet [Oxtellar] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1365657 | oxcarbazepine Extended Release Oral Tablet [Oxtellar] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365658 | Oxtellar Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1365659 | Oxtellar Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1365660 | Oxtellar XR 150 MG 24HR Extended Release Oral Tablet, Once-Daily | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1365660 | Oxtellar XR 150 MG 24HR Extended Release Oral Tablet, Once-Daily | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365660 | Oxtellar XR 150 MG 24HR Extended Release Oral Tablet, Once-Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365660 | Oxtellar XR 150 MG 24HR Extended Release Oral Tablet, Once-Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365660 | Oxtellar XR 150 MG 24HR Extended Release Oral Tablet, Once-Daily | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1365661 | oxcarbazepine 150 MG Extended Release Oral Tablet [Oxtellar] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1365661 | oxcarbazepine 150 MG Extended Release Oral Tablet [Oxtellar] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1365661 | oxcarbazepine 150 MG Extended Release Oral Tablet [Oxtellar] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365671 | camphor 0.032 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1365672 | camphor 3.2 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1365672 | camphor 3.2 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1365672 | camphor 3.2 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365673 | camphor 0.779 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1365674 | camphor 7.79 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1365674 | camphor 7.79 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1365674 | camphor 7.79 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365684 | Micrell | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1365685 | chloroxylenol 5 MG/ML [Micrell] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1365686 | chloroxylenol Medicated Liquid Soap [Micrell] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1365687 | Micrell Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1365688 | Micrell 0.5 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1365688 | Micrell 0.5 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1365688 | Micrell 0.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365688 | Micrell 0.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365690 | panthenol 0.005 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1365691 | panthenol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1365692 | panthenol Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1365693 | panthenol 0.5 MG per 100 ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1365693 | panthenol 0.5 MG per 100 ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1365693 | panthenol 0.5 MG per 100 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365694 | Equi-Phar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1365695 | phenylbutazone 200 MG/ML [Equi-Phar] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1365696 | phenylbutazone Injectable Solution [Equi-Phar] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1365697 | Equi-Phar Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1365698 | phenylbutazone 200 MG/ML Injectable Solution [Equi-Phar] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365698 | phenylbutazone 200 MG/ML Injectable Solution [Equi-Phar] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1365705 | potassium nitrite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1365706 | Ligusticum wallichii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1365707 | Panax notoginseng root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1365708 | Zanthoxylum nitidum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1365709 | Asarum heterotropoides var. mandshuricum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1365710 | ceteareth-22 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1365842 | OXcarbazepine 300 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1365842 | OXcarbazepine 300 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365842 | OXcarbazepine 300 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365842 | OXcarbazepine 300 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365842 | OXcarbazepine 300 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1365843 | oxcarbazepine 300 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1365843 | oxcarbazepine 300 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1365844 | OXcarbazepine 600 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1365844 | OXcarbazepine 600 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365844 | OXcarbazepine 600 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365844 | OXcarbazepine 600 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365844 | OXcarbazepine 600 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1365845 | oxcarbazepine 600 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1365845 | oxcarbazepine 600 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1365846 | oxcarbazepine 300 MG [Oxtellar] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1365846 | oxcarbazepine 300 MG [Oxtellar] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365847 | Oxtellar XR 300 MG 24HR Extended Release Oral Tablet, Once-Daily | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1365847 | Oxtellar XR 300 MG 24HR Extended Release Oral Tablet, Once-Daily | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365847 | Oxtellar XR 300 MG 24HR Extended Release Oral Tablet, Once-Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365847 | Oxtellar XR 300 MG 24HR Extended Release Oral Tablet, Once-Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365847 | Oxtellar XR 300 MG 24HR Extended Release Oral Tablet, Once-Daily | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1365848 | oxcarbazepine 300 MG Extended Release Oral Tablet [Oxtellar] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1365848 | oxcarbazepine 300 MG Extended Release Oral Tablet [Oxtellar] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1365848 | oxcarbazepine 300 MG Extended Release Oral Tablet [Oxtellar] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365849 | oxcarbazepine 600 MG [Oxtellar] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1365849 | oxcarbazepine 600 MG [Oxtellar] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365850 | Oxtellar XR 600 MG 24HR Extended Release Oral Tablet, Once-Daily | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1365850 | Oxtellar XR 600 MG 24HR Extended Release Oral Tablet, Once-Daily | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1365850 | Oxtellar XR 600 MG 24HR Extended Release Oral Tablet, Once-Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365850 | Oxtellar XR 600 MG 24HR Extended Release Oral Tablet, Once-Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365850 | Oxtellar XR 600 MG 24HR Extended Release Oral Tablet, Once-Daily | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1365851 | oxcarbazepine 600 MG Extended Release Oral Tablet [Oxtellar] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1365851 | oxcarbazepine 600 MG Extended Release Oral Tablet [Oxtellar] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1365851 | oxcarbazepine 600 MG Extended Release Oral Tablet [Oxtellar] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365862 | Ilevro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1365863 | nepafenac 3 MG/ML [Ilevro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1365864 | nepafenac Ophthalmic Suspension [Ilevro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1365865 | Ilevro Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1365866 | ILEVRO 0.3 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1365866 | ILEVRO 0.3 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365866 | ILEVRO 0.3 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365866 | ILEVRO 0.3 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1365880 | ketoprofen 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1365899 | MONO-LINYAH 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1365899 | MONO-LINYAH 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1365899 | MONO-LINYAH 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365902 | glucosamine sulfate 500 MG / chondroitin sulfates 400 MG / dimethyl sulfone 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365902 | glucosamine sulfate 500 MG / chondroitin sulfates 400 MG / dimethyl sulfone 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1365902 | glucosamine sulfate 500 MG / chondroitin sulfates 400 MG / dimethyl sulfone 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1365969 | rubella virus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1365970 | Thiostrepton | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1365970 | Thiostrepton | Designated preferred name (PT) | NO | |
| RxCUI: 1365970 | Thiostrepton | Full form of descriptor (FN) | NO | |
| RxCUI: 1365975 | Varizig | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1365976 | varicella-zoster immune globulin 100 UNT/ML [Varizig] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1365978 | Varizig Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1365979 | VARIZIG 125 UNT in 1.2 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1365979 | VARIZIG 125 UNT in 1.2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365979 | VARIZIG 125 UNT in 1.2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1365979 | VARIZIG 125 UNT in 1.2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365980 | vitamin C 35 MG/mL / cholecalciferol 0.01 MG/mL / sodium fluoride 0.55 MG/mL / vitamin A palmitate 450 MCG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1365980 | vitamin C 35 MG/mL / cholecalciferol 0.01 MG/mL / sodium fluoride 0.55 MG/mL / vitamin A palmitate 450 MCG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365980 | vitamin C 35 MG/mL / cholecalciferol 0.01 MG/mL / sodium fluoride 0.55 MG/mL / vitamin A palmitate 450 MCG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365980 | vitamin C 35 MG/mL / cholecalciferol 0.01 MG/mL / sodium fluoride 0.55 MG/mL / vitamin A palmitate 450 MCG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1365980 | vitamin C 35 MG/mL / cholecalciferol 0.01 MG/mL / sodium fluoride 0.55 MG/mL / vitamin A palmitate 450 MCG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365984 | ascorbic acid 35 MG/ML / cholecalciferol 400 UNT/ML / retinyl palmitate 1500 UNT/ML / sodium fluoride 1.1 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1365984 | ascorbic acid 35 MG/ML / cholecalciferol 400 UNT/ML / retinyl palmitate 1500 UNT/ML / sodium fluoride 1.1 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365984 | ascorbic acid 35 MG/ML / cholecalciferol 400 UNT/ML / retinyl palmitate 1500 UNT/ML / sodium fluoride 1.1 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365984 | ascorbic acid 35 MG/ML / cholecalciferol 400 UNT/ML / retinyl palmitate 1500 UNT/ML / sodium fluoride 1.1 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365984 | ascorbic acid 35 MG/ML / cholecalciferol 400 UNT/ML / retinyl palmitate 1500 UNT/ML / sodium fluoride 1.1 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1365991 | Fast Freeze Naturally Cool | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1365992 | menthol 100 MG/ML [Fast Freeze Naturally Cool] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1365993 | menthol Topical Spray [Fast Freeze Naturally Cool] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1365994 | Fast Freeze Naturally Cool Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1365995 | FAST FREEZE Naturally Cool 10 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1365995 | FAST FREEZE Naturally Cool 10 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365995 | FAST FREEZE Naturally Cool 10 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365995 | FAST FREEZE Naturally Cool 10 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1365996 | menthol 0.035 MG/MG [Fast Freeze Naturally Cool] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1365997 | menthol Topical Gel [Fast Freeze Naturally Cool] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1365998 | FAST FREEZE 3.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1365998 | FAST FREEZE 3.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365998 | FAST FREEZE 3.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1365998 | FAST FREEZE 3.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366021 | sulfur 6 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366021 | sulfur 6 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366021 | sulfur 6 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366027 | carrot juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 13661 | Nitroalkane oxidase | Designated preferred name (PT) | NO | |
| RxCUI: 13661 | Nitroalkane oxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 13661 | Nitroalkane oxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366113 | Hura crepitans sap extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366115 | bacitracin zinc 0.5 UNT/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1366116 | bacitracin zinc 500 UNT/GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1366116 | bacitracin zinc 500 UNT/GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366116 | bacitracin zinc 500 UNT/GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366117 | Lice MD | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1366118 | piperonyl butoxide 40 MG/ML / pyrethrins 3.3 MG/ML [Lice MD] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366119 | piperonyl butoxide / pyrethrins Medicated Shampoo [Lice MD] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1366120 | Lice MD Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1366121 | LiceMD 4 % / 0.33 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366121 | LiceMD 4 % / 0.33 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366121 | LiceMD 4 % / 0.33 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366138 | vitamin E 34 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1366139 | cholecalciferol / vitamin E Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1366140 | cholecalciferol / vitamin E Wafer Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1366141 | cholecalciferol / vitamin E Oral Wafer | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1366142 | cholecalciferol / vitamin E | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1366143 | cholecalciferol 14,000 UNT / vitamin E 34 UNT Chewable Oral Wafer | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366143 | cholecalciferol 14,000 UNT / vitamin E 34 UNT Chewable Oral Wafer | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1366143 | cholecalciferol 14,000 UNT / vitamin E 34 UNT Chewable Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366144 | Replesta NX | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1366145 | cholecalciferol 14000 UNT / vitamin E 34 UNT [Replesta NX] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1366146 | cholecalciferol / vitamin E Oral Wafer [Replesta NX] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1366147 | Replesta NX Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1366148 | Replesta NX Wafer Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1366149 | Replesta NX 14,000 UNT / 34 UNT Chewable Oral Wafer | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1366149 | Replesta NX 14,000 UNT / 34 UNT Chewable Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366149 | Replesta NX 14,000 UNT / 34 UNT Chewable Oral Wafer | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366150 | piperine 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1366151 | arginine / folic acid / piperine / vitamin B12 / vitamin B6 Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1366152 | arginine / folic acid / piperine / vitamin B12 / vitamin B6 Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1366153 | arginine / folic acid / piperine / vitamin B12 / vitamin B6 Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1366154 | arginine / folic acid / piperine / vitamin B12 / vitamin B6 | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1366155 | arginine 500 MG / folate 2 MG / piperine 5 MG / vitamin B12 0.5 MG / vitamin B6 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366155 | arginine 500 MG / folate 2 MG / piperine 5 MG / vitamin B12 0.5 MG / vitamin B6 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366155 | arginine 500 MG / folate 2 MG / piperine 5 MG / vitamin B12 0.5 MG / vitamin B6 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366189 | clobazam 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1366189 | clobazam 2.5 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1366190 | clobazam Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1366190 | clobazam Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1366191 | clobazam Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1366191 | clobazam Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1366192 | cloBAZam 2.5 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366192 | cloBAZam 2.5 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366192 | cloBAZam 2.5 MG in 1 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1366192 | cloBAZam 2.5 MG in 1 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1366192 | cloBAZam 2.5 MG in 1 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1366193 | clobazam 2.5 MG/ML [Onfi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1366193 | clobazam 2.5 MG/ML [Onfi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1366194 | clobazam Oral Suspension [Onfi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1366194 | clobazam Oral Suspension [Onfi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1366195 | Onfi Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1366196 | Onfi 2.5 MG in 1 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1366196 | Onfi 2.5 MG in 1 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1366196 | Onfi 2.5 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366196 | Onfi 2.5 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366196 | Onfi 2.5 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366197 | dimethyl sulfoxide 600 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1366198 | dimethyl sulfoxide / fluocinolone Otic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1366199 | dimethyl sulfoxide / fluocinolone Otic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1366200 | dimethyl sulfoxide / fluocinolone | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1366201 | fluocinolone acetonide 0.01 % / dimethyl sulfoxide 60 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366201 | fluocinolone acetonide 0.01 % / dimethyl sulfoxide 60 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366202 | Synotic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1366203 | dimethyl sulfoxide 600 MG/ML / fluocinolone acetonide 0.1 MG/ML [Synotic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366204 | dimethyl sulfoxide / fluocinolone Otic Solution [Synotic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1366205 | Synotic Otic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1366206 | Synotic 0.01 % / 60 % Otic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366206 | Synotic 0.01 % / 60 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366206 | Synotic 0.01 % / 60 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366211 | simethicone Oral Tablet [Bicarsim] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1366212 | Bicarsim Forte 125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366212 | Bicarsim Forte 125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366212 | Bicarsim Forte 125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366212 | Bicarsim Forte 125 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1366222 | Xylazine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366222 | Xylazine hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 1366222 | Xylazine hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 1366223 | carbomer interpolymer type B (allyl pentaerythritol crosslinked) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366224 | manganese acetate tetrahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366226 | oxacycloheptadec-8-en-2-one, (8Z)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366227 | dimethicone 20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366228 | tricontanyl povidone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366228 | tricontanyl povidone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366229 | potassium azeloyl diglycinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366231 | PEG PPG116-66 copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366232 | dimethiconol (2000 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366313 | camphor 56 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1366314 | menthol 56 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1366315 | camphor 5.6 % / menthol 5.6 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366315 | camphor 5.6 % / menthol 5.6 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366315 | camphor 5.6 % / menthol 5.6 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366316 | camphor 6 % / menthol 16 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366316 | camphor 6 % / menthol 16 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366316 | camphor 6 % / menthol 16 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366320 | Angelica biserrata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366321 | Bambusa textilis stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366322 | Ceratonia siliqua whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366324 | Citrus junos fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366325 | Coix lacryma-jobi seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366326 | Glycine max whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366327 | Ocimum gratissimum leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366328 | Orchis mascula whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366329 | Oryza sativa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366330 | Pinus palustris leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366331 | Tagetes minuta flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366333 | levonorgestrel 0.000583 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1366334 | levonorgestrel 13.5 MG Intrauterine System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1366334 | levonorgestrel 13.5 MG Intrauterine System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366334 | levonorgestrel 13.5 MG Intrauterine System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366334 | levonorgestrel 13.5 MG Intrauterine System | Designated preferred name (PT) | YES | |
| RxCUI: 1366334 | levonorgestrel 13.5 MG Intrauterine System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366334 | levonorgestrel 13.5 MG Intrauterine System | Full form of descriptor (FN) | YES | |
| RxCUI: 1366335 | Skyla | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1366336 | levonorgestrel 0.000583 MG/HR [Skyla] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1366338 | Skyla Drug Implant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1366339 | Skyla 13.5 MG Intrauterine System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1366339 | Skyla 13.5 MG Intrauterine System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366339 | Skyla 13.5 MG Intrauterine System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366339 | Skyla 13.5 MG Intrauterine System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366339 | Skyla 13.5 MG Intrauterine System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366342 | levonorgestrel 0.00354 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1366343 | levonorgestrel 36 MG Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366343 | levonorgestrel 36 MG Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366343 | levonorgestrel 36 MG Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366344 | levonorgestrel 0.00354 MG/HR [Norplant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366345 | levonorgestrel 0.00354 MG/HR Drug Implant [Norplant] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366345 | levonorgestrel 0.00354 MG/HR Drug Implant [Norplant] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366345 | levonorgestrel 0.00354 MG/HR Drug Implant [Norplant] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366345 | levonorgestrel 0.00354 MG/HR Drug Implant [Norplant] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366491 | chlorcyclizine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1366492 | chlorcyclizine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1366493 | chlorcyclizine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1366494 | chlorcyclizine HCl 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366494 | chlorcyclizine HCl 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1366495 | Ahist Antihistamine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1366496 | chlorcyclizine hydrochloride 25 MG [Ahist Antihistamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1366497 | chlorcyclizine Oral Tablet [Ahist Antihistamine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1366498 | Ahist Antihistamine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1366499 | Ahist Antihistamine Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1366500 | Ahist Antihistamine 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366500 | Ahist Antihistamine 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366500 | Ahist Antihistamine 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1366503 | methylephedrine hydrochloride, DL- 0.583 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1366504 | acetaminophen / caffeine / chlorpheniramine / guaifenesin / N-methylephedrine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1366504 | acetaminophen / caffeine / chlorpheniramine / guaifenesin / N-methylephedrine Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366505 | acetaminophen / caffeine / chlorpheniramine / guaifenesin / N-methylephedrine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1366505 | acetaminophen / caffeine / chlorpheniramine / guaifenesin / N-methylephedrine Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366506 | acetaminophen / caffeine / chlorpheniramine / guaifenesin / N-methylephedrine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1366506 | acetaminophen / caffeine / chlorpheniramine / guaifenesin / N-methylephedrine Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366507 | acetaminophen / caffeine / chlorpheniramine / guaifenesin / N-methylephedrine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1366507 | acetaminophen / caffeine / chlorpheniramine / guaifenesin / N-methylephedrine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366508 | APAP 10 MG/ML / Caffeine 1 MG/ML / Chlorpheniramine Maleate 0.083 MG/ML / Guaifenesin 2.78 MG/ML / METHYLEPHEDRINE HYDROCHLORIDE, DL- 0.583 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366508 | APAP 10 MG/ML / Caffeine 1 MG/ML / Chlorpheniramine Maleate 0.083 MG/ML / Guaifenesin 2.78 MG/ML / METHYLEPHEDRINE HYDROCHLORIDE, DL- 0.583 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366508 | APAP 10 MG/ML / Caffeine 1 MG/ML / Chlorpheniramine Maleate 0.083 MG/ML / Guaifenesin 2.78 MG/ML / METHYLEPHEDRINE HYDROCHLORIDE, DL- 0.583 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366508 | APAP 10 MG/ML / Caffeine 1 MG/ML / Chlorpheniramine Maleate 0.083 MG/ML / Guaifenesin 2.78 MG/ML / METHYLEPHEDRINE HYDROCHLORIDE, DL- 0.583 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366515 | chromous chloride 0.35 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1366516 | chromous chloride Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1366517 | chromous chloride Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1366518 | chromous chloride Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1366519 | chromium chloride 350 MCG MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366519 | chromium chloride 350 MCG MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366519 | chromium chloride 350 MCG MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366537 | Tepadina | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1366548 | budesonide 9 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1366549 | budesonide Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1366550 | budesonide 9 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1366550 | budesonide 9 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366550 | budesonide 9 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366550 | budesonide 9 MG 24HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1366550 | budesonide 9 MG 24HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1366551 | Uceris | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1366552 | budesonide 9 MG [Uceris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1366553 | budesonide Extended Release Oral Tablet [Uceris] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1366554 | Uceris Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1366555 | Uceris Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1366556 | Uceris 9 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1366556 | Uceris 9 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366556 | Uceris 9 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366556 | Uceris 9 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366557 | budesonide 9 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366558 | budesonide 9 MG Extended Release Oral Tablet [Uceris] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366558 | budesonide 9 MG Extended Release Oral Tablet [Uceris] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366567 | raxibacumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366567 | raxibacumab | Designated preferred name (PT) | YES | |
| RxCUI: 1366567 | raxibacumab | Full form of descriptor (FN) | YES | |
| RxCUI: 1366568 | raxibacumab 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1366569 | raxibacumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1366571 | raxibacumab 1700 MG in 34 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1366571 | raxibacumab 1700 MG in 34 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366571 | raxibacumab 1700 MG in 34 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366627 | steareth-30 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366629 | benzocaine 0.0205 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1366630 | benzocaine 2.05 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366630 | benzocaine 2.05 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366630 | benzocaine 2.05 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366645 | neomycin 140 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1366646 | neomycin 140 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366646 | neomycin 140 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366647 | Neovet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1366648 | neomycin 140 MG/ML [Neovet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366649 | neomycin Oral Solution [Neovet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1366650 | Neovet Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1366651 | Neovet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1366652 | neomycin 140 MG/ML Oral Solution [Neovet] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366652 | neomycin 140 MG/ML Oral Solution [Neovet] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366652 | neomycin 140 MG/ML Oral Solution [Neovet] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366654 | tildipirosin 180 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1366655 | tildipirosin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1366656 | tildipirosin Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1366657 | tildipirosin 180 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366658 | Zuprevo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1366659 | tildipirosin 180 MG/ML [Zuprevo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366660 | tildipirosin Injectable Solution [Zuprevo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1366661 | Zuprevo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1366662 | tildipirosin 180 MG/ML Injectable Solution [Zuprevo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366662 | tildipirosin 180 MG/ML Injectable Solution [Zuprevo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366662 | tildipirosin 180 MG/ML Injectable Solution [Zuprevo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366664 | glyceryl caprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366665 | hesperetin laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366666 | Rotenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366666 | Rotenone | Designated preferred name (PT) | NO | |
| RxCUI: 1366666 | Rotenone | Full form of descriptor (FN) | NO | |
| RxCUI: 1366667 | propionamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366668 | PEG-15 cocamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366669 | PEG-6 isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366670 | isopropylbenzyl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366671 | isocetyl stearoyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366710 | silk, enzyme hydrolyzed (1000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366731 | Prevantics | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1366732 | chlorhexidine gluconate 31.5 MG/ML / isopropyl alcohol 0.7 ML/ML [Prevantics] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366733 | chlorhexidine / isopropyl alcohol Medicated Pad [Prevantics] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1366734 | Prevantics Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1366735 | Prevantics Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1366736 | Prevantics 3.15 % / 70 % Swabstick | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366736 | Prevantics 3.15 % / 70 % Swabstick | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366736 | Prevantics 3.15 % / 70 % Swabstick | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366736 | Prevantics 3.15 % / 70 % Swabstick | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366737 | Limonium gerberi flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366739 | decamethyltetrasiloxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366783 | dimethicone 1.75 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366783 | dimethicone 1.75 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366783 | dimethicone 1.75 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366784 | Promectin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1366785 | ivermectin 10 MG/ML [Promectin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366786 | ivermectin Injectable Solution [Promectin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1366787 | Promectin Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1366788 | ivermectin 10 MG/ML Injectable Solution [Promectin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366788 | ivermectin 10 MG/ML Injectable Solution [Promectin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366789 | lidocaine 5 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366789 | lidocaine 5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366789 | lidocaine 5 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1366790 | Dr. Numb | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1366791 | lidocaine 50 MG/ML [Dr. Numb] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366792 | lidocaine Rectal Cream [Dr. Numb] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1366793 | Dr. Numb Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1366794 | Dr. Numb 5 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366794 | Dr. Numb 5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366794 | Dr. Numb 5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366794 | Dr. Numb 5 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366796 | miconazole / triclosan Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1366797 | miconazole / triclosan Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1366798 | miconazole / triclosan | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1366799 | miconazole nitrate 20 MG/ML / triclosan 3 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366800 | Dermasana | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1366801 | miconazole nitrate 20 MG/ML / triclosan 3 MG/ML [Dermasana] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366802 | miconazole / triclosan Topical Cream [Dermasana] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1366803 | Dermasana Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1366804 | miconazole nitrate 20 MG/ML / triclosan 3 MG/ML Topical Cream [Dermasana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366804 | miconazole nitrate 20 MG/ML / triclosan 3 MG/ML Topical Cream [Dermasana] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366805 | SUMAtriptan 1.63 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1366805 | SUMAtriptan 1.63 MG/HR | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366806 | SUMAtriptan Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1366806 | SUMAtriptan Topical Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366807 | SUMAtriptan Transdermal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1366807 | SUMAtriptan Transdermal Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366809 | SUMAtriptan 1.63 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366809 | SUMAtriptan 1.63 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366810 | Zecuity | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1366811 | SUMAtriptan 1.63 MG/HR [Zecuity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366811 | SUMAtriptan 1.63 MG/HR [Zecuity] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366813 | Zecuity Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1366814 | Zecuity Transdermal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1366815 | sumatriptan 1.63 MG/HR Transdermal System [Zecuity] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366815 | sumatriptan 1.63 MG/HR Transdermal System [Zecuity] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366815 | sumatriptan 1.63 MG/HR Transdermal System [Zecuity] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366816 | N-acetyl-DL-tryptophan sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366816 | N-acetyl-DL-tryptophan sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366817 | acetyltryptophanate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366818 | chlorpheniramine maleate 0.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1366819 | acetaminophen 80 MG / chlorpheniramine maleate 0.5 MG / pseudoephedrine HCl 7.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366819 | acetaminophen 80 MG / chlorpheniramine maleate 0.5 MG / pseudoephedrine HCl 7.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366819 | acetaminophen 80 MG / chlorpheniramine maleate 0.5 MG / pseudoephedrine HCl 7.5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366822 | APAP 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Pseudoephedrine Hydrochloride 3 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366822 | APAP 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Pseudoephedrine Hydrochloride 3 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366825 | acetaminophen 80 MG / chlorpheniramine maleate 0.5 MG / dextromethorphan HBr 2.5 MG / pseudoephedrine HCl 7.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366825 | acetaminophen 80 MG / chlorpheniramine maleate 0.5 MG / dextromethorphan HBr 2.5 MG / pseudoephedrine HCl 7.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1366825 | acetaminophen 80 MG / chlorpheniramine maleate 0.5 MG / dextromethorphan HBr 2.5 MG / pseudoephedrine HCl 7.5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366830 | disodium cocoyl glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366832 | disodium stearoyl glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366834 | sodium cocoyl glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366835 | APAP 160 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366835 | APAP 160 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366835 | APAP 160 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366839 | sodium cocoyl isethionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366840 | cocoyl isethionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366841 | chlorophyllin copper complex sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366841 | chlorophyllin copper complex sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366842 | sodium cumenesulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366844 | acetaminophen 80 MG / pseudoephedrine HCl 7.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366844 | acetaminophen 80 MG / pseudoephedrine HCl 7.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366844 | acetaminophen 80 MG / pseudoephedrine HCl 7.5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366847 | sodium dehydroacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366849 | sodium starch glycolate Type A potato | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366851 | sodium starch glycolate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366853 | sodium oleanolate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366855 | chlorpheniramine maleate 2 MG / pseudoephedrine HCl 15 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366855 | chlorpheniramine maleate 2 MG / pseudoephedrine HCl 15 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366858 | sodium hydrogen sulfite | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366859 | hydrogen sulfite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366860 | chlorpheniramine maleate 0.8 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366861 | chlorpheniramine maleate 0.8 MG/ML [Pediox-S] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366862 | chlorpheniramine maleate 0.8 MG/ML Oral Suspension [Pediox-S] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366862 | chlorpheniramine maleate 0.8 MG/ML Oral Suspension [Pediox-S] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366862 | chlorpheniramine maleate 0.8 MG/ML Oral Suspension [Pediox-S] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366863 | sodium lauryl sarcosinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366867 | sodium stannate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366870 | guaiFENesin 50 MG / pseudoephedrine HCl 15 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366870 | guaiFENesin 50 MG / pseudoephedrine HCl 15 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366870 | guaiFENesin 50 MG / pseudoephedrine HCl 15 MG Chewable Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366873 | HYDROcodone bitartrate 5 MG / pseudoephedrine HCl 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366873 | HYDROcodone bitartrate 5 MG / pseudoephedrine HCl 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1366873 | HYDROcodone bitartrate 5 MG / pseudoephedrine HCl 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1366874 | hydrocodone bitartrate 5 MG / pseudoephedrine hydrochloride 60 MG [P-V-Tussin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1366874 | hydrocodone bitartrate 5 MG / pseudoephedrine hydrochloride 60 MG [P-V-Tussin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1366875 | P-V-Tussin 5 MG / 60 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1366875 | P-V-Tussin 5 MG / 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1366875 | P-V-Tussin 5 MG / 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366875 | P-V-Tussin 5 MG / 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1366875 | P-V-Tussin 5 MG / 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366876 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / pseudoephedrine hydrochloride 6 MG/ML [P-V-Tussin Syrup] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366876 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / pseudoephedrine hydrochloride 6 MG/ML [P-V-Tussin Syrup] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366877 | disodium cocoamphodipropionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366879 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution [P-V-Tussin Syrup] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366879 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution [P-V-Tussin Syrup] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366879 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution [P-V-Tussin Syrup] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366879 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution [P-V-Tussin Syrup] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1366881 | calcium versetamide sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366883 | benzophenone-9 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366885 | disodium C12-14 sec-pareth-12 sulfosuccinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366887 | disodium EDTA-copper | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366888 | copper EDTA | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366889 | disodium hydrogen citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366891 | disodium laureth sulfosuccinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366895 | disodium lauroamphodiacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366898 | disodium lauryl sulfosuccinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366900 | disodium oleamido monoethanolamine sulfosuccinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366900 | disodium oleamido monoethanolamine sulfosuccinate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1366902 | disodium oleamido mipa-sulfosuccinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366906 | sodium C12 olefin sulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366909 | sodium C12-14 olefin sulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366911 | sodium C12-15 pareth-15 sulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366913 | sodium C14 olefin sulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366917 | sodium caseinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366919 | sodium cetyl sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366920 | cetyl sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366921 | sodium chlorate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366923 | sodium cholesteryl sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366924 | cholesteryl sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366926 | sodium coco-sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366928 | sodium cocoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366930 | sodium dichloroacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366931 | sodium dodecylbenzenesulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366933 | sodium tetrachloroaurate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366935 | sodium ursolate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366937 | tetrasodium iminodisuccinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366938 | iminodisuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366939 | chlorpheniramine tannate 0.8 MG/mL / phenylephrine tannate 1 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1366939 | chlorpheniramine tannate 0.8 MG/mL / phenylephrine tannate 1 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366939 | chlorpheniramine tannate 0.8 MG/mL / phenylephrine tannate 1 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366942 | N-(carbonyl-methoxypolyethylene glycol 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine, sodium salt | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366944 | sodium 2,5-dimethylbenzene-1-sulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366946 | sodium 2-naphthalenesulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366947 | 2-naphthalenesulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366948 | chlorpheniramine tannate 8 MG / phenylephrine tannate 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1366948 | chlorpheniramine tannate 8 MG / phenylephrine tannate 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1366953 | Chlorphenamine tannate 800 microgram/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366953 | Chlorphenamine tannate 800 microgram/mL oral suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366953 | Chlorphenamine tannate 800 microgram/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366953 | Chlorphenamine tannate 800 microgram/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 1366953 | Chlorphenamine tannate 800 microgram/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 1366954 | chlorpheniramine tannate 0.8 MG/ML [Ricobid H] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366955 | chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Ricobid H] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366955 | chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Ricobid H] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366955 | chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Ricobid H] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366956 | entsufon sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366957 | entsufon | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366958 | phenylephrine tannate 5 MG per 5 ML Oral Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 1366958 | phenylephrine tannate 5 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1366958 | phenylephrine tannate 5 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366958 | phenylephrine tannate 5 MG per 5 ML Oral Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 1366959 | phenylephrine tannate 1 MG/ML [Ricobid D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1366960 | phenylephrine tannate 1 MG/ML Oral Suspension [Ricobid D] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1366960 | phenylephrine tannate 1 MG/ML Oral Suspension [Ricobid D] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366960 | phenylephrine tannate 1 MG/ML Oral Suspension [Ricobid D] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1366961 | erythrosine sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366962 | prasterone sodium sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366964 | sodium acryloyldimethyltaurate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366966 | sodium acryloyldimethyltaurate-acrylamide copolymer (1:1; 90000-150000 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366968 | sodium anisate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366970 | sodium bentonite | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366971 | sodium octoxynol-2 ethane sulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366973 | sodium starch | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366974 | chondroitin sulfate sodium (porcine) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366975 | sodium polyacrylate (8000 MW) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366977 | dried sodium phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366978 | polarcrillin sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1366980 | sodium dihydroxycetyl phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366982 | sodium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366983 | sodium peroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366984 | sodium stearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366986 | sodium stearoyl lactylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1366989 | gamma-cyclodextrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366990 | gelatin hydrolysate (porcine skin, MW 3000) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366991 | hexadecyl povidone (4 hexadecyl branches-repeat) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1366992 | PEG-8 & SMDI copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366993 | PEG:PPG-4-12:dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1366994 | polyisobutylene (200000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367 | bencyclane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367006 | Alendronic acid- and colecalciferol-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1367006 | Alendronic acid- and colecalciferol-containing product in oral dose form | Designated preferred name (PT) | YES | |
| RxCUI: 1367006 | Alendronic acid- and colecalciferol-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367006 | Alendronic acid- and colecalciferol-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| RxCUI: 1367007 | alendronate / cholecalciferol Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1367008 | alendronate Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1367009 | alendronate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1367010 | Alendronic acid-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1367010 | Alendronic acid-containing product in oral dose form | Designated preferred name (PT) | YES | |
| RxCUI: 1367010 | Alendronic acid-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| RxCUI: 1367075 | Recombinant thrombin | Designated preferred name (PT) | YES | |
| RxCUI: 1367075 | Recombinant thrombin | Full form of descriptor (FN) | YES | |
| RxCUI: 1367075 | Recombinant thrombin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1367076 | nonoxynol, 4-sulfate, ammonium salt | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1367077 | nonoxynol-4 sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367078 | Softsoap Antibacterial | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1367079 | benzalkonium chloride 1.3 MG/ML [Softsoap Antibacterial] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1367080 | benzalkonium Medicated Liquid Soap [Softsoap Antibacterial] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1367081 | Softsoap Antibacterial Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367082 | Softsoap Antibacterial 0.13 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367082 | Softsoap Antibacterial 0.13 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367082 | Softsoap Antibacterial 0.13 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367082 | Softsoap Antibacterial 0.13 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367086 | rubidium chloride Rb-82 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1367087 | rubidium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1367088 | oftasceine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367099 | Aloe-Dip | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1367100 | iodine 10 MG/ML [Aloe-Dip] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1367101 | iodine Topical Solution [Aloe-Dip] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1367102 | Aloe-Dip Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367103 | ALOE-DIP 1 % Iodine Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367103 | ALOE-DIP 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367103 | ALOE-DIP 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367103 | ALOE-DIP 1 % Iodine Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367104 | Softkote | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1367105 | iodine 10 MG/ML [Softkote] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1367106 | iodine Topical Solution [Softkote] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1367107 | Softkote Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367108 | SOFTKOTE 1 % Iodine Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367108 | SOFTKOTE 1 % Iodine Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367108 | SOFTKOTE 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367108 | SOFTKOTE 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367109 | wheat starch | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367109 | wheat starch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367110 | polyethylene glycol 1450 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367111 | neotame | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367112 | Muricin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1367113 | mupirocin 0.02 MG/MG [Muricin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1367114 | mupirocin Topical Ointment [Muricin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1367115 | Muricin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367116 | MURICIN 2 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367116 | MURICIN 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367116 | MURICIN 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367116 | MURICIN 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367117 | rice starch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367117 | rice starch | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367118 | methyl gluceth-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367119 | Chloromethylisothiazolinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367119 | Chloromethylisothiazolinone | Designated preferred name (PT) | YES | |
| RxCUI: 1367119 | Chloromethylisothiazolinone | Full form of descriptor (FN) | YES | |
| RxCUI: 1367119 | Chloromethylisothiazolinone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367119 | Chloromethylisothiazolinone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367119 | Chloromethylisothiazolinone | Designated preferred name (PT) | YES | |
| RxCUI: 1367119 | Chloromethylisothiazolinone | Full form of descriptor (FN) | YES | |
| RxCUI: 1367120 | PEG-100 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367121 | steareth-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367122 | steareth-21 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367123 | Backhousia citriodora leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367124 | octyldodecanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367124 | octyldodecanol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367125 | pear preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367126 | hexyl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367127 | pegoxol 7 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367128 | polacrilin potassium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1367129 | polyvinyl acetate phthalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367130 | polyglyceryl-4 isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367131 | steareth-100 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367132 | zinc ricinoleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1367133 | polyethylene glycol 400 monostearate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367133 | polyethylene glycol 400 monostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367134 | ethylhexylglycerin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367135 | stannous oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367136 | neopentyl glycol diisostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367137 | dibutyl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367138 | dicaprylyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367139 | ethylhexyl isononanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367140 | potassium cetyl phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1367141 | povidone K25 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367142 | diethylbenzylidene malonate dimethicone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367142 | diethylbenzylidene malonate dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367143 | polyquaternium-10 (400 CPS at 2%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367144 | neopentyl glycol dicaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367145 | laureth-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367146 | sorbitan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367147 | steareth-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367148 | steareth-15 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367149 | stearoxytrimethylsilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367150 | sucrose palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367151 | APAP 500 MG / phenylephrine hydrochloride 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367151 | APAP 500 MG / phenylephrine hydrochloride 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367152 | PEG-12 dimethicone (300 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367153 | phenylephrine hydrochloride 12.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1367154 | APAP 500 MG / phenylephrine hydrochloride 12.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367154 | APAP 500 MG / phenylephrine hydrochloride 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367155 | methyl acrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367156 | methyl cinnamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367157 | phenylephrine hydrochloride 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1367158 | APAP 500 MG / phenylephrine hydrochloride 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367158 | APAP 500 MG / phenylephrine hydrochloride 6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367159 | phenylacetaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367160 | propylene glycol methyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367161 | retinamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367162 | hectorite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367164 | purslane oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367165 | laureth-23 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367166 | methylisothiazolinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367166 | methylisothiazolinone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367167 | isononyl isononanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367168 | methylpropanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367169 | hydroxyoctacosanyl hydroxystearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367170 | Meta-cresol | Designated preferred name (PT) | YES | |
| RxCUI: 1367170 | Meta-cresol | Full form of descriptor (FN) | YES | |
| RxCUI: 1367170 | Meta-cresol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367170 | Meta-cresol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367171 | quarternium-15 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367172 | budesonide (11.beta.,16.alpha.(S)) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1367173 | capryl-capramidopropyl betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367174 | treponemic skin canker preparation, human | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367175 | arbutin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367176 | Bambermycins | Designated preferred name (PT) | NO | |
| RxCUI: 1367176 | Bambermycins | Full form of descriptor (FN) | NO | |
| RxCUI: 1367176 | Bambermycins | Designated preferred name (PT) | NO | |
| RxCUI: 1367176 | Bambermycins | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367176 | Bambermycins | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367176 | Bambermycins | Full form of descriptor (FN) | NO | |
| RxCUI: 1367177 | cianidanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367177 | cianidanol | Designated preferred name (PT) | NO | |
| RxCUI: 1367177 | cianidanol | Full form of descriptor (FN) | NO | |
| RxCUI: 1367177 | cianidanol | Designated preferred name (PT) | NO | |
| RxCUI: 1367177 | cianidanol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367177 | cianidanol | Full form of descriptor (FN) | NO | |
| RxCUI: 1367178 | cerium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367179 | Clopindol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367179 | Clopindol | Designated preferred name (PT) | NO | |
| RxCUI: 1367179 | Clopindol | Full form of descriptor (FN) | NO | |
| RxCUI: 1367179 | Clopindol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367179 | Clopindol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367180 | cyclohexane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367183 | hydrocyanic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367183 | hydrocyanic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367184 | B-cell growth factor II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367184 | B-cell growth factor II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367184 | B-cell growth factor II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367184 | B-cell growth factor II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367184 | B-cell growth factor II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367184 | B-cell growth factor II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367184 | B-cell growth factor II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367184 | B-cell growth factor II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367184 | B-cell growth factor II | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367184 | B-cell growth factor II | Designated preferred name (PT) | NO | |
| RxCUI: 1367184 | B-cell growth factor II | Full form of descriptor (FN) | NO | |
| RxCUI: 1367184 | B-cell growth factor II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367185 | BSF-2 | Designated preferred name (PT) | NO | |
| RxCUI: 1367185 | BSF-2 | Full form of descriptor (FN) | NO | |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367185 | BSF-2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367186 | terbium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367187 | all-trans-retinol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367188 | glycol distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367189 | nonoxynol-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367190 | pentylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367191 | 1,2-dibromo-3-chloropropane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367192 | haemophilus influenzae immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367193 | lactococcus lactis immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367194 | streptococcus pneumoniae immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367195 | mycobacterium bovis immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367196 | mycobacterium microti immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367197 | streptococcus pyogenes immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367198 | reptococcus viridans group immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367199 | malarial plasmodium group immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367200 | treponema pallidum immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367201 | staphylococcus epidermidis immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367202 | IL-7 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367202 | IL-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367202 | IL-7 | Designated preferred name (PT) | NO | |
| RxCUI: 1367202 | IL-7 | Full form of descriptor (FN) | NO | |
| RxCUI: 1367202 | IL-7 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367203 | acetaminophen 162 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367203 | acetaminophen 162 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367203 | acetaminophen 162 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367204 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367204 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367204 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1367204 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367204 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1367205 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367205 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367205 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367206 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367206 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367206 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1367206 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367206 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1367207 | sodium bisulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367208 | APAP 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367208 | APAP 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 15 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367208 | APAP 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367208 | APAP 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 15 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367209 | APAP 500 MG / caffeine 25 MG / chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367209 | APAP 500 MG / caffeine 25 MG / chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367210 | acetaminophen 500 MG / caffeine 32.5 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367210 | acetaminophen 500 MG / caffeine 32.5 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367210 | acetaminophen 500 MG / caffeine 32.5 MG / phenylephrine HCl 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367211 | acetaminophen 500 MG / caffeine 75 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367211 | acetaminophen 500 MG / caffeine 75 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367211 | acetaminophen 500 MG / caffeine 75 MG / phenylephrine HCl 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367212 | acetaminophen 500 MG / phenylephrine HCl 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367212 | acetaminophen 500 MG / phenylephrine HCl 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367212 | acetaminophen 500 MG / phenylephrine HCl 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367213 | acetaminophen 650 MG / guaiFENesin 600 MG / phenylephrine HCl 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367213 | acetaminophen 650 MG / guaiFENesin 600 MG / phenylephrine HCl 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367213 | acetaminophen 650 MG / guaiFENesin 600 MG / phenylephrine HCl 20 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367213 | acetaminophen 650 MG / guaiFENesin 600 MG / phenylephrine HCl 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367213 | acetaminophen 650 MG / guaiFENesin 600 MG / phenylephrine HCl 20 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367214 | acetaminophen 81 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367214 | acetaminophen 81 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367214 | acetaminophen 81 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367215 | ASA 81 MG / phenylephrine hydrochloride 1.25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367215 | ASA 81 MG / phenylephrine hydrochloride 1.25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367216 | ASA 500 MG / phenylephrine hydrochloride 6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367216 | ASA 500 MG / phenylephrine hydrochloride 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367217 | brompheniramine tannate 2.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1367218 | phenylephrine tannate 1.58 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1367219 | phenylephrine tannate 1.58 MG / brompheniramine tannate 2.2 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367219 | phenylephrine tannate 1.58 MG / brompheniramine tannate 2.2 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 136722 | GIP 1-42 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367220 | deoxycholic acid, monosodium salt | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1367221 | sodium sulfite, anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1367222 | chlorpheniramine maleate 1 MG / phenylephrine HCl 2.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367222 | chlorpheniramine maleate 1 MG / phenylephrine HCl 2.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367223 | sodium hydroxymethylglycinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1367225 | chlorpheniramine maleate 2 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367225 | chlorpheniramine maleate 2 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367225 | chlorpheniramine maleate 2 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1367226 | chlorpheniramine maleate 3.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1367227 | chlorpheniramine maleate 3.5 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367227 | chlorpheniramine maleate 3.5 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367228 | pseudoephedrine HCl 120 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367228 | pseudoephedrine HCl 120 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367229 | dextromethorphan tannate 25 MG / phenylephrine tannate 25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367230 | pseudoephedrine hydrochloride 120 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367231 | pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367231 | pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367232 | guaifenesin 600 MG / phenylephrine hydrochloride 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367232 | guaifenesin 600 MG / phenylephrine hydrochloride 40 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367233 | azatadine maleate 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1367234 | azatadine maleate 1 MG / pseudoephedrine sulfate 120 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367234 | azatadine maleate 1 MG / pseudoephedrine sulfate 120 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367234 | azatadine maleate 1 MG / pseudoephedrine sulfate 120 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 1367234 | azatadine maleate 1 MG / pseudoephedrine sulfate 120 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 1367264 | dipotassium glycyrrhizinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1367265 | polysorbate 40 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367266 | benzoyl peroxide Medicated Liquid Soap [Oscion] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1367267 | Oscion Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367268 | benzoyl peroxide 30 MG/ML Medicated Liquid Soap [Oscion] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367268 | benzoyl peroxide 30 MG/ML Medicated Liquid Soap [Oscion] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367268 | benzoyl peroxide 30 MG/ML Medicated Liquid Soap [Oscion] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367269 | pradofloxacin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367269 | pradofloxacin | Designated preferred name (PT) | NO | |
| RxCUI: 1367269 | pradofloxacin | Full form of descriptor (FN) | NO | |
| RxCUI: 1367270 | pradofloxacin 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1367273 | pradofloxacin Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1367274 | pradofloxacin 25 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367274 | pradofloxacin 25 MG in 1 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367275 | Veraflox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1367276 | pradofloxacin 25 MG/ML [Veraflox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1367277 | pradofloxacin Oral Suspension [Veraflox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1367278 | Veraflox Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367279 | Veraflox Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367280 | Veraflox 25 MG in 1 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367280 | Veraflox 25 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367280 | Veraflox 25 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367280 | Veraflox 25 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367281 | moxidectin 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1367282 | moxidectin Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1367283 | moxidectin Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1367284 | moxidectin 2 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367284 | moxidectin 2 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367284 | moxidectin 2 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367291 | pirlimycin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1367291 | pirlimycin hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 1367291 | pirlimycin hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1367292 | pirlimycin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367292 | pirlimycin | Designated preferred name (PT) | NO | |
| RxCUI: 1367292 | pirlimycin | Full form of descriptor (FN) | NO | |
| RxCUI: 1367294 | pirlimycin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1367295 | pirlimycin Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1367297 | Pirsue | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1367299 | pirlimycin Prefilled Syringe [Pirsue] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1367300 | Pirsue Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367305 | Sorbus aucuparia fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367306 | benzoyl peroxide 60 MG/ML Medicated Liquid Soap [Oscion] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367306 | benzoyl peroxide 60 MG/ML Medicated Liquid Soap [Oscion] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367306 | benzoyl peroxide 60 MG/ML Medicated Liquid Soap [Oscion] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367307 | benzoyl peroxide 90 MG/ML Medicated Liquid Soap [Oscion] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367307 | benzoyl peroxide 90 MG/ML Medicated Liquid Soap [Oscion] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367307 | benzoyl peroxide 90 MG/ML Medicated Liquid Soap [Oscion] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367308 | chlorpheniramine maleate 0.4 MG/ML [Allerlief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1367309 | chlorpheniramine maleate 0.4 MG/ML Oral Solution [Allerlief] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367309 | chlorpheniramine maleate 0.4 MG/ML Oral Solution [Allerlief] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367310 | brompheniramine maleate 4 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367311 | brompheniramine maleate 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1367312 | brompheniramine maleate 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367312 | brompheniramine maleate 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367313 | dextromethorphan hydrobromide 15 MG / guaiFENesin 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367313 | dextromethorphan hydrobromide 15 MG / guaiFENesin 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367313 | dextromethorphan hydrobromide 15 MG / guaiFENesin 100 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367314 | dextromethorphan hydrobromide 15 MG / guaiFENesin 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367314 | dextromethorphan hydrobromide 15 MG / guaiFENesin 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367314 | dextromethorphan hydrobromide 15 MG / guaiFENesin 200 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367315 | dextromethorphan hydrobromide 20 MG / guaifenesin 800 MG / phenylephrine hydrochloride 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367315 | dextromethorphan hydrobromide 20 MG / guaifenesin 800 MG / phenylephrine hydrochloride 20 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367316 | dextromethorphan hydrobromide 25 MG / guaifenesin 550 MG / phenylephrine hydrochloride 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367316 | dextromethorphan hydrobromide 25 MG / guaifenesin 550 MG / phenylephrine hydrochloride 20 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367317 | dextromethorphan hydrobromide 30 MG / guaifenesin 580 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367317 | dextromethorphan hydrobromide 30 MG / guaifenesin 580 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367318 | dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / phenylephrine hydrochloride 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367318 | dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / phenylephrine hydrochloride 15 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367319 | dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367319 | dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367320 | guaifenesin 600 MG / pseudoephedrine hydrochloride 120 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367320 | guaifenesin 600 MG / pseudoephedrine hydrochloride 120 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367321 | guaiFENesin 600 MG / pseudoephedrine HCl 45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367321 | guaiFENesin 600 MG / pseudoephedrine HCl 45 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367321 | guaiFENesin 600 MG / pseudoephedrine HCl 45 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367371 | Selsun Blue Sensitive Scalp | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1367372 | zinc pyrithione 10 MG/ML [Selsun Blue Sensitive Scalp] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1367373 | zinc pyrithione Medicated Shampoo [Selsun Blue Sensitive Scalp] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1367374 | Selsun Blue Sensitive Scalp Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1367375 | Selsun blue Sensitive Scalp 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367375 | Selsun blue Sensitive Scalp 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367375 | Selsun blue Sensitive Scalp 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367375 | Selsun blue Sensitive Scalp 1 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1367376 | Nail MD | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1367377 | miconazole nitrate 20 MG/ML [Nail MD] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1367378 | miconazole Topical Solution [Nail MD] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1367379 | Nail MD Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367380 | miconazole nitrate 20 MG/ML Topical Solution [Nail MD] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367380 | miconazole nitrate 20 MG/ML Topical Solution [Nail MD] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367380 | miconazole nitrate 20 MG/ML Topical Solution [Nail MD] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367380 | miconazole nitrate 20 MG/ML Topical Solution [Nail MD] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367381 | pseudoephedrine hydrochloride 120 MG / terfenadine 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367382 | pseudoephedrine hydrochloride 120 MG / terfenadine 60 MG [Seldane-D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1367383 | pseudoephedrine hydrochloride 120 MG / terfenadine 60 MG Extended Release Oral Tablet [Seldane-D] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367383 | pseudoephedrine hydrochloride 120 MG / terfenadine 60 MG Extended Release Oral Tablet [Seldane-D] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367384 | acetaminophen 160 MG / pheniramine maleate 4 MG / phenylephrine HCl 4 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367384 | acetaminophen 160 MG / pheniramine maleate 4 MG / phenylephrine HCl 4 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367384 | acetaminophen 160 MG / pheniramine maleate 4 MG / phenylephrine HCl 4 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367384 | acetaminophen 160 MG / pheniramine maleate 4 MG / phenylephrine HCl 4 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367391 | Rhamnus cathartica fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367392 | lanolin 0.3 MG/MG [Lantiseptic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1367393 | lanolin Topical Ointment [Lantiseptic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1367394 | Lantiseptic 30 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367394 | Lantiseptic 30 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367394 | Lantiseptic 30 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367394 | Lantiseptic 30 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367395 | guaiFENesin 300 MG / phenylephrine HCl 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367395 | guaiFENesin 300 MG / phenylephrine HCl 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367395 | guaiFENesin 300 MG / phenylephrine HCl 10 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367396 | pheniramine maleate 12.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1367397 | phenylephrine HCl 10 MG / pheniramine maleate 12.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367397 | phenylephrine HCl 10 MG / pheniramine maleate 12.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367398 | guaiFENesin 200 MG / phenylephrine HCl 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367398 | guaiFENesin 200 MG / phenylephrine HCl 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367398 | guaiFENesin 200 MG / phenylephrine HCl 10 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367399 | Symphytum x uplandicum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367399 | Symphytum x uplandicum leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367400 | chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367402 | methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG [Extendryl PSE] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1367403 | 12 HR methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Extendryl PSE] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367403 | 12 HR methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Extendryl PSE] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367403 | 12 HR methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Extendryl PSE] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367404 | methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Extendryl PSE] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367405 | chlorpheniramine maleate 6 MG / phenylephrine hydrochloride 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367409 | calcium 240 MG / vitamin D2 200 UNT Oral Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367409 | calcium 240 MG / vitamin D2 200 UNT Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367409 | calcium 240 MG / vitamin D2 200 UNT Oral Tablet, as calcium carbonate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367409 | calcium 240 MG / vitamin D2 200 UNT Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367409 | calcium 240 MG / vitamin D2 200 UNT Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367410 | ergocalciferol 1.25 MG (50,000 UNT) Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367410 | ergocalciferol 1.25 MG (50,000 UNT) Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1367410 | ergocalciferol 1.25 MG (50,000 UNT) Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367410 | ergocalciferol 1.25 MG (50,000 UNT) Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1367410 | ergocalciferol 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367410 | ergocalciferol 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367410 | ergocalciferol 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367410 | ergocalciferol 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367411 | sodium sesquicarbonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1367411 | sodium sesquicarbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367414 | Deltalin 1.25 MG (50,000 UNT) Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367414 | Deltalin 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367414 | Deltalin 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367414 | Deltalin 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367414 | Deltalin 1.25 MG (50,000 UNT) Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367414 | Deltalin 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367414 | Deltalin 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367416 | Drisdol 1.25 MG (50,000 UNT) Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367416 | Drisdol 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367416 | Drisdol 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367416 | Drisdol 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367416 | Drisdol 1.25 MG (50,000 UNT) Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1367416 | Drisdol 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367416 | Drisdol 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367417 | thrombin alfa 1000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1367418 | thrombin alfa 1000 UNT in 1 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367418 | thrombin alfa 1000 UNT in 1 ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367418 | thrombin alfa 1000 UNT in 1 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367418 | thrombin alfa 1000 UNT in 1 ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367418 | thrombin alfa 1000 UNT in 1 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367419 | thrombin alfa 1000 UNT/ML [Recothrom] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1367420 | Recothrom 1000 UNT in 1 ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367420 | Recothrom 1000 UNT in 1 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367420 | Recothrom 1000 UNT in 1 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367420 | Recothrom 1000 UNT in 1 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367420 | Recothrom 1000 UNT in 1 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367420 | Recothrom 1000 UNT in 1 ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1367421 | calcium carbonate 500 MG / vitamin D2 125 UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367421 | calcium carbonate 500 MG / vitamin D2 125 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367421 | calcium carbonate 500 MG / vitamin D2 125 UNT Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367421 | calcium carbonate 500 MG / vitamin D2 125 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367421 | calcium carbonate 500 MG / vitamin D2 125 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367422 | coco-betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367423 | diphenyltrichloroethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367425 | Ruta graveolens flowering top oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367426 | naproxen sodium 220 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367426 | naproxen sodium 220 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367426 | naproxen sodium 220 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367429 | naproxen sodium 220 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367432 | ethinyl estradiol 0.000625 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1367434 | ethinyl estradiol / etonogestrel Vaginal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1367436 | etonogestrel 0.12 MG / ethinyl estradiol 0.015 MG per 24HR 3 Week Vaginal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367436 | etonogestrel 0.12 MG / ethinyl estradiol 0.015 MG per 24HR 3 Week Vaginal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367436 | etonogestrel 0.12 MG / ethinyl estradiol 0.015 MG per 24HR 3 Week Vaginal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367436 | etonogestrel 0.12 MG / ethinyl estradiol 0.015 MG per 24HR 3 Week Vaginal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367437 | ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR [NuvaRing] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1367439 | NuvaRing 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1367439 | NuvaRing 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367439 | NuvaRing 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367440 | ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367441 | ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [NuvaRing] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367441 | ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [NuvaRing] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367442 | guaifenesin 400 MG / phenylephrine hydrochloride 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367442 | guaifenesin 400 MG / phenylephrine hydrochloride 30 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1367483 | Gentacalm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1367486 | Gentacalm Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367492 | aminopropyl dihydrogen phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367493 | Cocos nucifera whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367494 | octadecene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367495 | PEG-7 methyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367496 | Pinus densiflora root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367497 | Plantago asiatica extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367498 | polyglyceryl-3 distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367499 | stearyl triethoxysilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367507 | Adasuve Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1367515 | loxapine 10 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1367516 | loxapine Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1367517 | loxapine Dry Powder Inhaler | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1367518 | loxapine 10 MG/INHAL Dry Powder Inhaler, 1 Actuation | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367518 | loxapine 10 MG/INHAL Dry Powder Inhaler, 1 Actuation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367518 | loxapine 10 MG/INHAL Dry Powder Inhaler, 1 Actuation | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367519 | loxapine 10 MG/ACTUAT [Adasuve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1367520 | loxapine Dry Powder Inhaler [Adasuve] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1367521 | ADASUVE 10 MG/INHAL Dry Powder Inhaler, 1 Actuation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367521 | ADASUVE 10 MG/INHAL Dry Powder Inhaler, 1 Actuation | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1367521 | ADASUVE 10 MG/INHAL Dry Powder Inhaler, 1 Actuation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367521 | ADASUVE 10 MG/INHAL Dry Powder Inhaler, 1 Actuation | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367522 | loxapine 10 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367523 | loxapine 10 MG/ACTUAT Dry Powder Inhaler [Adasuve] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367523 | loxapine 10 MG/ACTUAT Dry Powder Inhaler [Adasuve] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367687 | Zanthoxylum bungeanum fruit rind extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1367691 | Gildagia 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1367691 | Gildagia 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367691 | Gildagia 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367692 | ethanol 60 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367692 | ethanol 60 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367692 | ethanol 60 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367698 | Vetromax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1367701 | Vetromax Otic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367702 | VETROMAX 3 MG / 1 MG / 10 MG per GM Otic Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367702 | VETROMAX 3 MG / 1 MG / 10 MG per GM Otic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367702 | VETROMAX 3 MG / 1 MG / 10 MG per GM Otic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367830 | Clear Men Scalp Therapy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1367831 | zinc pyrithione 10 MG/ML [Clear Men Scalp Therapy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1367832 | zinc pyrithione Medicated Shampoo [Clear Men Scalp Therapy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1367833 | Clear Men Scalp Therapy Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367834 | CLEAR MEN 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367834 | CLEAR MEN 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367834 | CLEAR MEN 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367834 | CLEAR MEN 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367834 | CLEAR MEN 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367834 | CLEAR MEN 1 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367838 | mipomersen sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1367838 | mipomersen sodium | Designated preferred name (PT) | YES | |
| RxCUI: 1367838 | mipomersen sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 1367839 | mipomersen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1367839 | mipomersen | Designated preferred name (PT) | YES | |
| RxCUI: 1367839 | mipomersen | Full form of descriptor (FN) | YES | |
| RxCUI: 1367840 | mipomersen sodium 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1367841 | mipomersen Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1367842 | mipomersen Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1367843 | mipomersen sodium 200 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1367843 | mipomersen sodium 200 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1367843 | mipomersen sodium 200 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1367844 | Kynamro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1367845 | mipomersen sodium 200 MG/ML [Kynamro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1367846 | mipomersen Prefilled Syringe [Kynamro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1367847 | Kynamro Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1367848 | Kynamro 200 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367848 | Kynamro 200 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367848 | Kynamro 200 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1367848 | Kynamro 200 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367849 | mipomersen sodium 200 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367850 | mipomersen sodium 200 MG/ML Prefilled Syringe [Kynamro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1367850 | mipomersen sodium 200 MG/ML Prefilled Syringe [Kynamro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367996 | antihemophilic factor, human recombinant residues 743-1636 deleted 125 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1367997 | antihemophilic factor, human recombinant residues 743-1636 deleted 125 UNT/ML Prefilled Syringe [Xyntha] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1367997 | antihemophilic factor, human recombinant residues 743-1636 deleted 125 UNT/ML Prefilled Syringe [Xyntha] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368000 | alogliptin benzoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368000 | alogliptin benzoate | Designated preferred name (PT) | YES | |
| RxCUI: 1368000 | alogliptin benzoate | Full form of descriptor (FN) | YES | |
| RxCUI: 1368001 | alogliptin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368001 | alogliptin | Designated preferred name (PT) | YES | |
| RxCUI: 1368001 | alogliptin | Full form of descriptor (FN) | YES | |
| RxCUI: 1368001 | alogliptin | Designated preferred name (PT) | YES | |
| RxCUI: 1368001 | alogliptin | Full form of descriptor (FN) | YES | |
| RxCUI: 1368002 | alogliptin 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1368003 | alogliptin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1368003 | alogliptin Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1368003 | alogliptin Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1368004 | alogliptin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1368005 | alogliptin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1368006 | alogliptin 25 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1368006 | alogliptin 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368006 | alogliptin 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368006 | alogliptin 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368006 | alogliptin 25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1368007 | Nesina | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1368008 | alogliptin 25 MG [Nesina] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368009 | alogliptin Oral Tablet [Nesina] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1368010 | Nesina Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1368011 | Nesina Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1368012 | Nesina 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368012 | Nesina 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368012 | Nesina 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368012 | Nesina 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368015 | antihemophilic factor, human recombinant residues 743-1636 deleted 62.5 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368016 | antihemophilic factor, human recombinant residues 743-1636 deleted 62.5 UNT/ML Prefilled Syringe [Xyntha] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368016 | antihemophilic factor, human recombinant residues 743-1636 deleted 62.5 UNT/ML Prefilled Syringe [Xyntha] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368017 | alogliptin 6.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1368018 | alogliptin 6.25 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1368018 | alogliptin 6.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368018 | alogliptin 6.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368018 | alogliptin 6.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368018 | alogliptin 6.25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1368019 | alogliptin 6.25 MG [Nesina] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368020 | Nesina 6.25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368020 | Nesina 6.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368020 | Nesina 6.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368020 | Nesina 6.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368021 | aluminum hydroxide 0.012 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1368022 | aluminum hydroxide 1.2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368022 | aluminum hydroxide 1.2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368022 | aluminum hydroxide 1.2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368028 | antihemophilic factor, human recombinant residues 743-1636 deleted 750 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368030 | antihemophilic factor, human recombinant residues 743-1636 deleted 750 UNT/ML Prefilled Syringe [Xyntha] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368030 | antihemophilic factor, human recombinant residues 743-1636 deleted 750 UNT/ML Prefilled Syringe [Xyntha] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368033 | alogliptin 12.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1368034 | alogliptin 12.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1368034 | alogliptin 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368034 | alogliptin 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368034 | alogliptin 12.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368034 | alogliptin 12.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1368035 | alogliptin 12.5 MG [Nesina] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368036 | Nesina 12.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368036 | Nesina 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368036 | Nesina 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368036 | Nesina 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368111 | antihemophilic factor, human recombinant residues 743-1636 deleted 250 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368112 | antihemophilic factor, human recombinant residues 743-1636 deleted 250 UNT/ML Prefilled Syringe [Xyntha] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368112 | antihemophilic factor, human recombinant residues 743-1636 deleted 250 UNT/ML Prefilled Syringe [Xyntha] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368115 | antihemophilic factor, human recombinant residues 743-1636 deleted 500 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368116 | antihemophilic factor, human recombinant residues 743-1636 deleted 500 UNT/ML Prefilled Syringe [Xyntha] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368116 | antihemophilic factor, human recombinant residues 743-1636 deleted 500 UNT/ML Prefilled Syringe [Xyntha] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368125 | acrylamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368126 | alcohol, x-ray exposed (1000 rad) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1368127 | amniotic fluid (bovine) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368128 | Amylopectin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368128 | Amylopectin | Designated preferred name (PT) | YES | |
| RxCUI: 1368128 | Amylopectin | Full form of descriptor (FN) | YES | |
| RxCUI: 1368129 | apaflurane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368130 | apigenin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368131 | arachidyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368132 | arachidyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368133 | argon | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368134 | bakuchiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368135 | beef tallow preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368136 | betasizofiran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368137 | biotinoyl tripeptide-1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368138 | 2,2-bis(4-glycidyloxyphenyl)propane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368139 | Brugia malayi preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368140 | butyl ester of methyl vinyl ether/maleic anhydride copolymer (125000 mw) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368140 | butyl ester of methyl vinyl ether/maleic anhydride copolymer (125000 mw) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368141 | butylene glycol dicaprylate-dicaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368142 | C10-30 cholesterol-lanosterol esters | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368143 | C12-16 alcohols | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368144 | C30-45 olefin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368145 | cadmium sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368146 | caprylyl-capryl oligoglucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368147 | Captan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368147 | Captan | Designated preferred name (PT) | NO | |
| RxCUI: 1368147 | Captan | Full form of descriptor (FN) | NO | |
| RxCUI: 1368147 | Captan | Designated preferred name (PT) | NO | |
| RxCUI: 1368147 | Captan | Full form of descriptor (FN) | NO | |
| RxCUI: 1368148 | caryophyllene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368149 | Centaurium erythraea preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368150 | cetyl lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368151 | Chelidonium majus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368152 | poliglusam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368152 | poliglusam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368153 | cinnamaldehyde | Designated preferred name (PT) | YES | |
| RxCUI: 1368153 | cinnamaldehyde | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368153 | cinnamaldehyde | Full form of descriptor (FN) | YES | |
| RxCUI: 1368153 | cinnamaldehyde | Designated preferred name (PT) | YES | |
| RxCUI: 1368153 | cinnamaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368153 | cinnamaldehyde | Full form of descriptor (FN) | YES | |
| RxCUI: 1368154 | ETO - Ethylene oxide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368154 | ETO - Ethylene oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368154 | ETO - Ethylene oxide | Designated preferred name (PT) | NO | |
| RxCUI: 1368154 | ETO - Ethylene oxide | Full form of descriptor (FN) | NO | |
| RxCUI: 1368154 | ETO - Ethylene oxide | Designated preferred name (PT) | NO | |
| RxCUI: 1368154 | ETO - Ethylene oxide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368154 | ETO - Ethylene oxide | Full form of descriptor (FN) | NO | |
| RxCUI: 1368155 | PEG-30 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368156 | PEG-150 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368157 | PEG-10 dimethicone (600 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368158 | quaternium-91 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368159 | isocetyl ethylhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368160 | palmitoyl lysylthreonine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368160 | palmitoyl lysylthreonine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368161 | polyester-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368162 | neopentyl glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368163 | marine collagen, soluble | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368163 | marine collagen, soluble | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368164 | tridecyl neopentanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368165 | polyethylene glycol 350 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368166 | hydroxylysine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368166 | hydroxylysine | Designated preferred name (PT) | NO | |
| RxCUI: 1368166 | hydroxylysine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368166 | hydroxylysine | Full form of descriptor (FN) | NO | |
| RxCUI: 1368167 | phloretin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368168 | glyceryl trioleate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368168 | glyceryl trioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368169 | tripalmitin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368170 | 1,3-diphenylguanidine (DPG) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368170 | 1,3-diphenylguanidine (DPG) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368170 | 1,3-diphenylguanidine (DPG) | Designated preferred name (PT) | NO | |
| RxCUI: 1368170 | 1,3-diphenylguanidine (DPG) | Full form of descriptor (FN) | NO | |
| RxCUI: 1368170 | 1,3-diphenylguanidine (DPG) | Designated preferred name (PT) | NO | |
| RxCUI: 1368170 | 1,3-diphenylguanidine (DPG) | Full form of descriptor (FN) | NO | |
| RxCUI: 1368171 | disperse blue 106 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368171 | disperse blue 106 | Designated preferred name (PT) | NO | |
| RxCUI: 1368171 | disperse blue 106 | Full form of descriptor (FN) | NO | |
| RxCUI: 1368171 | disperse blue 106 | Designated preferred name (PT) | NO | |
| RxCUI: 1368171 | disperse blue 106 | Full form of descriptor (FN) | NO | |
| RxCUI: 1368172 | isoamyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368173 | naringenin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368174 | phenylisothiocyanate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368175 | propylene oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368176 | Vanillin | Full form of descriptor (FN) | YES | |
| RxCUI: 1368176 | Vanillin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368176 | Vanillin | Designated preferred name (PT) | YES | |
| RxCUI: 1368176 | Vanillin | Full form of descriptor (FN) | YES | |
| RxCUI: 1368176 | Vanillin | Designated preferred name (PT) | YES | |
| RxCUI: 1368177 | vinyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368178 | triethanolamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1368179 | di-C12-15 alkyl fumarate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368180 | Terpineol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368180 | Terpineol | Designated preferred name (PT) | YES | |
| RxCUI: 1368180 | Terpineol | Full form of descriptor (FN) | YES | |
| RxCUI: 1368181 | ethyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368182 | poloxamer 184 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368183 | PPG-20 methyl glucose ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368184 | nonoxynol-4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368185 | octoxynol-1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368186 | alpha-isomethylionone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368187 | tridecyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368188 | monostearyl citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368189 | triethylhexanoin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368190 | trisiloxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368191 | isocetyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368192 | PPG-14 butyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368193 | glyceryl monolinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368193 | glyceryl monolinoleate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368194 | 1-ethyl-2-pyrrolecarboxaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368195 | diethylhexyl syringylidenemalonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368196 | hard fat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368197 | Tragacanth | Full form of descriptor (FN) | YES | |
| RxCUI: 1368197 | Tragacanth | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368197 | Tragacanth | Designated preferred name (PT) | YES | |
| RxCUI: 1368197 | Tragacanth | Full form of descriptor (FN) | YES | |
| RxCUI: 1368197 | Tragacanth | Designated preferred name (PT) | YES | |
| RxCUI: 1368198 | 1,2-benzisothiazoline-3-one | Designated preferred name (PT) | YES | |
| RxCUI: 1368198 | 1,2-benzisothiazoline-3-one | Full form of descriptor (FN) | YES | |
| RxCUI: 1368198 | 1,2-benzisothiazoline-3-one | Designated preferred name (PT) | YES | |
| RxCUI: 1368198 | 1,2-benzisothiazoline-3-one | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368198 | 1,2-benzisothiazoline-3-one | Full form of descriptor (FN) | YES | |
| RxCUI: 1368199 | cadmium sulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368200 | cholesteryl oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368201 | diclazuril | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368202 | Bornyl alcohol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368202 | Bornyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368202 | Bornyl alcohol | Designated preferred name (PT) | YES | |
| RxCUI: 1368202 | Bornyl alcohol | Full form of descriptor (FN) | YES | |
| RxCUI: 1368202 | Bornyl alcohol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368203 | behenic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368204 | behenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368205 | Beta vulgaris extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368206 | Lentinula edodes mycelium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368207 | menthyl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368208 | monensin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368208 | monensin | Designated preferred name (PT) | NO | |
| RxCUI: 1368208 | monensin | Full form of descriptor (FN) | NO | |
| RxCUI: 1368209 | nickel gluconate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1368210 | olivine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368211 | 3,7,11,15-tetramethyl-1,2,3-hexadecanetriol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368212 | N-acetyl-DL-tryptophan | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368212 | N-acetyl-DL-tryptophan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368213 | 1-butyl oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368214 | nickel sulfate hexahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1368215 | stearamide amp | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368270 | Ketaject | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1368271 | ketamine 100 MG/ML [Ketaject] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1368272 | ketamine Injectable Solution [Ketaject] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1368273 | Ketaject Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1368274 | ketamine 100 MG/ML Injectable Solution [Ketaject] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368274 | ketamine 100 MG/ML Injectable Solution [Ketaject] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368275 | camphor 4 % / menthol 4 % / methyl salicylate 11 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368275 | camphor 4 % / menthol 4 % / methyl salicylate 11 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368275 | camphor 4 % / menthol 4 % / methyl salicylate 11 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368276 | thiostrepton 2500 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1368277 | neomycin / nystatin / thiostrepton / triamcinolone Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1368278 | neomycin / nystatin / thiostrepton / triamcinolone Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1368279 | neomycin / nystatin / thiostrepton / triamcinolone | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1368280 | neomycin 2.5 MG/ML / nystatin 100,000 UNT/ML / thiostrepton 2500 UNT/ML / triamcinolone acetonide 1 MG/ML Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368280 | neomycin 2.5 MG/ML / nystatin 100,000 UNT/ML / thiostrepton 2500 UNT/ML / triamcinolone acetonide 1 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368281 | Animax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1368282 | neomycin 2.5 MG/ML / nystatin 100000 UNT/ML / thiostrepton 2500 UNT/ML / triamcinolone acetonide 1 MG/ML [Animax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1368283 | neomycin / nystatin / thiostrepton / triamcinolone Topical Cream [Animax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1368284 | Animax Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1368285 | Animax (neomycin 2.5 MG/mL / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 MG per 1 mL) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368285 | Animax (neomycin 2.5 MG/mL / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 MG per 1 mL) Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368285 | Animax (neomycin 2.5 MG/mL / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 MG per 1 mL) Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368296 | Santalia Daily Cleanser | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1368297 | salicylic acid 5 MG/ML [Santalia Daily Cleanser] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1368298 | salicylic acid Medicated Liquid Soap [Santalia Daily Cleanser] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1368299 | Santalia Daily Cleanser Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1368300 | Santalia Daily Cleanser 0.5 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368300 | Santalia Daily Cleanser 0.5 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368300 | Santalia Daily Cleanser 0.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368300 | Santalia Daily Cleanser 0.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368301 | {1 (15000 MG) (salicylic acid 0.02 MG/MG Topical Gel) / 1 (30000 MG) (salicylic acid 0.05 MG/MG Topical Gel) / 1 (120000 MG) (salicylic acid 5 MG/ML Medicated Liquid Soap) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1368302 | Santalia Spot Treatment | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1368303 | salicylic acid 0.02 MG/MG [Santalia Spot Treatment] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1368304 | salicylic acid Topical Gel [Santalia Spot Treatment] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1368305 | Santalia Spot Treatment Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1368306 | Santalia Spot Treatment 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368306 | Santalia Spot Treatment 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368306 | Santalia Spot Treatment 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368307 | Santalia Daily Serum | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1368308 | salicylic acid 0.05 MG/MG [Santalia Daily Serum] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1368309 | salicylic acid Topical Gel [Santalia Daily Serum] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1368310 | Santalia Daily Serum Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1368311 | Santalia Daily Acne Serum 5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368311 | Santalia Daily Acne Serum 5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368311 | Santalia Daily Acne Serum 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368311 | Santalia Daily Acne Serum 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368312 | Santalia Clinical Acne Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1368312 | Santalia Clinical Acne Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368312 | Santalia Clinical Acne Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368325 | Teucrium marum top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368326 | Verbascum densiflorum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368327 | Galphimia glauca whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368328 | Ambrosia psilostachya top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368331 | Commiphora madagascariensis resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368332 | Helianthus annuus sprout extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368333 | antihemophilic factor, human 31 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1368334 | antihemophilic factor, human 31 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368335 | antihemophilic factor, human 31 UNT/ML [Monarc-M] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1368336 | antihemophilic factor, human 31 UNT/ML Injectable Solution [Monarc-M] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368336 | antihemophilic factor, human 31 UNT/ML Injectable Solution [Monarc-M] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368336 | antihemophilic factor, human 31 UNT/ML Injectable Solution [Monarc-M] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368337 | Petasites japonicus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368338 | Phoenix dactylifera seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368339 | Phragmites australis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368342 | prickly pear fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368343 | Porphyra umbilicalis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368348 | antihemophilic factor, human recombinant 150 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1368349 | antihemophilic factor, human recombinant 500 UNT per 10 ML (1241 - 1800 IU per vial) Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368349 | antihemophilic factor, human recombinant 500 UNT per 10 ML (1241 - 1800 IU per vial) Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368350 | antihemophilic factor, human recombinant 150 UNT/ML [Recombinate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1368351 | antihemophilic factor, human recombinant 150 UNT/ML Injectable Solution [Recombinate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368351 | antihemophilic factor, human recombinant 150 UNT/ML Injectable Solution [Recombinate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368351 | antihemophilic factor, human recombinant 150 UNT/ML Injectable Solution [Recombinate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368357 | Aspergillus nidulans allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368361 | Solanum lycopersicum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368363 | lauryl pyrrolidone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368364 | human parvovirus B19 virus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368365 | Trichinella britovi | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368371 | Bacillus anthracis strain V770-NP1-R antigens | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368372 | benzotriazolyl dodecyl p-cresol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368373 | methyleugenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368374 | myricetin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368375 | tris(tetramethylhydroxypiperidinol) citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1368376 | tris(tetramethylhydroxypiperidinol) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368377 | Ilex paraguariensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368378 | Terminalia bellirica fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368379 | sulfide ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368381 | alogliptin / metFORMIN Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1368381 | alogliptin / metFORMIN Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368381 | alogliptin / metFORMIN Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1368381 | alogliptin / metFORMIN Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1368382 | alogliptin / metFORMIN Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1368382 | alogliptin / metFORMIN Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368383 | alogliptin / metFORMIN Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1368383 | alogliptin / metFORMIN Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368384 | alogliptin / metFORMIN | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1368384 | alogliptin / metFORMIN | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368384 | alogliptin / metFORMIN | Designated preferred name (PT) | YES | |
| RxCUI: 1368384 | alogliptin / metFORMIN | Full form of descriptor (FN) | YES | |
| RxCUI: 1368385 | alogliptin 12.5 MG / metFORMIN HCl 1000 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1368385 | alogliptin 12.5 MG / metFORMIN HCl 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368385 | alogliptin 12.5 MG / metFORMIN HCl 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368385 | alogliptin 12.5 MG / metFORMIN HCl 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368385 | alogliptin 12.5 MG / metFORMIN HCl 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368385 | alogliptin 12.5 MG / metFORMIN HCl 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368385 | alogliptin 12.5 MG / metFORMIN HCl 1000 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1368387 | alogliptin 12.5 MG / metFORMIN hydrochloride 1000 MG [Kazano] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368387 | alogliptin 12.5 MG / metFORMIN hydrochloride 1000 MG [Kazano] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368391 | Kazano 12.5 MG / 1000 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368391 | Kazano 12.5 MG / 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368391 | Kazano 12.5 MG / 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368391 | Kazano 12.5 MG / 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368391 | Kazano 12.5 MG / 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368391 | Kazano 12.5 MG / 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368392 | alogliptin 12.5 MG / metFORMIN HCl 500 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1368392 | alogliptin 12.5 MG / metFORMIN HCl 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368392 | alogliptin 12.5 MG / metFORMIN HCl 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368392 | alogliptin 12.5 MG / metFORMIN HCl 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368392 | alogliptin 12.5 MG / metFORMIN HCl 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368392 | alogliptin 12.5 MG / metFORMIN HCl 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368392 | alogliptin 12.5 MG / metFORMIN HCl 500 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1368394 | alogliptin 12.5 MG / metFORMIN hydrochloride 500 MG [Kazano] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368394 | alogliptin 12.5 MG / metFORMIN hydrochloride 500 MG [Kazano] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368395 | alogliptin / metFORMIN Oral Tablet [Kazano] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1368395 | alogliptin / metFORMIN Oral Tablet [Kazano] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368396 | Kazano Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1368397 | Kazano Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1368398 | Kazano 12.5 MG / 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368398 | Kazano 12.5 MG / 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368398 | Kazano 12.5 MG / 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368398 | Kazano 12.5 MG / 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368398 | Kazano 12.5 MG / 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1368398 | Kazano 12.5 MG / 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368399 | alogliptin / pioglitazone Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1368399 | alogliptin / pioglitazone Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1368399 | alogliptin / pioglitazone Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1368400 | alogliptin / pioglitazone Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1368401 | alogliptin / pioglitazone Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1368402 | alogliptin / pioglitazone | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1368402 | alogliptin / pioglitazone | Designated preferred name (PT) | YES | |
| RxCUI: 1368402 | alogliptin / pioglitazone | Full form of descriptor (FN) | YES | |
| RxCUI: 1368403 | alogliptin 12.5 MG / pioglitazone 15 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1368403 | alogliptin 12.5 MG / pioglitazone 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368403 | alogliptin 12.5 MG / pioglitazone 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368403 | alogliptin 12.5 MG / pioglitazone 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368403 | alogliptin 12.5 MG / pioglitazone 15 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1368405 | alogliptin 12.5 MG / pioglitazone 15 MG [Oseni] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368409 | Oseni 12.5 MG / 15 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368409 | Oseni 12.5 MG / 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368409 | Oseni 12.5 MG / 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368409 | Oseni 12.5 MG / 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368410 | alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1368410 | alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368410 | alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368410 | alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368410 | alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1368412 | alogliptin 12.5 MG / pioglitazone 30 MG [Oseni] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368416 | Oseni 12.5 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368416 | Oseni 12.5 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368416 | Oseni 12.5 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368416 | Oseni 12.5 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368417 | alogliptin 12.5 MG / pioglitazone 45 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1368417 | alogliptin 12.5 MG / pioglitazone 45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368417 | alogliptin 12.5 MG / pioglitazone 45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368417 | alogliptin 12.5 MG / pioglitazone 45 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368417 | alogliptin 12.5 MG / pioglitazone 45 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1368419 | alogliptin 12.5 MG / pioglitazone 45 MG [Oseni] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368423 | Oseni 12.5 MG / 45 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368423 | Oseni 12.5 MG / 45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368423 | Oseni 12.5 MG / 45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368423 | Oseni 12.5 MG / 45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368424 | alogliptin 25 MG / pioglitazone 15 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1368424 | alogliptin 25 MG / pioglitazone 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368424 | alogliptin 25 MG / pioglitazone 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368424 | alogliptin 25 MG / pioglitazone 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368424 | alogliptin 25 MG / pioglitazone 15 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1368426 | alogliptin 25 MG / pioglitazone 15 MG [Oseni] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368430 | Oseni 25 MG / 15 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368430 | Oseni 25 MG / 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368430 | Oseni 25 MG / 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368430 | Oseni 25 MG / 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368431 | alogliptin 25 MG / pioglitazone 30 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1368431 | alogliptin 25 MG / pioglitazone 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368431 | alogliptin 25 MG / pioglitazone 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368431 | alogliptin 25 MG / pioglitazone 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368431 | alogliptin 25 MG / pioglitazone 30 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1368433 | alogliptin 25 MG / pioglitazone 30 MG [Oseni] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368434 | alogliptin / pioglitazone Oral Tablet [Oseni] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1368435 | Oseni Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1368436 | Oseni Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1368437 | Oseni 25 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368437 | Oseni 25 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368437 | Oseni 25 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368437 | Oseni 25 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368438 | alogliptin 25 MG / pioglitazone 45 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1368438 | alogliptin 25 MG / pioglitazone 45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368438 | alogliptin 25 MG / pioglitazone 45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368438 | alogliptin 25 MG / pioglitazone 45 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368438 | alogliptin 25 MG / pioglitazone 45 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1368440 | alogliptin 25 MG / pioglitazone 45 MG [Oseni] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368444 | Oseni 25 MG / 45 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368444 | Oseni 25 MG / 45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368444 | Oseni 25 MG / 45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368444 | Oseni 25 MG / 45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368451 | glycerol phenylbutyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368451 | glycerol phenylbutyrate | Designated preferred name (PT) | YES | |
| RxCUI: 1368451 | glycerol phenylbutyrate | Full form of descriptor (FN) | YES | |
| RxCUI: 1368452 | glycerol phenylbutyrate 1100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1368453 | glycerol phenylbutyrate 1.1 GM in 1 mL Oral Solution | Designated preferred name (PT) | YES | |
| RxCUI: 1368453 | glycerol phenylbutyrate 1.1 GM in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368453 | glycerol phenylbutyrate 1.1 GM in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368453 | glycerol phenylbutyrate 1.1 GM in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368453 | glycerol phenylbutyrate 1.1 GM in 1 mL Oral Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 1368454 | Ravicti | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1368455 | glycerol phenylbutyrate 1100 MG/ML [Ravicti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368457 | Ravicti Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1368458 | Ravicti Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1368459 | RAVICTI 1.1 GM in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368459 | RAVICTI 1.1 GM in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368459 | RAVICTI 1.1 GM in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368468 | tylvalosin tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1368469 | tylvalosin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368471 | dimethicone-vinyl dimethicone crosspolymer (hard particle) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368476 | Zeranol | Full form of descriptor (FN) | NO | |
| RxCUI: 1368476 | Zeranol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368476 | Zeranol | Designated preferred name (PT) | NO | |
| RxCUI: 1368476 | Zeranol | Full form of descriptor (FN) | NO | |
| RxCUI: 1368476 | Zeranol | Designated preferred name (PT) | NO | |
| RxCUI: 1368477 | zeranol 12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1368478 | zeranol Drug Implant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1368479 | zeranol Drug Implant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1368480 | zeranol 12 MG Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368480 | zeranol 12 MG Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368481 | Ralgro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1368482 | zeranol 12 MG [Ralgro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1368483 | zeranol Drug Implant [Ralgro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1368484 | Ralgro Drug Implant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1368485 | RALGRO 12 MG Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368485 | RALGRO 12 MG Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368485 | RALGRO 12 MG Drug Implant | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368486 | hydroxypropyl bisstearyldimonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368487 | hydroxypropyl bisstearyldimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368530 | Panax ginseng whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368533 | Gly-His-Lys-OH | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368533 | Gly-His-Lys-OH | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368534 | snail preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368617 | guar hydroxypropyltrimonium chloride (1.7 substituents per saccharide) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368618 | guar hydroxypropyltrimonium (1.7 substituents per saccharide) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368619 | sodium capryloamphopropionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1368620 | capryloamphopropionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368621 | human adipose preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368622 | 10-hydroxydecanoic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368622 | 10-hydroxydecanoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368623 | 10-hydroxydecanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368624 | arachidonic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1368625 | arachidonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368626 | acrylic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368628 | 12-hydroxystearic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368629 | 12-hydroxystearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368632 | 2,4-dihydroxybenzoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368632 | 2,4-dihydroxybenzoic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368634 | Sensodyne Pronamel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1368635 | sodium fluoride 0.5 MG/ML [Sensodyne Pronamel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1368636 | sodium fluoride Mouthwash [Sensodyne Pronamel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1368637 | Sensodyne Pronamel Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1368638 | Sensodyne Pronamel Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1368639 | Sensodyne Pronamel Mouthwash Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1368640 | SENSODYNE PRONAMEL 0.05 % (fluoride ion 0.02 % ) Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368640 | SENSODYNE PRONAMEL 0.05 % (fluoride ion 0.02 % ) Oral Rinse | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368640 | SENSODYNE PRONAMEL 0.05 % (fluoride ion 0.02 % ) Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368640 | SENSODYNE PRONAMEL 0.05 % (fluoride ion 0.02 % ) Oral Rinse | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1368641 | gentisic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368642 | gentisate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368643 | carminic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368644 | carminate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368645 | foscolic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1368646 | foscolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368647 | ferulic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368648 | ferulate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368650 | cinnamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368701 | disilver oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368702 | triethylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368703 | isopentane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368704 | microcrystalline wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368705 | potassium stearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368706 | stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368707 | ethylhexyl hydroxystearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368708 | maritime pine extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368862 | Carrageenin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368862 | Carrageenin | Designated preferred name (PT) | YES | |
| RxCUI: 1368862 | Carrageenin | Full form of descriptor (FN) | YES | |
| RxCUI: 1368862 | Carrageenin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368863 | polyethylene glycol 1000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368864 | polyethylene glycol 200 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368866 | polyethylene glycol 3000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368867 | polysorbate 60 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368868 | Sanguisorba officinalis top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368869 | dipropylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368870 | morpholine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368871 | Thymine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368871 | Thymine | Designated preferred name (PT) | NO | |
| RxCUI: 1368871 | Thymine | Full form of descriptor (FN) | NO | |
| RxCUI: 1368872 | glyceryl tristearate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368872 | glyceryl tristearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368873 | tropolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368874 | N,N-dimethylacetamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368874 | N,N-dimethylacetamide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368875 | Geraniol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368875 | Geraniol | Designated preferred name (PT) | YES | |
| RxCUI: 1368875 | Geraniol | Full form of descriptor (FN) | YES | |
| RxCUI: 1368875 | Geraniol | Designated preferred name (PT) | YES | |
| RxCUI: 1368875 | Geraniol | Full form of descriptor (FN) | YES | |
| RxCUI: 1368876 | glaucine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368877 | ilomastat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368878 | isoceteth 20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368879 | isopropylparaben | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368880 | trilaurin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368881 | trimethylolpropane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368882 | trimyristin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368883 | oleylamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368884 | N-hydroxysuccinimide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368885 | imidurea | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368886 | octyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368886 | octyl stearate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368887 | polysorbate 85 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368888 | thiotaurine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368889 | tetrafluoromethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368890 | hypromellose phthalate (24% phthalate, 55 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368891 | hypromellose phthalate (31% phthalate, 170 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368892 | hypromellose phthalate (31% phthalate, 40 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368893 | polyethylene glycol 14000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368894 | polyethylene glycol 35000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368895 | polyisobutylene (1000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368896 | linalool, (+-)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1368898 | shellac | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368899 | Morantel tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1368899 | Morantel tartrate | Designated preferred name (PT) | NO | |
| RxCUI: 1368899 | Morantel tartrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1368900 | Morantel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368900 | Morantel | Designated preferred name (PT) | NO | |
| RxCUI: 1368900 | Morantel | Full form of descriptor (FN) | NO | |
| RxCUI: 1368901 | isostearyl palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368902 | Eleuthero extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368902 | Eleuthero extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368903 | mercuric cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368904 | calamine 8 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368904 | calamine 8 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368904 | calamine 8 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368905 | C12-13 pareth-23 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368907 | C12-13 pareth-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1368908 | cyanocobalamin 1500 MCG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368908 | cyanocobalamin 1500 MCG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368908 | cyanocobalamin 1500 MCG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368912 | melatonin 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1368932 | riboflavin 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368932 | riboflavin 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368933 | theanine 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1368934 | theanine Disintegrating Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1368935 | theanine Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1368936 | theanine 50 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1368936 | theanine 50 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1368950 | edetate calcium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1368953 | mesalamine Delayed Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1368954 | mesalamine 400 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368954 | mesalamine 400 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368955 | Delzicol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1368956 | mesalamine 400 MG [Delzicol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1368957 | mesalamine Delayed Release Oral Capsule [Delzicol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1368958 | Delzicol Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1368959 | Delzicol Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1368960 | DELZICOL 400 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368960 | DELZICOL 400 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1368960 | DELZICOL 400 MG Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1368961 | chlophedianol / chlorpheniramine / phenylephrine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1368962 | chlophedianol / chlorpheniramine / phenylephrine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1368963 | chlophedianol HCl 25 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1368963 | chlophedianol HCl 25 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1368965 | AllePak Dose Pack 10 | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1368965 | AllePak Dose Pack 10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368966 | Vaso Dose Pack 10 | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1368966 | Vaso Dose Pack 10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1368972 | Vaso Dose Pack 30 | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1368972 | Vaso Dose Pack 30 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369 | Bendrofluazide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369 | Bendrofluazide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1369 | Bendrofluazide | Designated preferred name (PT) | YES | |
| RxCUI: 1369 | Bendrofluazide | Full form of descriptor (FN) | YES | |
| RxCUI: 1369 | Bendrofluazide | Designated preferred name (PT) | YES | |
| RxCUI: 1369 | Bendrofluazide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369 | Bendrofluazide | Full form of descriptor (FN) | YES | |
| RxCUI: 13690 | 2-oxoaldehyde dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 13690 | 2-oxoaldehyde dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 13692 | 2-oxoglutarate synthase | Designated preferred name (PT) | NO | |
| RxCUI: 13692 | 2-oxoglutarate synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 1369395 | apple seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1369396 | Tropaeolum majus flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1369397 | chlophedianol hydrochloride 2.5 MG/mL / guaiFENesin 20 MG/mL / pseudoephedrine hydrochloride 6 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369397 | chlophedianol hydrochloride 2.5 MG/mL / guaiFENesin 20 MG/mL / pseudoephedrine hydrochloride 6 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1369397 | chlophedianol hydrochloride 2.5 MG/mL / guaiFENesin 20 MG/mL / pseudoephedrine hydrochloride 6 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1369397 | chlophedianol hydrochloride 2.5 MG/mL / guaiFENesin 20 MG/mL / pseudoephedrine hydrochloride 6 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369397 | chlophedianol hydrochloride 2.5 MG/mL / guaiFENesin 20 MG/mL / pseudoephedrine hydrochloride 6 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1369398 | cholecalciferol / levocarnitine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1369398 | cholecalciferol / levocarnitine Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1369399 | cholecalciferol / levocarnitine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1369399 | cholecalciferol / levocarnitine Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 13694 | 2-oxoisovalerate dehydrogenase (acylating) | Designated preferred name (PT) | NO | |
| RxCUI: 13694 | 2-oxoisovalerate dehydrogenase (acylating) | Full form of descriptor (FN) | NO | |
| RxCUI: 1369400 | cholecalciferol / levocarnitine Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1369400 | cholecalciferol / levocarnitine Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1369401 | cholecalciferol / levocarnitine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1369401 | cholecalciferol / levocarnitine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1369402 | cholecalciferol 500 UNT / levOCARNitine 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1369402 | cholecalciferol 500 UNT / levOCARNitine 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369402 | cholecalciferol 500 UNT / levOCARNitine 500 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1369403 | chlophedianol HCl 12.5 MG / dexbrompheniramine maleate 1 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369403 | chlophedianol HCl 12.5 MG / dexbrompheniramine maleate 1 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369403 | chlophedianol HCl 12.5 MG / dexbrompheniramine maleate 1 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369404 | cobalt acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1369405 | pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1369406 | glucosamine sulfate 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369406 | glucosamine sulfate 500 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1369406 | glucosamine sulfate 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369406 | glucosamine sulfate 500 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1369407 | Synovacin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1369408 | glucosamine sulfate 500 MG [Synovacin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1369409 | glucosamine Oral Capsule [Synovacin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1369410 | Synovacin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1369411 | Synovacin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1369412 | Synovacin 500 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369412 | Synovacin 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369412 | Synovacin 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369420 | chlophedianol HCl 12.5 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369420 | chlophedianol HCl 12.5 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369420 | chlophedianol HCl 12.5 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369424 | chlophedianol HCl 12.5 MG / dexchlorpheniramine maleate 1 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369424 | chlophedianol HCl 12.5 MG / dexchlorpheniramine maleate 1 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369424 | chlophedianol HCl 12.5 MG / dexchlorpheniramine maleate 1 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369432 | ambroxol hydrochloride 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369433 | chlophedianol hydrochloride 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369434 | ambroxol hydrochloride 25 MG / chlophedianol hydrochloride 75 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369437 | ambroxol hydrochloride 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369438 | chlophedianol hydrochloride 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369439 | ambroxol hydrochloride 250 MG / chlophedianol hydrochloride 300 MG per 5 ML Syrup | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369439 | ambroxol hydrochloride 250 MG / chlophedianol hydrochloride 300 MG per 5 ML Syrup | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369442 | bromhexine hydrochloride 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369443 | chlophedianol hydrochloride 1.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369444 | bromhexine hydrochloride 1 MG / chlophedianol hydrochloride 7 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369444 | bromhexine hydrochloride 1 MG / chlophedianol hydrochloride 7 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369447 | bromhexine hydrochloride 0.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369448 | bromhexine hydrochloride 2 MG / chlophedianol hydrochloride 12.5 MG per 5 ML Syrup | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369448 | bromhexine hydrochloride 2 MG / chlophedianol hydrochloride 12.5 MG per 5 ML Syrup | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369451 | chlophedianol hydrochloride 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369452 | chlophedianol hydrochloride 15 MG / guaiacol ethylglycolate 10 MG / oxatomide 10 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369452 | chlophedianol hydrochloride 15 MG / guaiacol ethylglycolate 10 MG / oxatomide 10 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369454 | chlophedianol hydrochloride 25 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369454 | chlophedianol hydrochloride 25 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369470 | Paper mulberry pollen | Designated preferred name (PT) | NO | |
| RxCUI: 1369470 | Paper mulberry pollen | Full form of descriptor (FN) | NO | |
| RxCUI: 1369470 | Paper mulberry pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369478 | Overcup oak pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369478 | Overcup oak pollen | Designated preferred name (PT) | NO | |
| RxCUI: 1369478 | Overcup oak pollen | Full form of descriptor (FN) | NO | |
| RxCUI: 1369486 | Blackjack oak pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369486 | Blackjack oak pollen | Designated preferred name (PT) | NO | |
| RxCUI: 1369486 | Blackjack oak pollen | Full form of descriptor (FN) | NO | |
| RxCUI: 1369494 | Hackberry pollen | Designated preferred name (PT) | NO | |
| RxCUI: 1369494 | Hackberry pollen | Full form of descriptor (FN) | NO | |
| RxCUI: 1369494 | Hackberry pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369495 | Willow oak pollen | Designated preferred name (PT) | NO | |
| RxCUI: 1369495 | Willow oak pollen | Full form of descriptor (FN) | NO | |
| RxCUI: 1369495 | Willow oak pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13695 | Branched-chain alpha-keto acid dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 13695 | Branched-chain alpha-keto acid dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 13695 | Branched-chain alpha-keto acid dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369508 | Ficus pollen | Designated preferred name (PT) | NO | |
| RxCUI: 1369508 | Ficus pollen | Full form of descriptor (FN) | NO | |
| RxCUI: 1369534 | Turkey oak pollen | Designated preferred name (PT) | NO | |
| RxCUI: 1369534 | Turkey oak pollen | Full form of descriptor (FN) | NO | |
| RxCUI: 1369534 | Turkey oak pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369563 | erythritol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1369564 | Physalis alkekengi calyx extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1369565 | Thymus mastichina flowering top oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1369567 | edetate calcium Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1369575 | Fluciclatide (18-F) | Designated preferred name (PT) | NO | |
| RxCUI: 1369575 | Fluciclatide (18-F) | Full form of descriptor (FN) | NO | |
| RxCUI: 1369575 | Fluciclatide (18-F) | Designated preferred name (PT) | NO | |
| RxCUI: 1369575 | Fluciclatide (18-F) | Full form of descriptor (FN) | NO | |
| RxCUI: 1369583 | edetate calcium Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1369584 | edetate calcium Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1369585 | sulfonated phenol 500 MG/ML / sulfuric acid 300 MG/ML [Debacterol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1369586 | sulfonated phenol / sulfuric acid Medicated Pad [Debacterol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1369587 | Debacterol Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1369588 | Debacterol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1369589 | Debacterol 50 % / 30 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369589 | Debacterol 50 % / 30 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369589 | Debacterol 50 % / 30 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369590 | pentetate calcium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1369591 | pentetate calcium Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1369593 | factor VIII Urethral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1369682 | ethylhexyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1369683 | isoceteth-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1369684 | linoleamidopropyl PG-dimonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1369685 | linoleamidopropyl PG-dimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1369686 | Lonicera japonica top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1369687 | Petasites hybridus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1369688 | propylene glycol dioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1369689 | Simmondsia chinensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1369690 | Zanthoxylum bungeanum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 13697 | Ketopantoyl lactone reductase | Designated preferred name (PT) | NO | |
| RxCUI: 13697 | Ketopantoyl lactone reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 13697 | Ketopantoyl lactone reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13697 | Ketopantoyl lactone reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369702 | cocoyl caprylocaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1369702 | cocoyl caprylocaprate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369713 | pomalidomide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1369713 | pomalidomide | Designated preferred name (PT) | YES | |
| RxCUI: 1369713 | pomalidomide | Full form of descriptor (FN) | YES | |
| RxCUI: 1369713 | pomalidomide | Designated preferred name (PT) | YES | |
| RxCUI: 1369713 | pomalidomide | Full form of descriptor (FN) | YES | |
| RxCUI: 1369714 | pomalidomide 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1369715 | pomalidomide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1369715 | pomalidomide Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1369715 | pomalidomide Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1369716 | pomalidomide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1369717 | pomalidomide Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1369718 | pomalidomide 1 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369718 | pomalidomide 1 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1369718 | pomalidomide 1 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369718 | pomalidomide 1 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1369719 | Pomalyst | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1369720 | pomalidomide 1 MG [Pomalyst] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1369721 | pomalidomide Oral Capsule [Pomalyst] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1369722 | Pomalyst Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1369723 | Pomalyst Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1369724 | Pomalyst 1 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369724 | Pomalyst 1 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369724 | Pomalyst 1 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369725 | pomalidomide 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1369726 | pomalidomide 2 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369726 | pomalidomide 2 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1369726 | pomalidomide 2 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369726 | pomalidomide 2 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1369727 | pomalidomide 2 MG [Pomalyst] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1369728 | Pomalyst 2 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369728 | Pomalyst 2 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369728 | Pomalyst 2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369729 | pomalidomide 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1369730 | pomalidomide 3 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369730 | pomalidomide 3 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1369730 | pomalidomide 3 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369730 | pomalidomide 3 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1369731 | pomalidomide 3 MG [Pomalyst] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1369732 | Pomalyst 3 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369732 | Pomalyst 3 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369732 | Pomalyst 3 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369733 | pomalidomide 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1369734 | pomalidomide 4 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369734 | pomalidomide 4 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1369734 | pomalidomide 4 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369734 | pomalidomide 4 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1369735 | pomalidomide 4 MG [Pomalyst] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1369736 | Pomalyst 4 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369736 | Pomalyst 4 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369736 | Pomalyst 4 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369737 | Estarylla 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1369737 | Estarylla 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369737 | Estarylla 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369738 | docosahexaenoic acid 338 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369739 | pyridoxine hydrochloride 28 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369740 | alpha Tocopherol 30 UNT / vit-C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 338 MG / DOSS Sodium 55 MG / Ferrous fumarate 29 MG / folate 1.25 MG / vitamin B6 Hydrochloride 28 MG / tricalcium phosphate 160 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369740 | alpha Tocopherol 30 UNT / vit-C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 338 MG / DOSS Sodium 55 MG / Ferrous fumarate 29 MG / folate 1.25 MG / vitamin B6 Hydrochloride 28 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369740 | alpha Tocopherol 30 UNT / vit-C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 338 MG / DOSS Sodium 55 MG / Ferrous fumarate 29 MG / folate 1.25 MG / vitamin B6 Hydrochloride 28 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369740 | alpha Tocopherol 30 UNT / vit-C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 338 MG / DOSS Sodium 55 MG / Ferrous fumarate 29 MG / folate 1.25 MG / vitamin B6 Hydrochloride 28 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369740 | alpha Tocopherol 30 UNT / vit-C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 338 MG / DOSS Sodium 55 MG / Ferrous fumarate 29 MG / folate 1.25 MG / vitamin B6 Hydrochloride 28 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369741 | Nexa Select Reformulated Feb 2013 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1369742 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 338 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 28 MG / tricalcium phosphate 160 MG [Nexa Select Reformulated Feb 2013] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1369743 | alpha tocopherol / ascorbic acid / cholecalciferol / docosahexaenoate / docusate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate Oral Capsule [Nexa Select Reformulated Feb 2013] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1369744 | Nexa Select Reformulated Feb 2013 Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1369745 | Nexa Select Reformulated Feb 2013 Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1369746 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 338 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 28 MG / tricalcium phosphate 160 MG Oral Capsule [Nexa Select Reformulated Feb 2013] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1369746 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 338 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 28 MG / tricalcium phosphate 160 MG Oral Capsule [Nexa Select Reformulated Feb 2013] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369746 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 338 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 28 MG / tricalcium phosphate 160 MG Oral Capsule [Nexa Select Reformulated Feb 2013] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369746 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 338 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 28 MG / tricalcium phosphate 160 MG Oral Capsule [Nexa Select Reformulated Feb 2013] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369746 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 338 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 28 MG / tricalcium phosphate 160 MG Oral Capsule [Nexa Select Reformulated Feb 2013] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369746 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 338 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 28 MG / tricalcium phosphate 160 MG Oral Capsule [Nexa Select Reformulated Feb 2013] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369748 | Allerclear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1369749 | loratadine 5 MG / pseudoephedrine sulfate 120 MG [Allerclear] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1369750 | loratadine / pseudoephedrine Extended Release Oral Tablet [Allerclear] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1369751 | Allerclear Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1369752 | Allerclear Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1369753 | AllerClear-D 5 MG / 120 MG 12HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369753 | AllerClear-D 5 MG / 120 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369753 | AllerClear-D 5 MG / 120 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369754 | loratadine 5 MG / pseudoephedrine sulfate 120 MG Extended Release Oral Tablet [Allerclear] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369754 | loratadine 5 MG / pseudoephedrine sulfate 120 MG Extended Release Oral Tablet [Allerclear] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1369755 | loratadine 10 MG / pseudoephedrine sulfate 240 MG [Allerclear] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1369756 | AllerClear D 10 MG / 240 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369756 | AllerClear D 10 MG / 240 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369756 | AllerClear D 10 MG / 240 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369757 | loratadine 10 MG / pseudoephedrine sulfate 240 MG Extended Release Oral Tablet [Allerclear] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369757 | loratadine 10 MG / pseudoephedrine sulfate 240 MG Extended Release Oral Tablet [Allerclear] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1369759 | Phenylbute | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1369760 | phenylbutazone 1000 MG [Phenylbute] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1369761 | phenylbutazone Oral Tablet [Phenylbute] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1369762 | Phenylbute Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1369763 | Phenylbute Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1369764 | Phenylbute Boluses 1 GM Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1369764 | Phenylbute Boluses 1 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369764 | Phenylbute Boluses 1 GM Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1369765 | vitamin E 1 UNT/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369766 | vitamin E 1000 UNT per GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369766 | vitamin E 1000 UNT per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369770 | Tri-Estarylla 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1369770 | Tri-Estarylla 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369770 | Tri-Estarylla 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369775 | ibuprofen 200 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369775 | ibuprofen 200 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369778 | Effaclar Duo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1369779 | benzoyl peroxide 55 MG/ML [Effaclar Duo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1369780 | benzoyl peroxide Topical Lotion [Effaclar Duo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1369781 | Effaclar Duo Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1369782 | benzoyl peroxide 55 MG/ML Topical Lotion [Effaclar Duo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1369782 | benzoyl peroxide 55 MG/ML Topical Lotion [Effaclar Duo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369782 | benzoyl peroxide 55 MG/ML Topical Lotion [Effaclar Duo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369783 | baclofen 10,000 MCG in 20 ML (500 MCG/ML) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369783 | baclofen 10,000 MCG in 20 ML (500 MCG/ML) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369783 | baclofen 10,000 MCG in 20 ML (500 MCG/ML) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369784 | Gablofen 10,000 MCG in 20 ML (500 MCG/ML) Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369784 | Gablofen 10,000 MCG in 20 ML (500 MCG/ML) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369784 | Gablofen 10,000 MCG in 20 ML (500 MCG/ML) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369784 | Gablofen 10,000 MCG in 20 ML (500 MCG/ML) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369785 | baclofen 0.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369786 | baclofen 0.5 MG/ML Prefilled Syringe [Gablofen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1369786 | baclofen 0.5 MG/ML Prefilled Syringe [Gablofen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369787 | baclofen 20,000 MCG in 20 ML (1,000 MCG/ML) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369787 | baclofen 20,000 MCG in 20 ML (1,000 MCG/ML) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369787 | baclofen 20,000 MCG in 20 ML (1,000 MCG/ML) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369788 | Gablofen 20,000 MCG in 20 ML (1,000 MCG/ML) Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369788 | Gablofen 20,000 MCG in 20 ML (1,000 MCG/ML) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369788 | Gablofen 20,000 MCG in 20 ML (1,000 MCG/ML) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369788 | Gablofen 20,000 MCG in 20 ML (1,000 MCG/ML) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369789 | baclofen 1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369790 | baclofen 1 MG/ML Prefilled Syringe [Gablofen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1369790 | baclofen 1 MG/ML Prefilled Syringe [Gablofen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369791 | baclofen 40,000 MCG in 20 ML (2,000 MCG/ML) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369791 | baclofen 40,000 MCG in 20 ML (2,000 MCG/ML) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369791 | baclofen 40,000 MCG in 20 ML (2,000 MCG/ML) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369791 | baclofen 40,000 MCG in 20 ML (2,000 MCG/ML) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369792 | Gablofen 40,000 MCG in 20 ML (2,000 MCG/ML) Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369792 | Gablofen 40,000 MCG in 20 ML (2,000 MCG/ML) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369792 | Gablofen 40,000 MCG in 20 ML (2,000 MCG/ML) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369792 | Gablofen 40,000 MCG in 20 ML (2,000 MCG/ML) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369792 | Gablofen 40,000 MCG in 20 ML (2,000 MCG/ML) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369793 | baclofen 2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369794 | baclofen 2 MG/ML Prefilled Syringe [Gablofen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1369794 | baclofen 2 MG/ML Prefilled Syringe [Gablofen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13698 | 2-keto-4-pentenoate hydratase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13698 | 2-keto-4-pentenoate hydratase | Designated preferred name (PT) | NO | |
| RxCUI: 13698 | 2-keto-4-pentenoate hydratase | Full form of descriptor (FN) | NO | |
| RxCUI: 1369801 | APAP 80 MG / dextromethorphan hydrobromide 2.5 MG / phenylephrine hydrochloride 1.25 MG per 0.8 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369801 | APAP 80 MG / dextromethorphan hydrobromide 2.5 MG / phenylephrine hydrochloride 1.25 MG per 0.8 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369801 | APAP 80 MG / dextromethorphan hydrobromide 2.5 MG / phenylephrine hydrochloride 1.25 MG per 0.8 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369805 | sodium hyaluronate 1 % in 3 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369805 | sodium hyaluronate 1 % in 3 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369805 | sodium hyaluronate 1 % in 3 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369806 | Gel-One | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1369807 | sodium hyaluronate 10 MG/ML [Gel-One] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1369808 | hyaluronate Prefilled Syringe [Gel-One] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1369809 | Gel-One Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1369810 | Gel-One 1 % in 3 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369810 | Gel-One 1 % in 3 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369810 | Gel-One 1 % in 3 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369810 | Gel-One 1 % in 3 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369811 | sodium hyaluronate 10 MG/ML Prefilled Syringe [Gel-One] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369811 | sodium hyaluronate 10 MG/ML Prefilled Syringe [Gel-One] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1369812 | APAP 80 MG / phenylephrine hydrochloride 1.25 MG per 0.8 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369812 | APAP 80 MG / phenylephrine hydrochloride 1.25 MG per 0.8 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369812 | APAP 80 MG / phenylephrine hydrochloride 1.25 MG per 0.8 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369815 | APAP 80 MG / pseudoephedrine hydrochloride 7.5 MG per 0.8 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369815 | APAP 80 MG / pseudoephedrine hydrochloride 7.5 MG per 0.8 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369815 | APAP 80 MG / pseudoephedrine hydrochloride 7.5 MG per 0.8 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369818 | APAP 80 MG/ML / Pseudoephedrine Hydrochloride 7.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369818 | APAP 80 MG/ML / Pseudoephedrine Hydrochloride 7.5 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369822 | cloZAPine 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1369822 | cloZAPine 50 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1369823 | cloZAPine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1369823 | cloZAPine Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1369824 | cloZAPine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1369824 | cloZAPine Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1369825 | cloZAPine 50 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369825 | cloZAPine 50 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369825 | cloZAPine 50 MG in 1 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1369825 | cloZAPine 50 MG in 1 mL Oral Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 1369825 | cloZAPine 50 MG in 1 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369825 | cloZAPine 50 MG in 1 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1369825 | cloZAPine 50 MG in 1 mL Oral Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 1369826 | Versacloz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1369827 | cloZAPine 50 MG/ML [Versacloz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1369827 | cloZAPine 50 MG/ML [Versacloz] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1369828 | cloZAPine Oral Suspension [Versacloz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1369828 | cloZAPine Oral Suspension [Versacloz] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1369829 | Versacloz Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1369830 | Versacloz Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1369831 | Versacloz 50 MG in 1 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1369831 | Versacloz 50 MG in 1 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1369831 | Versacloz 50 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369831 | Versacloz 50 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369831 | Versacloz 50 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369832 | chlorpheniramine maleate 0.0178 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369833 | pseudoephedrine hydrochloride 0.267 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369838 | dextromethorphan hydrobromide 0.133 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369839 | APAP 2.89 MG/ML / Chlorpheniramine Maleate 0.0178 MG/ML / Dextromethorphan Hydrobromide 0.133 MG/ML / Pseudoephedrine Hydrochloride 0.267 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369839 | APAP 2.89 MG/ML / Chlorpheniramine Maleate 0.0178 MG/ML / Dextromethorphan Hydrobromide 0.133 MG/ML / Pseudoephedrine Hydrochloride 0.267 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369842 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369842 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1369842 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369842 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369842 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1369842 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369842 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1369842 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369842 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1369845 | APAP 650 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 180 ML Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369845 | APAP 650 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 180 ML Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369845 | APAP 650 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 180 ML Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369848 | APAP 160 MG / chlorpheniramine maleate 1 MG / dextromethorphan hydrobromide 5 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369848 | APAP 160 MG / chlorpheniramine maleate 1 MG / dextromethorphan hydrobromide 5 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369848 | APAP 160 MG / chlorpheniramine maleate 1 MG / dextromethorphan hydrobromide 5 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369851 | ranitidine 0.5 MG/ML [Zantac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1369852 | ranitidine 0.5 MG/ML Injectable Solution [Zantac] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1369852 | ranitidine 0.5 MG/ML Injectable Solution [Zantac] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369893 | dodecylbenzenesulfonic acid 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369894 | dodecylbenzenesulfonic acid Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1369895 | dodecylbenzenesulfonic acid Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1369896 | dodecylbenzenesulfonic acid 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1369896 | dodecylbenzenesulfonic acid 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369896 | dodecylbenzenesulfonic acid 2 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369897 | Quassia amara whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1369898 | lauryl-myristyl benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1369899 | ethanol 0.905 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1369900 | ethanol 90.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369900 | ethanol 90.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369900 | ethanol 90.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369903 | APAP 160 MG / chlorpheniramine maleate 1 MG / dextromethorphan hydrobromide 7.5 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369903 | APAP 160 MG / chlorpheniramine maleate 1 MG / dextromethorphan hydrobromide 7.5 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369903 | APAP 160 MG / chlorpheniramine maleate 1 MG / dextromethorphan hydrobromide 7.5 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369910 | APAP 160 MG / chlorpheniramine maleate 1 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369910 | APAP 160 MG / chlorpheniramine maleate 1 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369910 | APAP 160 MG / chlorpheniramine maleate 1 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369913 | APAP 160 MG / chlorpheniramine maleate 2 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369913 | APAP 160 MG / chlorpheniramine maleate 2 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369913 | APAP 160 MG / chlorpheniramine maleate 2 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369920 | APAP 160 MG / dextromethorphan hydrobromide 5 MG / phenylephrine hydrochloride 2.5 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369920 | APAP 160 MG / dextromethorphan hydrobromide 5 MG / phenylephrine hydrochloride 2.5 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369920 | APAP 160 MG / dextromethorphan hydrobromide 5 MG / phenylephrine hydrochloride 2.5 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369927 | APAP 1000 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 30 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369927 | APAP 1000 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 30 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369927 | APAP 1000 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 30 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369959 | pectin 4.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369960 | kaolin 196 MG/ML / pectin 4.5 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369961 | pectin 9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1369962 | kaolin 196 MG/ML / pectin 9 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369963 | APAP 650 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 15 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369963 | APAP 650 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 15 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369963 | APAP 650 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 15 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369966 | APAP 250 MG / dextromethorphan hydrobromide 5 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1369966 | APAP 250 MG / dextromethorphan hydrobromide 5 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369966 | APAP 250 MG / dextromethorphan hydrobromide 5 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1369969 | chlophedianol hydrochloride 6.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1369970 | dexchlorpheniramine maleate 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1369971 | chlophedianol HCl 6.25 MG / dexchlorpheniramine maleate 0.5 MG / pseudoephedrine HCl 15 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369971 | chlophedianol HCl 6.25 MG / dexchlorpheniramine maleate 0.5 MG / pseudoephedrine HCl 15 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369971 | chlophedianol HCl 6.25 MG / dexchlorpheniramine maleate 0.5 MG / pseudoephedrine HCl 15 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1369972 | chlophedianol HCl 25 MG / dexchlorpheniramine maleate 2 MG / pseudoephedrine HCl 60 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1369972 | chlophedianol HCl 25 MG / dexchlorpheniramine maleate 2 MG / pseudoephedrine HCl 60 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1369972 | chlophedianol HCl 25 MG / dexchlorpheniramine maleate 2 MG / pseudoephedrine HCl 60 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |